≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

Other symptoms and signs involving general sensations and perceptions

MESH Endpoint Browser

R18_OTHER_SYMPTOMS_SIGNS_INVOLVI_GENERAL_SENSA_PERCEP

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — R44
  • Cause of death: ICD-10 — R44

2 out of 7 registries used, show all original rules.

1802

4. Check minimum number of events

None

1802

5. Include endpoints

None

1802

6. Filter based on genotype QC (FinnGen only)

1713

Control definitions (FinnGen only)

Control exclude
R18_SYMPTOMS_SIGNS_INVOLVI_COGNITION_PERCEP_EMOTIONAL_STATE_BEHVI

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
R4[0-6]
Name in latin
Alia symptomata et signa ad sensualitatem generalem et perceptiones pertinentia

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 1713 1025 688
Unadjusted period prevalence (%) 0.34 0.36 0.32
Median age at first event (years) 65.71 67.44 63.13

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1802
Matched controls
18020
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
11.9
320.6
357
366
R44.0
ICD-10 Finland
Auditory hallucinations
426.2
307.7
495
16
N05AX08
ATC
risperidone; systemic
19.2
307.7
860
816
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
13.7
307.7
531
534
R44.3
ICD-10 Finland
Hallucinations, unspecified
573.0
307.7
608
16
R41.0
ICD-10 Finland
Disorientation, unspecified
68.4
307.7
190
31
N05AX12
ATC
aripiprazole; systemic
19.6
307.7
388
249
N05AH04
ATC
quetiapine; oral
10.9
307.7
981
1784
R44.1
ICD-10 Finland
Visual hallucinations
682.8
307.7
595
13
N05AH03
ATC
olanzapine; systemic
21.8
307.7
656
462
F29
ICD-10 Finland
Unspecified nonorganic psychosis
27.4
307.7
516
260
R42
ICD-10 Finland
Dizziness and giddiness
6.6
272.9
558
1154
F22.0
ICD-10 Finland
Delusional disorder
31.7
270.2
178
62
AA1AD
NOMESCO Finland
CT of head and brain
4.8
237.6
905
3133
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
6.6
229.3
434
822
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
10.9
225.7
259
273
T36
ICD-10 Finland
Poisoning by systemic antibiotics
10.6
216.6
253
273
N05AH02
ATC
clozapine; systemic
19.5
203.4
162
91
N05BA04
ATC
oxazepam; oral
4.3
199.7
834
3015
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
7.8
193.5
294
438
P29
ICPC
Psychological sympt/compl other
6.4
193.3
370
702
N03AG01
ATC
valproic acid; systemic, rectal
7.9
190.2
286
421
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
10.8
187.8
214
222
N05AA02
ATC
levomepromazine; systemic
10.4
185.2
217
234
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
13.7
184.6
178
143
F32.9
ICD-10 Finland
Depressive episode, unspecified
5.1
182.0
476
1192
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
10.9
181.4
205
210
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
11.3
175.5
193
190
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
10.0
173.8
209
233
R44.8
ICD-10 Finland
Other and unspecified symptoms and signs involving general sensations and perceptions
610.6
171.3
167
*
IGY02
NOMESCO Finland
Psychiatric monitoring contact
9.3
169.3
216
260
F05.9
ICD-10 Finland
Delirium, unspecified
13.7
167.8
161
128
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
11.8
166.8
177
165
N05AB03
ATC
perphenazine; systemic, rectal
9.9
161.0
195
219
N05AD01
ATC
haloperidol; systemic
9.9
160.7
194
217
P99
ICPC
Psychological disorders other
10.2
154.9
182
196
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
15.3
149.8
134
94
ZY000
NOMESCO Finland
Hospital inpatient
16.8
142.3
121
77
R44.2
ICD-10 Finland
Other hallucinations
498.9
141.4
139
*
IGV01
NOMESCO Finland
Psychiatric network contact
18.4
140.5
114
66
N03AX09
ATC
lamotrigine; oral
7.6
139.8
212
312
P72
ICPC
Schizophrenia
13.1
134.8
132
108
IGY99
NOMESCO Finland
Other psychiatric treatment contact
10.7
134.0
151
153
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.2
133.6
308
682
P98
ICPC
Psychosis NOS/other
36.2
132.2
83
24
N05BA06
ATC
lorazepam; systemic, sublingual
6.4
132.2
238
419
N05AF03
ATC
chlorprothixene; systemic
11.5
130.3
139
130
N06AX11
ATC
mirtazapine; oral
3.2
129.7
873
4050
F10.20
ICD-10 Finland
Alcohol dependence currently independent
14.4
128.1
118
87
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
28.2
126.7
86
32
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
12.6
123.9
124
105
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
19.8
123.0
96
51
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
17.5
121.8
101
61
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
20.2
121.4
94
49
F20.9
ICD-10 Finland
Schizophrenia, unspecified
11.8
119.7
125
113
F06.0
ICD-10 Finland
Organic hallucinosis
54.3
119.3
68
13
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
23.1
117.7
86
39
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
14.7
117.6
107
77
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
11.6
116.5
123
113
N07BB01
ATC
disulfiram; oral
7.7
116.3
171
242
N05BA01
ATC
diazepam; systemic, rectal
4.0
115.7
398
1197
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
17.7
110.6
91
54
ZY010
NOMESCO Finland
Hospital outpatient
5.7
110.0
222
434
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
9.6
106.0
128
142
P15
ICPC
Chronic alcohol abuse
8.5
105.1
140
176
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
9.5
104.0
127
143
R53
ICD-10 Finland
Malaise and fatigue
3.0
102.8
674
2997
R56.8
ICD-10 Finland
Other and unspecified convulsions
6.1
101.7
189
341
F10.24
ICD-10 Finland
Alcohol depence active use
13.7
100.4
95
73
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
46.1
98.2
58
13
F28
ICD-10 Finland
Other nonorganic psychotic disorders
38.8
97.4
60
16
N06AB04
ATC
citalopram; systemic
3.2
97.0
511
1998
N04AA02
ATC
biperiden; systemic
11.3
96.4
103
96
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
11.4
96.2
102
94
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
11.2
95.8
103
97
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
3.9
95.5
332
997
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.1
94.8
534
2167
N06AB06
ATC
sertraline; oral
3.7
94.7
348
1085
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
5.1
94.5
218
478
P19
ICPC
Drug abuse
16.0
93.6
81
53
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
6.5
93.5
161
269
Z2446
NOMESCO Finland
Social worker
4.6
93.3
245
597
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
19.5
93.0
73
39
N06AX16
ATC
venlafaxine; oral
3.5
92.0
379
1272
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
19.0
92.0
73
40
N05AN01
ATC
lithium; oral
9.2
91.8
114
131
Z2445
NOMESCO Finland
Psychologist
6.2
91.7
165
288
IEV99
NOMESCO Finland
Other psychiatric network intervention
18.5
90.9
73
41
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
5.3
90.8
197
409
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
8.3
90.6
123
158
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
29.5
89.9
60
21
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
5.0
89.8
209
461
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
18.9
89.3
71
39
F10.25
ICD-10 Finland
Alcohol dependence continuous use
11.5
89.1
94
86
A28
ICPC
Limited function/disability NOS
3.0
88.7
527
2193
F39
ICD-10 Finland
Unspecified mood [affective] disorder
10.0
87.3
102
108
P20
ICPC
Memory disturbance
3.2
86.0
421
1566
F60.9
ICD-10 Finland
Personality disorder, unspecified
13.1
85.9
83
66
N05CF01
ATC
zopiclone; oral
2.7
85.3
750
3811
ICB06, ,
NOMESCO Finland
16.9
83.4
70
43
F22.9
ICD-10 Finland
Persistent delusional disorder, unspecified
28.9
83.3
56
20
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
16.1
81.5
70
45
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
12.2
81.2
82
70
ZXY49
NOMESCO Finland
Other health care provider
23.9
80.7
58
25
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
15.8
80.6
70
46
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
8.0
80.0
111
146
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
5.1
79.3
177
376
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
8.1
79.2
109
142
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
5.8
79.2
151
278
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.5
78.9
778
4140
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
10.1
78.3
90
93
P16
ICPC
Acute alcohol abuse
10.6
78.1
87
86
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
9.1
75.9
95
110
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
9.9
75.3
88
93
F10.09
ICD-10 Finland
Alcohol intoxication UNS
8.4
75.2
100
125
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
27.6
74.7
51
19
N03AE01
ATC
clonazepam; systemic
4.9
74.6
173
379
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
15.6
74.5
65
43
F61.0
ICD-10 Finland
Mixed personality disorders
11.4
74.0
78
71
R41.3
ICD-10 Finland
Other amnesia
11.0
73.8
80
76
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
10.8
73.1
80
77
IGY02, ,
SPAT
10.4
73.0
82
82
IEY01
NOMESCO Finland
Psychoeducation, individual
14.5
72.7
66
47
F99
ICD-10 Finland
Mental disorder, not otherwise specified
8.5
72.3
95
117
C07AA05
ATC
propranolol; systemic
2.8
72.2
472
2039
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.5
71.8
189
459
F05.8
ICD-10 Finland
Other delirium
20.2
71.4
55
28
P27
ICPC
Fear of mental disorder
10.0
71.4
83
87
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.4
71.4
192
474
F03
ICD-10 Finland
Unspecified dementia
4.8
71.3
170
381
N05AX13
ATC
paliperidone; systemic
19.2
71.1
56
30
ZYY79
NOMESCO Finland
Other indirect service without contact with patient
37.6
70.8
44
12
ZXY60
NOMESCO Finland
2-person team, nurses
21.0
69.9
53
26
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
4.9
69.3
163
361
N06DA03
ATC
rivastigmine; oral, transdermal
4.6
69.1
177
420
Z72.8
ICD-10 Finland
Other problems related to lifestyle
20.2
68.8
53
27
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
3.6
68.8
249
760
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
36.7
68.7
43
12
L28
ICPC
Limited function/disability (L)
2.6
68.4
506
2319
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
15.0
68.4
61
42
N05AX15
ATC
cariprazine; oral
33.9
67.2
43
13
N06AB10
ATC
escitalopram; oral
2.7
67.2
474
2120
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
4.6
66.3
168
395
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
10.8
66.0
72
69
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
21.9
65.8
49
23
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
31.4
65.7
43
14
S06.0
ICD-10 Finland
Concussion
3.1
65.1
307
1103
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.8
64.2
213
612
SPAT1216
SPAT
Assessment of functional ability
2.7
63.9
427
1853
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.7
62.1
419
1825
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
25.9
61.6
43
17
F23.99
ICD-10 Finland
Acute and transient psychosis, unspecified UNS
26.9
60.9
42
16
B18.2
ICD-10 Finland
Chronic viral hepatitis C
10.7
60.8
67
65
IER01
NOMESCO Finland
Psychoeducation, group
13.3
59.9
57
44
IGP01
NOMESCO Finland
Psychiatric family contact
10.2
59.8
68
69
ZYC01
NOMESCO Finland
Remote contact by phone
4.0
59.8
186
510
SPAT1240
SPAT
Therapeutic discussion
3.1
59.6
279
995
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
4.8
59.6
140
309
Z72.2
ICD-10 Finland
Drug use
16.6
59.1
50
31
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
26.2
59.0
41
16
N05BE01
ATC
buspirone; oral
6.2
58.4
102
172
N05AF05
ATC
zuclopenthixol; systemic
13.1
58.2
56
44
N05AA01
ATC
chlorpromazine; systemic, rectal
11.7
58.0
60
53
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
18.9
57.9
46
25
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.6
57.8
208
630
N06AX26
ATC
vortioxetine; oral
3.6
57.5
211
647
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.4
56.7
224
720
SPAT1254
SPAT
Administration of medicine
2.6
56.5
426
1949
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
12.3
55.9
56
47
SPAT1234
SPAT
Support of social functional capacity
3.8
54.7
182
522
P01
ICPC
Feeling anxious/nervous/tense
2.7
54.6
336
1389
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.0
54.1
166
450
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
18.3
53.5
43
24
R51.80
ICD-10 Finland
Headache
2.6
53.3
361
1564
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
7.5
53.2
77
106
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
20.0
53.0
41
21
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
22.1
52.6
39
18
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
17.6
52.4
43
25
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
5.3
51.6
107
212
A04
ICPC
Weakness/tiredness general
2.5
51.5
418
1971
A06AD11
ATC
lactulose; oral
2.5
51.1
377
1700
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
18.2
50.8
41
23
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.5
50.5
369
1655
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
17.5
49.8
41
24
SPAT1265
SPAT
Breathalyser
11.4
49.5
52
47
N06AB03
ATC
fluoxetine; oral
2.8
49.4
289
1159
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
4.6
49.4
121
276
P18
ICPC
Medication abuse
11.9
49.1
50
43
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
11.9
49.1
50
43
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
16.8
48.8
41
25
I95.1
ICD-10 Finland
Orthostatic hypotension
4.7
48.1
116
261
G20
ICD-10 Finland
Parkinson disease
4.8
48.1
111
241
XA800
NOMESCO Finland
Neuropsychological investigation
5.2
48.1
102
206
C07AB07
ATC
bisoprolol; oral
2.1
48.1
965
6479
IAB08
NOMESCO Finland
Consultation concerning a patient who has attempted suicide
19.9
47.7
37
19
IEY02
NOMESCO Finland
Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)
18.5
47.4
38
21
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
47.3
942
6295
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
10.5
46.8
52
51
N06AX21
ATC
duloxetine; oral
2.8
46.8
266
1050
IFA99, ,
SPAT
18.9
46.6
37
20
N05CD07
ATC
temazepam; oral
2.7
46.5
287
1182
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.0
46.4
233
860
ZYY01
NOMESCO Finland
Contact between professionals
16.6
46.2
39
24
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.9
46.2
248
949
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
8.0
46.1
63
81
F05.1
ICD-10 Finland
Delirium superimposed on dementia
13.2
46.1
44
34
AA400
NOMESCO Finland
Electroconvulsive therapy
15.0
46.0
41
28
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.9
46.0
142
386
N03AX16
ATC
[U] pregabalin
2.3
45.5
458
2356
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.4
45.5
391
1880
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
10.3
44.4
50
50
Z3231
NOMESCO Finland
Registered nurse
2.1
44.3
569
3220
P76
ICPC
Depressive disorder
3.3
43.8
175
564
X78
ICD-10 Finland
Intentional self-harm by sharp object
12.6
43.6
43
35
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
14.1
43.4
40
29
S01.0
ICD-10 Finland
Open wound of scalp
3.0
43.1
209
755
SPAT1243
SPAT
Psychiatric/psychological examination
5.2
42.8
91
184
N30.0
ICD-10 Finland
Acute cystitis
2.3
41.9
406
2048
K59.09
ICD-10 Finland
Constipation, unspecified
3.2
41.9
183
622
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
6.8
41.8
66
100
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
10.5
41.4
46
45
N87
ICPC
Parkinsonism
6.9
41.3
64
95
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
6.8
41.0
65
99
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.8
40.9
236
936
N17
ICPC
Vertigo/dizziness
2.5
40.2
288
1270
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
39.9
369
1822
R07.4
ICD-10 Finland
Chest pain, unspecified
2.0
39.7
554
3211
IHZ07, ,
SPAT
12.9
39.3
38
30
F12.1
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, harmful use
15.7
39.2
34
22
N06AX12
ATC
bupropion; oral
3.2
38.9
166
556
Z71.8
ICD-10 Finland
Other specified counselling
2.0
38.9
662
4108
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.5
38.8
266
1147
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
38.8
699
4421
F31.8
ICD-10 Finland
Other bipolar affective disorders
6.2
38.1
66
110
P74
ICPC
Anxiety disorder/anxiety state
3.5
37.8
140
429
P03
ICPC
Feeling depressed
2.6
37.8
245
1028
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.0
37.5
529
3066
IAB01, ,
SPAT
15.3
37.4
33
22
A01
ICPC
Pain general/multiple sites
2.6
37.4
244
1027
R25.1
ICD-10 Finland
Tremor, unspecified
4.4
37.2
96
228
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
8.5
36.9
48
58
F10.52
ICD-10 Finland
Psychotic alcohol hallucination
132.8
36.8
39
*
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
12.6
36.7
36
29
SPAT1301
SPAT
No procedures
1.9
36.3
650
4081
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.6
36.1
124
362
A29
ICPC
General symptom/complaint other
2.3
36.0
318
1535
W19
ICD-10 Finland
Unspecified fall
2.6
35.9
240
1021
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
4.4
35.9
91
213
R11
ICD-10 Finland
Nausea and vomiting
2.6
35.8
221
904
IHZ04, ,
SPAT
6.3
35.8
61
100
F43.1
ICD-10 Finland
Post-traumatic stress disorder
4.8
35.7
83
181
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
35.3
551
3298
SPAT1307
SPAT
Psychosocial counselling and guidance
3.0
35.2
168
600
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
14.1
34.8
32
23
SPAT1053
SPAT
Memory test
2.2
34.3
323
1598
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
10.5
34.3
38
37
N04BC04
ATC
ropinirole; oral
9.1
34.3
42
47
R55
ICD-10 Finland
Syncope and collapse
2.5
34.1
246
1083
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.4
34.1
131
411
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
8.6
33.6
43
51
Z29
ICPC
Social problem NOS
4.5
33.5
84
195
F10.03
ICD-10 Finland
Alcohol-related acute intoxication with delirium
56.9
33.3
39
7
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
33.3
323
1616
N05BA02
ATC
chlordiazepoxide; systemic
5.2
33.1
69
137
C03CA01
ATC
furosemide; systemic
1.9
33.1
658
4247
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.9
32.9
168
622
N06AX05
ATC
trazodone; oral
5.0
32.7
72
150
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.1
32.6
372
1981
Z3229
NOMESCO Finland
Other healthcare associate professional
2.7
32.4
195
786
N06AB05
ATC
paroxetine; oral
3.3
32.4
126
398
EBA00
NOMESCO Finland
Extraction of tooth
1.8
32.3
712
4734
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.6
31.9
202
835
TAB00
NOMESCO Finland
Lumbar puncture
3.9
31.6
96
257
F41.8
ICD-10 Finland
Other specified anxiety disorders
4.0
31.2
91
237
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
3.5
31.1
109
322
F51.0
ICD-10 Finland
Nonorganic insomnia
2.1
31.1
328
1693
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
11.6
31.0
32
28
H53.1
ICD-10 Finland
Subjective visual disturbances
2.9
30.6
153
560
Z02.7
ICD-10 Finland
Issue of medical certificate
2.7
30.4
182
731
T74.1
ICD-10 Finland
Physical abuse
5.4
30.4
61
117
Z04.4
ICD-10 Finland
Examination and observation following alleged rape and seduction
11.2
30.3
32
29
SPAT1260
SPAT
Consultation of another employee
2.1
30.0
357
1927
F06.7
ICD-10 Finland
Mild cognitive disorder
4.1
29.9
83
208
F23.8
ICD-10 Finland
Other acute and transient psychotic disorders
29.2
29.9
40
14
SPAT1229
SPAT
Assessment of need for aid
2.6
29.8
185
757
A27
ICPC
Fear of other disease NOS
3.1
29.8
129
435
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.9
29.7
150
551
X59
ICD-10 Finland
Exposure to unspecified factor
2.0
29.5
381
2117
SPAT1227
SPAT
Substance abuse rehabilitation
11.2
29.4
31
28
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.7
28.9
168
665
SPAT1263
SPAT
Sampling
1.8
28.7
793
5582
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
28.3
279
1398
N03AX12
ATC
[U] gabapentin; oral
2.1
28.3
299
1540
Z00.0
ICD-10 Finland
General medical examination
2.0
28.2
398
2276
N05AL01
ATC
sulpiride; systemic
6.7
28.2
45
69
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.6
28.1
168
674
N02BE01
ATC
paracetamol; systemic, rectal
2.3
28.1
1595
13896
188
Kela drug reimbursment
Psychosis requiring demanding treatment
10.5
28.1
31
30
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
10.5
28.1
31
30
R52.9
ICD-10 Finland
Pain, unspecified
2.4
27.8
211
947
Z03
ICPC
Housing/neighbourhood problem
7.6
27.6
39
52
J45.9
ICD-10 Finland
Asthma, unspecified
2.0
27.6
378
2138
N05AE04
ATC
ziprasidone; systemic
11.3
27.6
29
26
F41.09
ICD-10 Finland
UNS Panic Syndrome
4.1
27.6
77
194
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.4
27.6
215
977
OAB43, ,
SPAT
0.4
27.3
137
3205
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
4.5
27.3
67
153
N05BA12
ATC
alprazolam; oral
2.4
27.2
195
853
N04BD01
ATC
selegiline; oral
5.7
27.2
51
92
M54.5
ICD-10 Finland
Low back pain
1.8
27.1
650
4375
G30.8
ICD-10 Finland
Other Alzheimer disease
3.9
27.1
80
210
SAA01
NOMESCO Finland
Simple examination of mouth
1.8
27.0
1244
10026
M79.6
ICD-10 Finland
Pain in limb
1.7
27.0
775
5485
IAB12
NOMESCO Finland
Psychiatric psychosis consultation
63.0
27.0
31
5
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
4.7
27.0
63
138
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
9.1
26.9
33
37
F32
ICD-10 Finland
Depressive episode
3.0
26.8
122
423
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
26.6
314
1684
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
4.2
26.3
70
170
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.8
26.3
82
224
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
26.2
26.2
36
14
P73
ICPC
Affective psychosis
26.2
26.2
36
14
N06AA09
ATC
amitriptyline; systemic
2.4
26.2
187
816
F33.8
ICD-10 Finland
Other recurrent depressive disorders
8.4
26.2
34
41
N03AX11
ATC
topiramate; oral
4.7
26.0
60
130
F93.89
ICD-10 Finland
Other childhood emotional disorders
6.7
26.0
41
62
A02BC02
ATC
pantoprazole; systemic
1.7
25.9
1184
9462
F31
ICD-10 Finland
Bipolar affective disorder
6.8
25.5
40
60
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
7.2
25.5
38
54
N04BD02
ATC
rasagiline; oral
8.8
25.4
32
37
SPAT1310
SPAT
Counselling related to known health issue
1.7
25.3
594
3958
N05AX16
ATC
brexpiprazole; oral
22.9
25.2
36
16
F34.1
ICD-10 Finland
Dysthymia
3.6
25.2
85
245
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.6
25.0
158
651
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.7
24.9
784
5652
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
24.8
237
1170
ZXY83
NOMESCO Finland
Social worker in multidisciplinary team
23.8
24.8
35
15
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
21.6
24.8
36
17
L17
ICPC
Foot/toe symptom/complaint
1.7
24.8
566
3739
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
7.9
24.7
34
44
Z2221
NOMESCO Finland
Medical doctor
1.8
24.5
483
3056
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
24.5
409
2460
N05CF02
ATC
zolpidem; oral
2.0
24.3
310
1705
WYA20
NOMESCO Finland
Home visit
4.2
24.2
65
159
N02AA05
ATC
oxycodone; systemic
1.9
24.1
373
2187
N06AX03
ATC
mianserin; oral
3.1
24.1
102
339
IBZ07
NOMESCO Finland
Neurological assessment in psychiatry
56.8
24.1
28
5
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.8
24.0
522
3393
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.0
23.9
276
1464
F20.04
ICD-10 Finland
Paranoid schizophrenia with partial recurrence
9.2
23.9
29
32
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.0
23.8
283
1516
Z3226
NOMESCO Finland
Physiotherapist
1.9
23.8
338
1926
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.9
23.8
114
407
P06
ICPC
Sleep disturbance
2.1
23.7
245
1247
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.1
23.6
247
1263
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
23.5
513
3335
R60.0
ICD-10 Finland
Localized oedema
2.1
23.4
255
1323
N29
ICPC
Neurological sympt/complt other
4.7
23.2
54
118
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
8.5
23.2
30
36
RS220, ,
NOMESCO Finland
6.0
23.1
41
70
R02
ICPC
Shortness of breath/dyspnoea
2.0
23.1
277
1489
Z91.5
ICD-10 Finland
Personal history of self-harm
22.4
23.0
33
15
R33
ICD-10 Finland
Retention of urine
2.4
23.0
161
696
R20.2
ICD-10 Finland
Paraesthesia of skin
2.6
22.9
138
555
R4120
NOMESCO Finland
Occupational therapy
2.7
22.9
130
508
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
22.8
395
2396
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.6
22.6
912
6947
ZXY56
NOMESCO Finland
2-person team, nurse-psychologist
21.0
22.6
33
16
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
22.5
735
5309
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.8
22.5
51
109
N06DX01
ATC
memantine; oral
2.3
22.5
186
865
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
22.4
473
3041
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.9
22.4
332
1917
N05AF01
ATC
flupentixol; systemic
5.4
22.4
44
83
SPAT1252
SPAT
Overall medication plan or its review
2.5
22.3
147
618
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
18.2
22.2
34
19
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
24.2
22.2
31
13
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
21.7
22.1
32
15
R40.2
ICD-10 Finland
Coma, unspecified
52.7
22.1
26
5
Z00.8
ICD-10 Finland
Other general examinations
2.3
21.9
173
789
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.7
21.8
124
484
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.8
21.8
444
2822
ICZ04
NOMESCO Finland
Preparation of psychiatric treatment plan
25.4
21.8
30
12
R5110, ,
SPAT
2.3
21.7
182
850
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
6.2
21.6
37
61
SPAT1249
SPAT
Treatment-related counselling outside office
1.6
21.6
698
5015
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
4.9
21.4
47
98
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
19.1
21.3
32
17
IEY21
NOMESCO Finland
Other intensified psychiatric treatment
21.0
21.3
31
15
N06AA12
ATC
doxepin; systemic
2.8
21.2
111
416
N03AF02
ATC
oxcarbazepine; oral
3.6
21.1
71
204
WX110
NOMESCO Finland
Infiltration anesthesia
1.7
21.1
1231
10194
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.2
21.1
194
942
P70
ICPC
Dementia
3.4
21.0
78
239
D09
ICPC
Nausea
2.7
21.0
118
458
EBA15
NOMESCO Finland
Extraction of multiple teeth
3.1
20.9
87
286
G43.9
ICD-10 Finland
Migraine, unspecified
2.7
20.9
117
453
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
20.9
350
2097
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
3.5
20.8
73
216
K08.3
ICD-10 Finland
Retained dental root
2.3
20.8
160
721
N01
ICPC
Headache
2.0
20.4
249
1342
IEY19
NOMESCO Finland
Psychiatric health counselling and guidance
18.5
20.4
31
17
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.2
20.2
83
271
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
3.0
20.1
93
325
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.9
20.1
277
1558
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
2.2
20.0
172
811
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
5.1
20.0
42
84
Z72.1
ICD-10 Finland
Alcohol use
5.7
20.0
37
66
A99
ICPC
Disease/condition unspecnature/site
2.1
19.9
216
1116
ZXY59
NOMESCO Finland
2-person team, nurse-other special worker
58.2
19.9
23
*
N05AL05
ATC
amisulpride; oral
58.2
19.9
23
*
L03
ICPC
Low back symptom/complaint
1.7
19.9
519
3516
R06.0
ICD-10 Finland
Dyspnoea
1.7
19.7
502
3377
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.7
19.6
466
3078
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.7
19.6
505
3409
R60.9
ICD-10 Finland
Oedema, unspecified
2.6
19.5
120
487
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
7.5
19.5
28
38
F32.8
ICD-10 Finland
Other depressive episodes
4.5
19.5
48
110
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.8
19.4
372
2313
R1250
NOMESCO Finland
Evaluation of functional capability
3.9
19.4
58
154
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.6
19.3
65
187
SPAT1167
SPAT
Insertion of urinary catheter
3.2
19.2
78
253
D01
ICPC
Abdominal pain/cramps general
2.0
19.2
246
1348
P28
ICPC
Limited function/disability (P)
6.0
19.2
34
58
N05AE05
ATC
lurasidone; oral
16.9
19.2
30
18
E86
ICD-10 Finland
Volume depletion
3.5
19.2
65
188
G04BD12
ATC
mirabegron; oral
2.0
19.1
226
1204
F20
ICD-10 Finland
Schizophrenia
7.6
19.1
27
36
G81.9
ICD-10 Finland
Hemiplegia, unspecified
7.3
19.1
28
39
XF600
NOMESCO Finland
Bloodpressure measurement
2.5
19.1
129
548
JN3AD
NOMESCO Finland
Abdominal CT examination
2.0
19.1
240
1307
S00.0
ICD-10 Finland
Superficial injury of scalp
3.6
19.0
62
175
X84
ICD-10 Finland
Intentional self-harm by unspecified means
15.0
18.9
31
21
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.9
18.9
90
320
G44.2
ICD-10 Finland
Tension-type headache
2.0
18.9
227
1217
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
18.8
570
3998
F23.3
ICD-10 Finland
Other acute predominantly delusional psychotic disorders
17.3
18.7
29
17
SPAT1275
SPAT
Drug rehabilitation and replacement therapy of opioid-dependent person
7.4
18.7
27
37
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
5.2
18.7
38
74
WX892
NOMESCO Finland
Monitored bed care
2.3
18.7
150
688
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
3.2
18.6
75
242
ZXY57
NOMESCO Finland
2-person team, nurse-social worker
21.1
18.6
27
13
F20.0
ICD-10 Finland
Paranoid schizophrenia
14.3
18.6
31
22
SPAT1101
SPAT
Orthostatic test
2.7
18.6
100
380
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
15.2
18.5
30
20
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
18.3
347
2147
D64.9
ICD-10 Finland
Anaemia, unspecified
2.0
18.3
223
1200
S01.9
ICD-10 Finland
Open wound of head, part unspecified
4.2
18.3
49
120
ICB01, ,
SPAT
6.0
18.3
32
54
R07.3
ICD-10 Finland
Other chest pain
2.1
18.2
192
980
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.9
18.2
276
1597
U05
ICPC
Urination problems other
2.5
18.2
113
461
ZXD05
NOMESCO Finland
Urgent procedure
1.6
18.2
511
3513
F23.90
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
15.5
18.0
29
19
U04
ICPC
Incontinence urine
2.3
18.0
139
627
A02BC03
ATC
lansoprazole; oral
1.7
18.0
469
3164
P80
ICPC
Personality disorder
16.7
17.9
28
17
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
7.0
17.8
27
39
R4110
NOMESCO Finland
Physiotherapy
1.6
17.7
472
3201
G72.8
ICD-10 Finland
Other specified myopathies
4.2
17.6
47
115
K02.1
ICD-10 Finland
Caries of dentine
1.5
17.5
981
7875
IEP99
NOMESCO Finland
Other psychiatric family intervention
7.8
17.4
24
31
IDR03
NOMESCO Finland
Systematic group therapy, dialectical behaviour therapy (DBT)
29.1
17.4
23
8
ZYD01
NOMESCO Finland
Emergency clinic
24.3
17.3
24
10
F19.9
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder
21.1
17.3
25
12
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
21.1
17.3
25
12
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
14.0
17.3
29
21
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
14.0
17.3
29
21
T90
ICPC
Diabetes non-insulin dependent
1.7
17.3
408
2679
N06DA02
ATC
donepezil; oral
2.3
17.2
140
646
SPAT1241
SPAT
Extensive assessment of psychosocial situation
5.5
17.2
33
61
N04BC05
ATC
pramipexole; oral
2.2
17.1
145
680
S29
ICPC
Skin symptom/complaint other
1.7
17.0
377
2432
D12
ICPC
Constipation
2.8
17.0
86
316
F06.2
ICD-10 Finland
Organic delusional [schizophrenia-like] disorder
50.5
17.0
20
*
S18
ICPC
Laceration/cut
1.5
17.0
808
6248
F25.11
ICD-10 Finland
Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms
17.6
16.9
26
15
SPAT1312
SPAT
General health counselling
1.6
16.9
566
4048
N05AB01
ATC
dixyrazine; systemic
5.4
16.9
33
62
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.0
16.8
183
946
F19.30
ICD-10 Finland
Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated
63.9
16.8
19
*
R25.2
ICD-10 Finland
Cramp and spasm
3.6
16.7
56
161
F23.9
ICD-10 Finland
Acute and transient psychotic disorder, unspecified
35.4
16.7
21
6
Z08
ICPC
Social welfare problem
4.9
16.7
36
74
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.0
16.6
186
970
F19.00
ICD-10 Finland
Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated
90.9
16.6
18
*
S09.9
ICD-10 Finland
Unspecified injury of head
4.2
16.6
44
107
Z28
ICPC
Limited function/disability (Z)
7.0
16.6
25
36
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
3.7
16.6
52
143
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
16.5
248
1429
F10.22
ICD-10 Finland
Alcohol dependence is currently on clinically controlled discontinuation medication
18.1
16.5
25
14
ZXY81
NOMESCO Finland
Psychologist in multidisciplinary team
18.1
16.5
25
14
R50.9
ICD-10 Finland
Fever, unspecified
1.8
16.3
279
1672
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.9
16.3
226
1269
A46
ICD-10 Finland
Erysipelas
1.8
16.3
269
1596
K29.7
ICD-10 Finland
Gastritis, unspecified
2.9
16.2
75
263
A97
ICPC
No disease
1.7
16.1
376
2457
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.1
16.0
157
779
F10.4
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium
48.0
16.0
19
*
IEZ99
NOMESCO Finland
Other psychiatric rehabilitation intervention
18.7
16.0
24
13
N03AX14
ATC
levetiracetam; systemic
3.5
16.0
55
161
R52.2
ICD-10 Finland
Other chronic pain
2.9
15.9
76
271
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
4.2
15.9
42
102
IAZ98
NOMESCO Finland
Other internal psychiatric consultation
12.3
15.9
28
23
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.9
15.7
226
1284
S21
ICPC
Skin texture symptom/complaint
1.8
15.7
277
1675
U07
ICPC
Urine symptom/complaint other
2.0
15.6
167
857
N05AE03
ATC
sertindole; oral
22.3
15.5
22
10
SPAT1262
SPAT
Handing over of treatment supplies
1.7
15.5
300
1861
UKC02
NOMESCO Finland
Cystoscopy
1.8
15.5
259
1540
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.9
15.4
199
1090
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.6
15.4
89
351
F21
ICD-10 Finland
Schizotypal disorder
12.4
15.4
27
22
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
12.4
15.4
27
22
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
14.9
15.4
25
17
SPAT1396
SPAT
Meeting with multidisciplinary group of experts
6.7
15.3
24
36
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
15.3
316
1995
N88
ICPC
Epilepsy
7.0
15.3
23
33
L12
ICPC
Hand/finger symptom/complaint
1.7
15.2
309
1941
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
4.1
15.2
41
101
IAA01, ,
SPAT
6.1
15.1
26
43
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
3.0
15.1
65
219
183
Kela drug reimbursment
Lamotrigin and topiramate
6.3
15.0
25
40
N02BF02
ATC
pregabalin; oral
2.3
15.0
118
536
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
14.9
574
4212
F50.9
ICD-10 Finland
Eating disorder, unspecified
5.2
14.9
30
58
J01DB01
ATC
cefalexin; oral
1.6
14.8
1405
12415
ICC01
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
11.4
14.8
27
24
A11
ICPC
Chest pain NOS
2.0
14.7
158
811
F05
ICPC
Visual disturbance other
2.8
14.7
75
277
K59.0
ICD-10 Finland
Constipation
2.3
14.7
113
508
WZA90
NOMESCO Finland
Other medical or dental certificate
1.6
14.7
408
2776
ICB03, ,
SPAT
18.5
14.7
22
12
B01AC04
ATC
clopidogrel; oral
1.7
14.7
270
1650
F25.21
ICD-10 Finland
Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms
21.2
14.7
21
10
SPAT1172
SPAT
Guidance concerning hydration
3.0
14.6
63
212
S51.8
ICD-10 Finland
Open wound of other parts of forearm
4.6
14.5
34
75
W01
ICPC
Question of pregnancy
5.8
14.5
26
45
S61.9
ICD-10 Finland
Open wound of wrist and hand, part unspecified
2.9
14.5
67
235
F19.26
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction
36.3
14.4
18
5
R00.0
ICD-10 Finland
Tachycardia, unspecified
2.7
14.4
80
309
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
14.4
368
2452
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
2.8
14.3
72
264
-1, ,
NOMESCO Finland
1.5
14.3
562
4133
R96
ICPC
Asthma
1.9
14.3
178
963
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
14.3
599
4465
A98
ICPC
Health maint/preventive medicine
2.2
14.3
1691
15778
IBZ14, ,
SPAT
27.4
14.3
19
7
N05AC02
ATC
thioridazine; oral
3.8
14.3
43
115
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.1
14.2
142
710
L29
ICPC
Musculoskeletal sympt/complt other
2.0
14.2
165
872
I50.9
ICD-10 Finland
Heart failure, unspecified
1.7
14.2
299
1896
S00.8
ICD-10 Finland
Superficial injury of other parts of head
3.4
14.2
50
149
F19.2
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome
42.8
14.1
17
*
SFA30
NOMESCO Finland
Three-surface restoration
1.5
14.1
636
4810
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
14.1
201
1137
K92.0
ICD-10 Finland
Haematemesis
3.2
14.1
56
180
SAA02
NOMESCO Finland
Basic examination of mouth
1.5
14.0
1119
9463
S51.9
ICD-10 Finland
Open wound of forearm, part unspecified
4.7
14.0
32
69
Y94.0
ICD-10 Finland
Accident at home
3.4
14.0
51
155
Y07
ICD-10 Finland
Other maltreatment
5.9
14.0
25
43
N30.9
ICD-10 Finland
Cystitis, unspecified
2.1
14.0
138
687
N06AA04
ATC
clomipramine; systemic
4.2
14.0
37
90
F05.0
ICD-10 Finland
Delirium not superimposed on dementia, so described
15.9
13.9
22
14
U02
ICPC
Urinary frequency/urgency
1.7
13.9
270
1674
KMAK, ,
NOMESCO Finland
1.5
13.9
778
6141
E0000UV, ,
ATC
1.5
13.8
704
5452
N02AX02
ATC
tramadol; systemic, rectal
1.5
13.8
682
5251
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
10.5
13.7
26
25
H01
ICPC
Ear pain/earache
1.8
13.7
217
1267
IAA02
NOMESCO Finland
Consultation concerning further psychiatric treatment
13.7
13.7
23
17
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.8
13.7
209
1208
X58
ICD-10 Finland
Exposure to other specified factors
1.7
13.7
254
1555
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.1
13.6
57
189
D10
ICPC
Vomiting
2.2
13.5
113
527
Z86.4
ICD-10 Finland
Personal history of psychoactive substance abuse
12.9
13.4
23
18
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
6.1
13.4
23
38
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
3.8
13.4
41
111
ZXY03
NOMESCO Finland
Occupational therapist
18.4
13.4
20
11
F25
ICD-10 Finland
Schizoaffective disorders
25.9
13.4
18
7
WX290
NOMESCO Finland
Other blockage of nerve
1.5
13.3
748
5892
F42.9
ICD-10 Finland
Obsessive-compulsive disorder, unspecified
6.4
13.3
22
35
TKC20
NOMESCO Finland
Catheterisation of bladder
2.1
13.2
125
612
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.7
13.1
244
1493
IHZ05, ,
SPAT
2.4
13.1
89
379
SPAT1304
SPAT
Counselling and guidance related to ageing
2.0
13.1
158
845
F20.3
ICD-10 Finland
Undifferentiated schizophrenia
12.2
13.1
23
19
XF606
NOMESCO Finland
Ortostatic test
15.2
13.1
21
14
N03AF01
ATC
carbamazepine; oral, rectal
2.4
13.1
87
367
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
3.0
13.1
59
204
N06AX22
ATC
agomelatine; oral
3.5
13.1
44
127
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
13.0
653
5024
SPAT1272
SPAT
Drug screening
11.0
13.0
24
22
F20.08
ICD-10 Finland
Paranoid schizophrenia other definite
16.8
13.0
20
12
SFA10
NOMESCO Finland
One-surface restoration
1.4
13.0
891
7277
S10
ICPC
Boil/carbuncle
2.2
13.0
108
503
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
6.2
12.9
22
36
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.0
12.9
58
200
F41.00
ICD-10 Finland
Moderate panic disorder
4.0
12.9
36
91
F41.3
ICD-10 Finland
Other mixed anxiety disorders
3.9
12.8
37
96
C10AA01
ATC
simvastatin; oral
1.5
12.8
680
5287
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.5
12.7
420
2962
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.6
12.7
76
305
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.9
12.7
162
883
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.3
12.7
98
442
S20.2
ICD-10 Finland
Contusion of thorax
2.3
12.6
96
430
N06AB08
ATC
fluvoxamine; oral
3.3
12.6
48
150
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.9
12.6
172
958
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
4.5
12.6
30
67
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
12.4
12.6
22
18
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
3.8
12.6
38
102
WVA20
NOMESCO Finland
Medicine administration
2.9
12.5
58
204
ZXY58
NOMESCO Finland
2-person team, nurse-occupational therapist
24.5
12.5
17
7
F61
ICD-10 Finland
Mixed and other personality disorders
20.2
12.5
18
9
K04.08
ICD-10 Finland
Other specified pulpit
2.0
12.4
133
682
WZC00
NOMESCO Finland
Treatment plan or consultation
1.5
12.4
612
4685
SPAT1246
SPAT
Screening of depression or other psychiatric problem
2.5
12.3
79
328
T82
ICPC
Obesity
2.6
12.3
71
280
F20.8
ICD-10 Finland
Other schizophrenia
11.7
12.3
22
19
AXX01, ,
SPAT
2.5
12.3
78
322
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
2.2
12.3
102
474
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
12.3
670
5227
F10.01
ICD-10 Finland
Alcohol-related acute intoxication with permanent or other somatic damage
9.0
12.2
25
28
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
9.7
12.2
24
25
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.5
12.2
401
2822
R95
ICPC
Chron obstructive pulmonary disease
2.8
12.2
60
218
K04.0
ICD-10 Finland
Pulpitis
2.0
12.2
144
765
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
3.6
12.2
39
109
S97
ICPC
Chronic ulcer skin
2.0
12.1
125
633
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.8
12.1
202
1198
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
3.1
12.1
51
170
XF404
NOMESCO Finland
Ambulatory ECG
1.9
12.1
147
789
WVA20, ,
SPAT
2.5
12.1
77
319
P77
ICPC
Suicide/suicide attempt
18.2
12.0
18
10
IAB10
NOMESCO Finland
Psychiatric consultation concerning substance abuse
21.4
12.0
17
8
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
3.2
12.0
47
150
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.5
12.0
403
2851
Z73.8
ICD-10 Finland
Other problems related to life-management difficulty
5.1
12.0
25
50
R03AC02
ATC
salbutamol; inhalant
1.4
11.9
893
7363
IEY06
NOMESCO Finland
Psychiatric treatment and rehabilitation coaching
13.5
11.9
20
15
F44.88
ICD-10 Finland
Other definite dissociation disorder
47.0
11.9
14
*
J01EA01
ATC
trimethoprim; systemic
1.5
11.9
442
3193
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.4
11.9
79
334
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
5.4
11.8
23
43
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.7
11.8
222
1361
K04.1
ICD-10 Finland
Necrosis of pulp
1.8
11.8
170
965
P17
ICPC
Tobacco abuse
4.3
11.7
30
71
A02BC01
ATC
omeprazole; systemic
1.5
11.7
443
3210
UJF32
NOMESCO Finland
Coloscopy
1.5
11.7
404
2873
RS221, ,
NOMESCO Finland
3.9
11.7
34
89
X57
ICD-10 Finland
Unspecified privation
3.1
11.7
49
163
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.6
11.6
320
2161
F10.3
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Withdrawal state
12.6
11.6
20
16
G21.1
ICD-10 Finland
Other drug-induced secondary parkinsonism
65.4
11.6
13
*
IGY01, ,
SPAT
19.1
11.6
17
9
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.8
11.6
58
213
D20
ICPC
Mouth/tongue/lip symptom/complaint
2.3
11.5
89
402
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.5
11.5
384
2709
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
2.4
11.5
78
333
F23.91
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
13.7
11.5
19
14
F60.2
ICD-10 Finland
Dissocial personality disorder
13.7
11.5
19
14
F15.0
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, acute intoxication
120.8
11.4
12
*
J01CA08
ATC
pivmecillinam; oral
1.4
11.4
686
5427
Y96.9
ICD-10 Finland
Unspecified type of accident
3.4
11.4
41
124
L84
ICPC
Back syndrome without radiat pain
2.2
11.4
96
450
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
5.4
11.4
22
41
N05AD03
ATC
melperone; systemic
3.8
11.3
34
91
J46
ICD-10 Finland
Status asthmaticus
2.8
11.3
57
210
H53.2
ICD-10 Finland
Diplopia
2.7
11.3
61
233
N80
ICPC
Head injury other
2.9
11.3
51
177
J01MA02
ATC
ciprofloxacin; systemic
1.4
11.3
611
4741
F60.8
ICD-10 Finland
Other specific personality disorders
8.9
11.3
23
26
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
3.7
11.2
35
96
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.6
11.2
301
2020
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.8
11.2
168
964
D11
ICPC
Diarrhoea
1.7
11.2
205
1247
F09
ICD-10 Finland
Unspecified organic or symptomatic mental disorder
25.2
11.1
15
6
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.6
11.1
276
1817
ZXY52
NOMESCO Finland
2-person team, doctor-psychologist
12.8
11.1
19
15
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
3.4
11.1
39
116
N27
ICPC
Fear of neurological disease other
3.4
11.1
40
121
Z01.2
ICD-10 Finland
Dental examination
1.4
11.0
743
5988
ZYB04, ,
SPAT
9.3
11.0
22
24
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
4.4
11.0
27
62
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
2.8
11.0
55
202
M02AA10
ATC
ketoprofen; topical
1.6
11.0
255
1652
F11.1
ICD-10 Finland
Mental and behavioural disorders due to use of opioids, harmful use
14.0
11.0
18
13
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
4.5
11.0
26
58
R5140
NOMESCO Finland
Monitoring the use of the aid
1.8
10.9
164
941
SPAT1281
SPAT
Other administrative function
1.9
10.9
143
786
F10.51
ICD-10 Finland
Psychotic alcohol paranoia
43.6
10.9
13
*
K05.31
ICD-10 Finland
Periodontitis pronounced
1.8
10.9
167
966
A05
ICPC
Feeling ill
1.9
10.8
135
730
SPAT1139
SPAT
Nutrition survey
2.5
10.8
70
292
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
2.5
10.8
65
262
SPAT1360
SPAT
Extensive global examination
2.0
10.8
120
624
H81.9
ICD-10 Finland
Disorder of vestibular function, unspecified
5.2
10.8
22
43
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
5.2
10.8
22
43
F22.8
ICD-10 Finland
Other persistent delusional disorders
28.2
10.7
14
5
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.7
10.7
188
1130
ZXA10
NOMESCO Finland
Bilateral
1.6
10.7
313
2141
P01AB01
ATC
metronidazole; oral, rectal
1.4
10.7
591
4593
C08CA01
ATC
amlodipine; oral
1.4
10.7
621
4870
G47.3
ICD-10 Finland
Sleep apnoea
1.6
10.7
308
2101
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.8
10.7
154
874
ND1AA
NOMESCO Finland
Wrist X-ray examination
1.9
10.6
127
677
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
2.4
10.6
72
307
ZYY02
NOMESCO Finland
Contact between professionals and family members
60.4
10.6
12
*
F23.29
ICD-10 Finland
Acute schizophrenia-like psychosis UNS
60.4
10.6
12
*
AA3AD
NOMESCO Finland
CT of face
5.3
10.6
21
40
SPAT1100
SPAT
Long-term monitoring of blood pressure
2.0
10.6
121
636
K29
ICPC
Cardiovascular sympt/complt other
2.3
10.6
79
352
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.8
10.5
160
922
C07AB02
ATC
metoprolol; systemic
1.5
10.5
335
2334
SPAT1247
SPAT
Outpatient detoxication and monitoring
9.2
10.5
21
23
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
4.5
10.5
25
56
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.5
10.5
379
2713
F20.02
ICD-10 Finland
Paranoid schizophrenia stable periodically
14.3
10.5
17
12
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
10.5
671
5348
NF1AA
NOMESCO Finland
Hip X-ray examination
1.8
10.5
169
992
G21.0
ICD-10 Finland
Malignant neuroleptic syndrome
110.7
10.4
11
*
F19.22
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but using substitute intermittent medication
110.7
10.4
11
*
R44
ICD-10 Finland
Other symptoms and signs involving general sensations and perceptions
110.7
10.4
11
*
ZXY12
NOMESCO Finland
Trainee nurse, supervised
+∞
10.4
10
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
10.4
703
5651
XCK00
NOMESCO Finland
Perimetry
2.0
10.4
109
555
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
2.5
10.4
62
249
K90
ICPC
Stroke/cerebrovascular accident
2.7
10.4
56
214
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
10.4
282
1897
L30.4
ICD-10 Finland
Erythema intertrigo
3.6
10.3
34
97
F19.09
ICD-10 Finland
Intoxication caused by several drugs in combination and by other psychoactive substances UNS
32.7
10.3
13
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.3
10.3
80
362
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
4.0
10.3
29
74
SPAT1104
SPAT
Monitoring of emergency patient
2.0
10.3
115
599
WX002
NOMESCO Finland
Sedation and analgesia
1.6
10.3
304
2082
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.3
10.3
38
117
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.3
10.3
76
337
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
8.8
10.3
21
24
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
4.9
10.3
22
45
Z53.8
ICD-10 Finland
Procedure not carried out for other reasons
9.6
10.3
20
21
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.7
10.3
198
1222
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
4.6
10.3
24
53
B01AF02
ATC
apixaban; oral
1.6
10.3
242
1573
F19.59
ICD-10 Finland
Psychotic disorder caused by several drugs in combination and by other psychoactive substances UNS
23.5
10.2
14
6
G47.9
ICD-10 Finland
Sleep disorder, unspecified
2.7
10.2
54
204
A13
ICPC
Concern/fear medical treatment
3.1
10.2
41
133
S61.8
ICD-10 Finland
Open wound of other parts of wrist and hand
2.8
10.2
50
182
G04CA02
ATC
tamsulosin; oral
1.5
10.2
310
2139
SFA20
NOMESCO Finland
Two-surface restoration
1.4
10.1
888
7445
193
Kela drug reimbursment
Rasagiline
7.9
10.1
22
28
WX872
NOMESCO Finland
Intensive care
2.2
10.1
84
392
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
11.4
10.1
18
16
S01
ICD-10 Finland
Open wound of head
3.8
10.1
30
80
IHZ05
NOMESCO Finland
Therapeutic conversation
8.5
10.0
21
25
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
10.0
975
8305
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
4.8
10.0
22
46
SPF00
NOMESCO Finland
Reparation of dental prosthesis without impressions
2.6
10.0
57
224
SGA01
NOMESCO Finland
Emergency treatment
1.6
10.0
230
1485
IGV01, ,
SPAT
14.7
10.0
16
11
WX882
NOMESCO Finland
High dependency care
2.6
10.0
59
236
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
2.5
10.0
61
248
L14
ICPC
Leg/thigh symptom/complaint
1.8
10.0
148
847
R06AE07
ATC
cetirizine; oral
1.4
10.0
694
5597
B01AA03
ATC
warfarin; systemic
1.5
9.9
322
2250
S72.0
ICD-10 Finland
Fracture of neck of femur
2.1
9.9
94
461
N02BF01
ATC
gabapentin; oral
1.8
9.9
163
961
H25.1
ICD-10 Finland
Senile nuclear cataract
1.4
9.9
502
3831
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
9.9
391
2847
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.3
9.9
73
324
G04BD08
ATC
solifenacin; oral
2.0
9.9
107
552
S04
ICPC
Lump/swelling localized
1.7
9.9
189
1164
G40.39
ICD-10 Finland
Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures
12.2
9.9
17
14
R47.1
ICD-10 Finland
Dysarthria and anarthria
4.3
9.8
25
59
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
5.2
9.8
20
39
M54.4
ICD-10 Finland
Lumbago with sciatica
1.6
9.8
269
1810
T00.9
ICD-10 Finland
Multiple superficial injuries, unspecified
8.2
9.8
21
26
F11.21
ICD-10 Finland
Addiction-indiced dependence caused by opiates currently independent but staying in controlling environment
26.2
9.8
13
5
H03AA01
ATC
levothyroxine sodium; systemic
1.5
9.8
371
2677
F12.29
ICD-10 Finland
Addiction caused by cannabis UNS
20.1
9.8
14
7
XKD00
NOMESCO Finland
Uroflowmetry
1.7
9.8
210
1332
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
4.6
9.8
23
51
F11.29
ICD-10 Finland
Addiction caused by opiates UNS
10.7
9.8
18
17
A10BA02
ATC
metformin; oral
1.4
9.8
450
3373
IER03
NOMESCO Finland
Psychiatric disorder-specific group intervention
9.6
9.8
19
20
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.7
9.8
184
1128
N28
ICPC
Limited function/disability (N)
3.4
9.7
34
101
FP1B5
NOMESCO Finland
Resting ECG, 12 leads
2.9
9.7
44
153
C03DA01
ATC
spironolactone; oral
1.6
9.7
217
1390
R35
ICD-10 Finland
Polyuria
2.0
9.7
110
576
R03BB04
ATC
tiotropium bromide; inhalant
1.8
9.7
162
960
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.5
9.7
62
258
IAB11
NOMESCO Finland
Psychiatric mood consultation
13.4
9.7
16
12
IFC04, ,
SPAT
55.3
9.7
11
*
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
5.3
9.6
19
36
S80.0
ICD-10 Finland
Contusion of knee
1.9
9.6
130
722
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
2.9
9.6
44
154
J01MA12
ATC
levofloxacin; systemic
1.5
9.6
288
1979
H93.1
ICD-10 Finland
Tinnitus
2.0
9.5
102
524
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
9.1
9.5
19
21
F13.20
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent
10.1
9.5
18
18
S22.3
ICD-10 Finland
Fracture of rib
1.9
9.4
119
647
F00.22
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations
100.6
9.4
10
*
S72.1
ICD-10 Finland
Pertrochanteric fracture
2.5
9.4
56
225
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
3.9
9.4
27
70
OAA67, ,
SPAT
0.5
9.4
72
1472
F25.2
ICD-10 Finland
Schizoaffective disorder, mixed type
30.2
9.4
12
*
IEV99, ,
SPAT
17.6
9.4
14
8
S70.0
ICD-10 Finland
Contusion of hip
2.2
9.4
77
357
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.3
9.4
66
287
F06.9
ICD-10 Finland
Unspecified mental disorder due to brain damage and dysfunction and to physical disease
12.4
9.4
16
13
F12.5
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, psychotic disorder
21.8
9.3
13
6
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
3.0
9.3
40
135
M94.0
ICD-10 Finland
Chondrocostal junction syndrome [Tietze]
3.0
9.3
40
135
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
4.7
9.3
21
45
WX730
NOMESCO Finland
Conventional respirator
3.7
9.3
29
80
PA6AD
NOMESCO Finland
CT of neck arteries
2.4
9.2
63
270
A02BA02
ATC
ranitidine; systemic
1.5
9.2
297
2072
K04
ICPC
Palpitations/awareness of heart
2.0
9.2
95
482
R06.4
ICD-10 Finland
Hyperventilation
3.4
9.2
32
95
SPAT1299
SPAT
Other function in accordance with podiatry nomenclature
3.4
9.2
32
95
EBA30
NOMESCO Finland
Extraction of root of tooth
2.0
9.2
101
524
F20.01
ICD-10 Finland
Paranoid schizophrenia periodically with gradual deterioration
13.7
9.2
15
11
F13.24
ICD-10 Finland
Addiction relationship caused by sedative and hypnotic active addiction
13.7
9.2
15
11
IGY99, ,
SPAT
2.7
9.1
49
187
SGA02
NOMESCO Finland
Opening and preparing the root canals
1.7
9.1
185
1156
T90.5
ICD-10 Finland
Sequelae of intracranial injury
4.3
9.1
23
54
H13
ICPC
Plugged feeling ear
1.5
9.1
322
2289
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
9.1
583
4621
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
4.4
9.1
22
50
WYA10
NOMESCO Finland
Emergency care or similar visit
1.9
9.1
115
626
SGB10
NOMESCO Finland
Root filling of tooth with one root canal
1.7
9.1
177
1095
S61.7
ICD-10 Finland
Multiple open wounds of wrist and hand
4.6
9.1
21
46
U08
ICPC
Urinary retention
3.0
9.1
39
132
A02BC05
ATC
esomeprazole; systemic
1.4
9.1
597
4753
F10.05
ICD-10 Finland
Alcohol-related acute intoxication with coma
15.7
9.0
14
9
Y04.8
ICD-10 Finland
Assault by bodily force by other known person
9.1
9.0
18
20
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.8
9.0
124
693
S51.7
ICD-10 Finland
Multiple open wounds of forearm
7.1
9.0
21
30
T40.9
ICD-10 Finland
Poisoning: Other and unspecified psychodysleptics [hallucinogens]
36.9
9.0
11
*
G30.1
ICD-10 Finland
Alzheimer disease with late onset
1.9
9.0
123
686
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
3.0
8.9
39
133
G25.0
ICD-10 Finland
Essential tremor
2.6
8.9
50
195
L03.9
ICD-10 Finland
Cellulitis, unspecified
2.9
8.9
41
144
ZXY61
NOMESCO Finland
2-person team, special workers
18.7
8.9
13
7
D72
ICPC
Viral hepatitis
18.7
8.9
13
7
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.7
8.9
182
1139
M79.1
ICD-10 Finland
Myalgia
1.6
8.9
227
1501
F10.04
ICD-10 Finland
Alcohol-related acute intoxication with hallucinations
24.1
8.9
12
5
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
3.0
8.9
38
128
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.8
8.9
147
869
309
Kela drug reimbursment
Nalmefene and naltrexone
8.0
8.9
19
24
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
8.0
8.9
19
24
H02AA02
ATC
fludrocortisone; oral
4.9
8.8
19
39
NG4AA
NOMESCO Finland
Lower leg X-ray examination
2.4
8.8
61
263
X14
ICPC
Vaginal discharge
3.0
8.8
39
134
E66.00
ICD-10 Finland
Metabolic syndrome
2.1
8.8
83
407
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
2.3
8.8
67
302
M79.7
ICD-10 Finland
Fibromyalgia
2.6
8.8
50
197
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.1
8.8
82
401
N05BA09
ATC
clobazam; oral
7.2
8.7
20
28
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.8
8.7
145
858
SPAT1251
SPAT
Organisation of medication
2.2
8.7
68
309
207
Kela drug reimbursment
Chronic arrhythmias
1.5
8.7
277
1924
R05
ICPC
Cough
1.4
8.7
399
2979
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
2.9
8.7
41
146
IAZ99, ,
SPAT
14.1
8.7
14
10
F10.59
ICD-10 Finland
Alcohol psychosis, mixed type
50.2
8.7
10
*
Z11
ICPC
Compliance/being ill problem
4.3
8.7
22
52
R63.4
ICD-10 Finland
Abnormal weight loss
2.2
8.6
73
343
F40.1
ICD-10 Finland
Social phobias
2.4
8.6
58
247
F43.01
ICD-10 Finland
Acute stress reaction moderate
3.4
8.6
30
89
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
3.0
8.6
37
125
R00.2
ICD-10 Finland
Palpitations
1.8
8.6
127
725
U29
ICPC
Urinary symptom/complaint other
2.3
8.6
61
266
D16
ICPC
Rectal bleeding
2.6
8.6
48
187
J45
ICD-10 Finland
Asthma
1.7
8.6
156
947
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
8.3
8.6
18
22
F13.3
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state
11.6
8.6
15
13
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.9
8.6
38
131
D06
ICPC
Abdominal pain localized other
1.7
8.6
142
840
E66.01
ICD-10 Finland
Obesity due to excess calories
1.8
8.6
131
757
F01
ICPC
Eye pain
2.5
8.5
54
224
K04.7
ICD-10 Finland
Periapical abscess without sinus
2.0
8.5
87
440
B03BA03
ATC
hydroxocobalamin; parenteral
2.0
8.5
91
468
ZYA02
NOMESCO Finland
Contact at day ward in specialised medical care or in other intensive outpatient care setting
27.6
8.5
11
*
F15.3
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, withdrawal state
27.6
8.5
11
*
F10.06
ICD-10 Finland
Alcohol-related acute intoxication with seizures
27.6
8.5
11
*
F19.50
ICD-10 Finland
Psychotic disorder caused by several drugs in combination and by other psychoactive substances schizophrenic
27.6
8.5
11
*
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.5
8.5
287
2020
B17.1
ICD-10 Finland
Acute hepatitis C
20.1
8.5
12
6
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
3.7
8.5
26
71
T51.0
ICD-10 Finland
Toxic effect: Ethanol
7.4
8.4
19
26
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.8
8.4
124
708
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.6
8.4
225
1504
TKC22
NOMESCO Finland
Catheterisation instruction
3.0
8.4
37
127
S00.9
ICD-10 Finland
Superficial injury of head, part unspecified
3.6
8.4
27
76
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
4.3
8.4
21
49
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.4
8.4
55
232
F43.21
ICD-10 Finland
Adaptation disorder with prolonged depression
4.9
8.4
18
37
F01.2
ICD-10 Finland
Subcortical vascular dementia
7.9
8.4
18
23
K07
ICPC
Swollen ankles/oedema
2.0
8.4
95
499
SPAT1284
SPAT
Extensive health certificate
2.5
8.3
51
208
R40.0
ICD-10 Finland
Somnolence
+∞
8.3
8
*
A02BA04
ATC
nizatidine; systemic
1.8
8.3
121
689
Y09
ICD-10 Finland
Assault by unspecified means
8.6
8.3
17
20
Z04.0
ICD-10 Finland
Blood-alcohol and blood-drug test
9.5
8.3
16
17
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.5
8.3
49
197
A08
ICPC
Swelling
1.9
8.3
102
551
B01AC07
ATC
dipyridamole; systemic
2.1
8.3
75
363
S06
ICPC
Rash localized
1.9
8.2
105
573
R07.2
ICD-10 Finland
Precordial pain
2.9
8.2
38
134
H02AB06
ATC
prednisolone; systemic
1.3
8.2
737
6131
N05CD08
ATC
midazolam; nasal, systemic
2.6
8.2
45
174
C01DA14
ATC
isosorbide mononitrate; oral
1.5
8.2
270
1889
M47.9
ICD-10 Finland
Spondylosis, unspecified
2.4
8.2
52
216
L86
ICPC
Back syndrome with radiating pain
1.9
8.2
96
510
H53.9
ICD-10 Finland
Visual disturbance, unspecified
2.3
8.2
62
279
S76
ICPC
Skin infection other
2.0
8.2
92
482
M03BX01
ATC
baclofen; systemic
3.1
8.1
33
108
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.1
8.1
75
365
WVA30, ,
SPAT
1.9
8.1
106
583
A41.9
ICD-10 Finland
Sepsis, unspecified
2.2
8.1
65
299
L05
ICPC
Flank/axilla symptom/complaint
1.9
8.1
109
605
K92.1
ICD-10 Finland
Melaena
2.0
8.1
88
455
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.4
8.1
56
242
F01.9
ICD-10 Finland
Vascular dementia, unspecified
3.3
8.1
30
93
F44.7
ICD-10 Finland
Mixed dissociative [conversion] disorders
33.5
8.1
10
*
Z07
ICPC
Education problem
3.8
8.1
24
64
M03BX02
ATC
tizanidine; oral
1.3
8.1
877
7498
F11.20
ICD-10 Finland
Addiction-induced dependence caused by opiates currently independent
11.7
8.1
14
12
E87.6
ICD-10 Finland
Hypokalaemia
2.2
8.1
65
300
SPAT1097
SPAT
Recording of ECG
1.5
8.1
226
1527
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.4
8.1
559
4470
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.2
8.0
68
320
IBB03
NOMESCO Finland
Assessment of vocational rehabilitation needs in a mental health context
9.0
8.0
16
18
N04BC09
ATC
rotigotine; transdermal
9.0
8.0
16
18
Z60.8
ICD-10 Finland
Other problems related to social environment
9.0
8.0
16
18
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.7
8.0
141
848
F13.21
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but staying in a controlling environment
22.1
8.0
11
5
F13.09
ICD-10 Finland
Intoxication caused by sedative and hypnotic UNS
22.1
8.0
11
5
IDY04
NOMESCO Finland
Systematic individual therapy, dialectical behaviour therapy (DBT)
22.1
8.0
11
5
Z03.6
ICD-10 Finland
Observation for suspected toxic effect from ingested substance
22.1
8.0
11
5
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.8
8.0
114
645
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.6
8.0
207
1374
L76
ICPC
Fracture: other
2.3
8.0
59
263
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
4.3
7.9
20
47
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
2.8
7.9
38
137
ZXA05
NOMESCO Finland
Left side
1.4
7.9
383
2883
S42.2
ICD-10 Finland
Fracture of upper end of humerus
2.0
7.9
87
452
S00.1
ICD-10 Finland
Contusion of eyelid and periocular area
2.7
7.9
42
160
T68
ICD-10 Finland
Hypothermia
6.6
7.9
19
29
Y04.0
ICD-10 Finland
Assault by bodily force by spouse or partner
7.8
7.9
17
22
F90.0
ICD-10 Finland
Disturbance of activity and attention
2.0
7.8
78
391
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
8.5
7.8
16
19
F20.34
ICD-10 Finland
Undifferentiated schizophrenia with partial recurrence
8.5
7.8
16
19
R13
ICD-10 Finland
Dysphagia
1.8
7.8
111
628
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
2.4
7.8
50
209
RS140, ,
NOMESCO Finland
9.4
7.8
15
16
A62
ICPC
General and Unspecified, Administrative procedure
2.5
7.8
48
197
N03AX18
ATC
lacosamide; systemic
7.0
7.8
18
26
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
2.1
7.7
72
352
L75
ICPC
Fracture: femur
2.9
7.7
34
117
K10.3
ICD-10 Finland
Alveolitis of jaws
2.1
7.7
74
366
F44.4
ICD-10 Finland
Dissociative motor disorders
45.2
7.7
9
*
F10.50
ICD-10 Finland
Alcohol-related psychosis is schizophrenic
45.2
7.7
9
*
R5140, ,
SPAT
3.2
7.7
30
96
H04.10
ICD-10 Finland
Dry eye syndrome
1.6
7.7
172
1102
S02.30
ICD-10 Finland
Fracture of orbital floor, closed
4.4
7.7
19
44
Z27
ICPC
Fear of a social problem
5.9
7.7
20
34
IHZ01, ,
SPAT
3.5
7.7
26
76
F99
ICPC
Eye/adnexa disease other
4.5
7.7
18
40
A02BX02
ATC
sucralfate; oral
2.2
7.6
65
307
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
7.6
157
985
OAA80, ,
SPAT
0.4
7.6
33
848
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.9
7.6
88
465
R31
ICD-10 Finland
Unspecified haematuria
1.7
7.6
152
946
J45.8
ICD-10 Finland
Mixed asthma
2.3
7.6
53
230
G41.0
ICD-10 Finland
Grand mal status epilepticus
18.4
7.6
11
6
F95.2
ICD-10 Finland
Combined vocal and multiple motor tic disorder [de la Tourette]
18.4
7.6
11
6
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
8.1
7.6
16
20
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
2.3
7.6
55
243
F0012, G301,
ICD-10 Finland
25.1
7.6
10
*
F01.21
ICD-10 Finland
Subcortical vascular dementia without additional symptoms, mainly paranoidism
25.1
7.6
10
*
IER05
NOMESCO Finland
Rehabilitative psychiatric group intervention, social skills
25.1
7.6
10
*
F25.1
ICD-10 Finland
Schizoaffective disorder, depressive type
8.9
7.5
15
17
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
1.8
7.5
112
642
S01.50
ICD-10 Finland
Open wound in oral cavity
3.8
7.5
22
58
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
7.5
528
4221
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.3
7.5
55
244
P25
ICPC
Phase of life problem adult
2.2
7.5
63
296
F43.00
ICD-10 Finland
Acute stress reaction mild
2.7
7.5
39
147
K80
ICPC
Cardiac arrhythmia NOS
1.7
7.5
138
841
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
7.5
629
5165
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
2.4
7.5
50
213
NC2AA
NOMESCO Finland
Forearm X-ray examination
3.0
7.5
31
103
A03
ICPC
Fever
1.5
7.5
277
1984
QCB05
NOMESCO Finland
Revision of wound of skin of upper limb
4.4
7.4
18
41
IDY23
NOMESCO Finland
Systematic individual therapy, cognitive, psychotic-type symptoms
80.4
7.4
8
*
3094A
ICD-9 Finland
Adjustment reaction, With mixed disturbance of emotions and conduct
80.4
7.4
8
*
T18.2
ICD-10 Finland
Foreign body in stomach
80.4
7.4
8
*
F40.9
ICD-10 Finland
Phobic anxiety disorder, unspecified
6.5
7.4
18
28
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.9
7.4
89
477
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.5
7.4
286
2064
T08
ICPC
Weight loss
2.6
7.4
40
154
K30
ICD-10 Finland
Functional dyspepsia
1.6
7.4
164
1049
Z71.9
ICD-10 Finland
Counselling, unspecified
1.7
7.4
129
775
3000A
ICD-9 Finland
Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]
13.4
7.4
12
9
M54.2
ICD-10 Finland
Cervicalgia
1.8
7.4
119
699
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.2
7.4
61
285
AN1
HP
Coronary angiography
1.6
7.4
167
1074
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.4
7.3
348
2608
-69
ICPC
Other reason for encounter NEC
2.1
7.3
66
319
-1, ,
ICPC
2.1
7.3
64
306
D07AA02
ATC
hydrocortisone; topical
1.5
7.3
221
1518
SPAT1058
SPAT
PEF monitoring instruction
1.7
7.3
125
747
IBZ15, ,
SPAT
10.9
7.3
13
12
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
10.9
7.3
13
12
N07
ICPC
Convulsion/seizure
10.9
7.3
13
12
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.4
7.3
327
2426
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.3
7.3
54
241
N05CD02
ATC
nitrazepam; oral
2.8
7.3
34
121
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.4
7.3
359
2708
R52.1
ICD-10 Finland
Chronic intractable pain
4.2
7.3
19
46
RS222, ,
NOMESCO Finland
3.4
7.3
25
74
R21
ICPC
Throat symptom/complaint
1.4
7.3
340
2542
L02
ICPC
Back symptom/complaint
1.6
7.2
165
1062
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
7.2
101
568
Z35.7
ICD-10 Finland
Supervision of high-risk pregnancy due to social problems
15.8
7.2
11
7
F10.41
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol with seizures
15.8
7.2
11
7
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.8
7.2
106
606
K59.1
ICD-10 Finland
Functional diarrhoea
1.9
7.2
95
525
S01.51
ICD-10 Finland
Open wound on lip
2.7
7.2
36
133
WW200
NOMESCO Finland
Immunization
2.5
7.2
44
180
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.6
7.2
153
969
-50
ICPC
Medication/prescr/renewal
2.1
7.2
69
342
R04
ICPC
Breathing problem other
2.1
7.2
65
315
S06.2
ICD-10 Finland
Diffuse brain injury
4.0
7.2
20
51
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
4.0
7.2
20
51
F19.39
ICD-10 Finland
Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances UNS
30.1
7.1
9
*
F10.07
ICD-10 Finland
Pathological alcohol intoxication
30.1
7.1
9
*
F19.53
ICD-10 Finland
Psychotic disorder caused by several drugs in combination and by other psychoactive substances polymorphic
30.1
7.1
9
*
P71
ICPC
Organic psychosis other
30.1
7.1
9
*
ZXY13
NOMESCO Finland
Trainee psychologist, supervised
30.1
7.1
9
*
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
7.1
290
2112
F41
ICD-10 Finland
Other anxiety disorders
2.8
7.1
35
128
F13.00
ICD-10 Finland
Intoxication caused by sedatives and hypnotics uncomplicated
20.1
7.1
10
5
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
3.0
7.1
31
106
SPAT1394
SPAT
Counselling and guidance related to living conditions
6.6
7.1
17
26
H81.3
ICD-10 Finland
Other peripheral vertigo
2.7
7.1
36
134
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
3.8
7.1
21
56
N89
ICPC
Migraine
2.2
7.1
58
270
R41
ICD-10 Finland
Other symptoms and signs involving cognitive functions and awareness
4.1
7.1
19
47
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
12.1
7.1
12
10
XA400
NOMESCO Finland
EEG
6.0
7.1
18
30
OAA65, ,
SPAT
0.6
7.1
95
1626
F92.0
ICD-10 Finland
Depressive conduct disorder
8.8
7.0
14
16
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
8.8
7.0
14
16
Y19
ICD-10 Finland
Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent
8.8
7.0
14
16
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.4
7.0
285
2074
G40.6
ICD-10 Finland
Grand mal seizures, unspecified (with or without petit mal)
10.1
7.0
13
13
S01.8
ICD-10 Finland
Open wound of other parts of head
2.9
7.0
31
107
L15
ICPC
Knee symptom/complaint
1.4
7.0
396
3054
SPAT1127
SPAT
Enema
4.2
7.0
18
43
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.5
7.0
196
1323
A03CA02
ATC
clidinium and psycholeptics; oral
1.9
7.0
89
487
C10AA05
ATC
atorvastatin; oral
1.3
6.9
616
5086
EBA00, ,
SPAT
2.3
6.9
48
208
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
6.3
6.9
17
27
L13
ICPC
Hip symptom/complaint
1.4
6.9
300
2210
R10.0
ICD-10 Finland
Acute abdomen
2.2
6.9
53
240
SPAT1276
SPAT
Outlining of treatment with patient or their family members
2.4
6.9
47
202
A92
ICPC
Allergy/allergic reaction NOS
2.2
6.9
55
253
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
3.7
6.9
21
57
E22.1
ICD-10 Finland
Hyperprolactinaemia
5.9
6.9
18
31
IEP01
NOMESCO Finland
Psychoeducation, family
7.6
6.9
15
20
F51.9
ICD-10 Finland
Nonorganic sleep disorder, unspecified
2.6
6.9
37
142
X99.9
ICD-10 Finland
Assault by sharp object by unknown person
13.8
6.9
11
8
W17
ICD-10 Finland
Other fall from one level to another
2.0
6.9
70
355
F80.1
ICD-10 Finland
Expressive language disorder
3.5
6.8
23
67
XF402
NOMESCO Finland
ECG with work load test
1.6
6.8
148
941
G31.0
ICD-10 Finland
Circumscribed brain atrophy
8.3
6.8
14
17
IFA01, ,
SPAT
8.3
6.8
14
17
G40
ICD-10 Finland
Epilepsy
4.1
6.8
18
44
J01CA04
ATC
amoxicillin; systemic
1.4
6.8
1360
12524
I50.0
ICD-10 Finland
Congestive heart failure
1.6
6.8
140
879
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
11.0
6.8
12
11
3090A
ICD-9 Finland
Adjustment reaction, Brief depressive reaction
9.3
6.8
13
14
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.3
6.8
47
204
H60.8
ICD-10 Finland
Other otitis externa
2.3
6.8
50
223
Z71.4
ICD-10 Finland
Alcohol abuse counselling and surveillance
6.1
6.8
17
28
N06AG02
ATC
moclobemide; oral
2.1
6.8
62
302
IEY10
NOMESCO Finland
Art therapy
40.2
6.8
8
*
F12.24
ICD-10 Finland
Addiction caused by cannabis active addiction
40.2
6.8
8
*
IBB04
NOMESCO Finland
Risk assessment concerning problem behaviour
40.2
6.8
8
*
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.3
6.8
49
217
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
2.0
6.7
73
378
RS214, ,
NOMESCO Finland
16.8
6.7
10
6
G25.1
ICD-10 Finland
Drug-induced tremor
16.8
6.7
10
6
R32
ICD-10 Finland
Unspecified urinary incontinence
2.2
6.7
53
243
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
1.7
6.7
113
672
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.8
6.7
95
537
SPAT1153
SPAT
Removal of sutures
1.3
6.7
469
3737
R09.1
ICD-10 Finland
Pleurisy
2.9
6.7
31
110
D02
ICPC
Abdominal pain epigastric
1.8
6.7
98
560
U01
ICPC
Dysuria/painful urination
1.7
6.7
132
820
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.4
6.7
311
2320
ZYB01
NOMESCO Finland
Outreach service at unit of same specialty
22.6
6.7
9
*
ZYB07
NOMESCO Finland
Outreach service at sheltered housing unit
22.6
6.7
9
*
F01.22
ICD-10 Finland
Subcortical vascular dementia with additional symptoms, mainly hallucinations
22.6
6.7
9
*
F19.40
ICD-10 Finland
Withdrawal symptoms with delirium caused by several drugs in combination and by other psychoactive substances without seizures
22.6
6.7
9
*
N30
ICD-10 Finland
Cystitis
1.7
6.7
130
805
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
1.8
6.7
93
524
K85
ICPC
Elevated blood pressure
1.4
6.6
263
1905
SPAT1212
SPAT
Extensive examination of musculoskeletal system
1.7
6.6
124
759
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.6
6.6
36
139
L16
ICPC
Ankle symptom/complaint
1.5
6.6
193
1314
M54.3
ICD-10 Finland
Sciatica
1.9
6.6
84
459
J01FF01
ATC
clindamycin; systemic
1.4
6.6
385
2983
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.6
6.6
150
966
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.6
6.6
136
855
IFC01, ,
SPAT
12.3
6.6
11
9
A01AB09
ATC
miconazole; local oral
1.6
6.6
141
895
S01.3
ICD-10 Finland
Open wound of ear
3.4
6.6
23
69
OAB91, ,
SPAT
0.3
6.6
17
560
H29
ICPC
Ear symptom/complaint other
1.5
6.6
194
1326
Y34
ICD-10 Finland
Unspecified event, undetermined intent
4.2
6.6
17
41
R45.8
ICD-10 Finland
Other symptoms and signs involving emotional state
8.7
6.6
13
15
F60.0
ICD-10 Finland
Paranoid personality disorder
8.7
6.6
13
15
SPE90
NOMESCO Finland
Other partial denture
2.6
6.5
37
146
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.6
6.5
169
1121
R04.0
ICD-10 Finland
Epistaxis
1.7
6.5
126
778
H70
ICPC
Otitis externa
2.5
6.5
38
152
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
2.1
6.5
56
266
R00.1
ICD-10 Finland
Bradycardia, unspecified
2.1
6.5
56
266
T11.1
ICD-10 Finland
Open wound of upper limb, level unspecified
6.9
6.5
15
22
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
6.9
6.5
15
22
ZXE20
NOMESCO Finland
More than three and less than five hours
1.5
6.5
198
1361
N06BA04
ATC
methylphenidate; oral
2.0
6.5
68
348
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.6
6.5
133
834
J01MA14
ATC
moxifloxacin; systemic
1.7
6.5
126
780
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.8
6.5
98
566
OAB40, ,
SPAT
6.2
6.5
16
26
C09AA05
ATC
ramipril; oral
1.4
6.5
379
2938
G47.0
ICD-10 Finland
Disorders of initiating and maintaining sleep [insomnias]
2.5
6.5
38
153
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
2.5
6.5
38
153
V48.9
ICD-10 Finland
Car occupant injured in noncollision transport accident, unspecified car occupant injured in traffic accident
5.7
6.5
17
30
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.1
6.4
61
301
M54.6
ICD-10 Finland
Pain in thoracic spine
1.7
6.4
111
665
103
Kela drug reimbursment
Diabetes, insulin-treated
1.4
6.4
405
3173
ZXA00
NOMESCO Finland
Right side
1.4
6.4
386
3002
F23.01
ICD-10 Finland
Acute polymorphic psychosis without an actual schizophrenic disease picture with an acute stress factor
70.1
6.4
7
*
IBA05, ,
NOMESCO Finland
70.1
6.4
7
*
3012C
ICD-9 Finland
Personality disorders, Schizoid personality disorder[PSYKOOSIPIIRTEINEN PERSOONALLISUUS]
70.1
6.4
7
*
F02.82
ICD-10 Finland
Dementia in other specified disease that is classified elsewhere other symptoms, mainly hallucinations
70.1
6.4
7
*
F23.09
ICD-10 Finland
Acute polymorphic psychosis without actual schizophrenic disease picture UNS
70.1
6.4
7
*
IER04, ,
SPAT
70.1
6.4
7
*
V03AA01, ,
ATC
3.3
6.4
23
70
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
2.0
6.4
71
371
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.7
6.4
104
613
F10
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol
14.4
6.4
10
7
IHZ29, ,
SPAT
14.4
6.4
10
7
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
14.4
6.4
10
7
F60.1
ICD-10 Finland
Schizoid personality disorder
14.4
6.4
10
7
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.4
6.4
285
2110
K25.3
ICD-10 Finland
Gastric ulcer, Acute without haemorrhage or perforation
3.8
6.4
19
51
A07AA02
ATC
nystatin; oral
1.8
6.4
92
524
SPAT1042
SPAT
Guidance concerning balance maintenance
8.2
6.3
13
16
S01.41
ICD-10 Finland
Open wound in the temple-jaw region
3.1
6.3
25
81
SPAT1244
SPAT
Occupational therapy
3.6
6.3
20
56
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
3.6
6.3
20
56
WX704
NOMESCO Finland
Intubation
1.7
6.3
114
692
K02.2
ICD-10 Finland
Caries of cementum
1.9
6.3
77
416
ZYC02
NOMESCO Finland
Remote contact by video link
11.1
6.3
11
10
RT420, ,
NOMESCO Finland
11.1
6.3
11
10
S99
ICPC
Skin disease other
2.5
6.3
39
161
S22
ICPC
Nail symptom/complaint
1.7
6.3
107
639
SPE01
NOMESCO Finland
Mucosa-supported partial denture
2.5
6.3
36
143
A80
ICPC
Trauma/injury NOS
2.7
6.3
31
114
C09CA03
ATC
valsartan; oral
1.6
6.3
139
889
E66.8
ICD-10 Finland
Other obesity
1.9
6.3
72
381
F84.5
ICD-10 Finland
Asperger syndrome
3.9
6.3
18
47
ZYB01, ,
SPAT
+∞
6.3
6
*
F15.7
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, residual and late-onset psychotic disorder
+∞
6.3
6
*
ZXY70
NOMESCO Finland
2-person team, nurse-physiotherapist
+∞
6.3
6
*
R46.8
ICD-10 Finland
Other symptoms and signs involving appearance and behaviour
+∞
6.3
6
*
W10
ICD-10 Finland
Fall on and from stairs and steps
1.8
6.2
83
461
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.5
6.2
167
1117
F13.9
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, unspecified mental and behavioural disorder
26.8
6.2
8
*
IBZ04, ,
SPAT
26.8
6.2
8
*
R03BA01
ATC
beclometasone; inhalant
1.5
6.2
196
1358
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
3.7
6.2
19
52
RF220, ,
NOMESCO Finland
3.1
6.2
25
82
WZC00, ,
SPAT
1.4
6.2
236
1697
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
2.1
6.2
56
272
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.4
6.2
297
2227
R29.6
ICD-10 Finland
Tendency to fall, not elsewhere classified
6.3
6.2
15
24
R4110, ,
SPAT
1.5
6.1
194
1344
S06.3
ICD-10 Finland
Focal brain injury
3.4
6.1
21
62
N06AA06
ATC
trimipramine; systemic
2.4
6.1
39
163
SPAT1059
SPAT
Spirometry at the office
1.9
6.1
78
427
NFJ54
NOMESCO Finland
Internal fixation of fracture of upper femur with intramedullary nail
2.5
6.1
38
157
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
7.7
6.1
13
17
F84.8
ICD-10 Finland
Other pervasive developmental disorders
12.6
6.1
10
8
K29.2
ICD-10 Finland
Alcoholic gastritis
12.6
6.1
10
8
M54.8
ICD-10 Finland
Other dorsalgia
1.9
6.1
70
371
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.7
6.1
98
577
Z97.2
ICD-10 Finland
Presence of dental prosthetic device (complete)(partial)
2.1
6.1
53
254
XCK10
NOMESCO Finland
Photography of fundus of eye
1.6
6.0
145
946
S42.0
ICD-10 Finland
Fracture of clavicle
2.2
6.0
47
215
N04BX02
ATC
entacapone; oral
6.7
6.0
14
21
ZYC03
NOMESCO Finland
Remote contact, text-based
6.7
6.0
14
21
Y04.2
ICD-10 Finland
Assault by bodily force by friend
10.1
6.0
11
11
IEY15
NOMESCO Finland
Acute psychiatry, stabilising intervention
10.1
6.0
11
11
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
3.2
6.0
23
73
H57.1
ICD-10 Finland
Ocular pain
2.1
6.0
56
275
W06
ICD-10 Finland
Fall involving bed
3.3
6.0
22
68

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Unspecified nonorganic psychosis
F29 [45533099]
2.7e+00
3.5e+00
3.9e+00
—
5.1e+00
4.7e+00
3.9e+00
cases:5.73%
controls:0.42%
cases:5.39%
controls:0.18%
cases:3.17%
controls:0.07%
—
—
cases:8.51%
controls:0.06%
cases:14.83%
controls:0.15%
cases:16.85%
controls:0.42%
103
76
1695
17896
97
32
1702
17950
57
12
1742
17970
—
152
10
1634
17890
247
26
1418
16921
203
55
1002
12934
Psychiatry
26 [38004469]
1.9e+00
2.5e+00
2.9e+00
6.1e+00
3.9e+00
3.4e+00
2.6e+00
cases:23.47%
controls:4.43%
cases:20.46%
controls:2.11%
cases:13.45%
controls:0.89%
cases:27.24%
controls:0.08%
cases:28.61%
controls:0.84%
cases:38.20%
controls:2.10%
cases:42.41%
controls:5.27%
422
796
1376
17176
368
379
1431
17603
242
160
1557
17822
490
15
1309
17967
511
150
1275
17750
636
356
1029
16591
511
685
694
12304
risperidone; oral, parenteral
N05AX08 [21604559]
1.8e+00
2.2e+00
2.7e+00
3.5e+00
3.7e+00
3.3e+00
2.7e+00
cases:7.01%
controls:1.24%
cases:8.12%
controls:1.01%
cases:5.84%
controls:0.39%
cases:0.94%
controls:0.03%
cases:15.45%
controls:0.45%
cases:23.42%
controls:1.09%
cases:23.98%
controls:2.05%
126
222
1672
17750
146
181
1653
17801
105
71
1694
17911
17
5
1782
17977
276
80
1510
17820
390
185
1275
16762
289
266
916
12723
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
2.5e+00
3.1e+00
3.1e+00
1.0e+50
4.1e+00
3.1e+00
2.6e+00
cases:6.79%
controls:0.61%
cases:3.61%
controls:0.17%
cases:1.17%
controls:0.06%
cases:2.06%
controls:0.00%
cases:1.74%
controls:0.03%
cases:4.32%
controls:0.20%
cases:7.97%
controls:0.64%
122
109
1676
17863
65
31
1734
17951
21
10
1778
17972
37
0
1762
17982
31
5
1755
17895
72
34
1593
16913
96
83
1109
12906
Emotionally unstable personality disorder, borderline condition
F60.31 [2000502023]
2.8e+00
2.8e+00
3.1e+00
—
3.5e+00
3.3e+00
2.9e+00
cases:1.67%
controls:0.10%
cases:1.33%
controls:0.08%
cases:0.89%
controls:0.04%
—
—
cases:1.29%
controls:0.04%
cases:2.10%
controls:0.08%
cases:3.24%
controls:0.19%
30
18
1768
17954
24
15
1775
17967
16
7
1783
17975
—
23
7
1763
17893
35
13
1630
16934
39
25
1166
12964
olanzapine; oral, parenteral
N05AH03 [21604543]
2.3e+00
2.6e+00
2.9e+00
—
3.6e+00
3.7e+00
3.3e+00
cases:8.73%
controls:0.91%
cases:7.67%
controls:0.63%
cases:4.34%
controls:0.24%
—
—
cases:7.73%
controls:0.23%
cases:20.54%
controls:0.64%
cases:23.82%
controls:1.18%
157
163
1641
17809
138
114
1661
17868
78
44
1721
17938
—
138
41
1648
17859
342
108
1323
16839
287
153
918
12836
Neurology
13 [38004458]
1.3e+00
1.7e+00
2.3e+00
6.5e+00
2.7e+00
2.2e+00
1.5e+00
cases:25.25%
controls:8.81%
cases:16.45%
controls:3.50%
cases:5.78%
controls:0.62%
cases:15.45%
controls:0.03%
cases:8.85%
controls:0.64%
cases:23.42%
controls:3.33%
cases:28.80%
controls:8.18%
454
1584
1344
16388
296
629
1503
17353
104
112
1695
17870
278
5
1521
17977
158
114
1628
17786
390
564
1275
16383
347
1062
858
11927
quetiapine; oral
N05AH04 [21604544]
1.9e+00
2.1e+00
2.3e+00
3.5e+00
2.9e+00
2.7e+00
2.5e+00
cases:18.85%
controls:3.38%
cases:17.40%
controls:2.40%
cases:7.62%
controls:0.81%
cases:1.39%
controls:0.04%
cases:11.93%
controls:0.72%
cases:28.71%
controls:2.64%
cases:36.02%
controls:4.63%
339
608
1459
17364
313
431
1486
17551
137
146
1662
17836
25
8
1774
17974
213
128
1573
17772
478
447
1187
16500
434
601
771
12388
Emergency Room Visit
ER [9203]
1.0e+00
1.3e+00
2.3e+00
7.4e+00
2.5e+00
1.5e+00
1.2e+00
cases:59.84%
controls:35.27%
cases:32.02%
controls:11.11%
cases:12.67%
controls:1.43%
cases:35.63%
controls:0.03%
cases:14.28%
controls:1.39%
cases:34.53%
controls:10.61%
cases:55.52%
controls:28.09%
1076
6338
722
11634
576
1998
1223
15984
228
258
1571
17724
641
6
1158
17976
255
249
1531
17651
575
1798
1090
15149
669
3649
536
9340
Methadone [Presence] in Urine by Screen method
19550-3 [3028707]
2.1e+00
2.4e+00
2.5e+00
1.0e+50
4.2e+00
3.1e+00
2.4e+00
cases:3.17%
controls:0.42%
cases:2.39%
controls:0.21%
cases:0.83%
controls:0.07%
cases:0.89%
controls:0.00%
cases:1.90%
controls:0.03%
cases:3.18%
controls:0.15%
cases:6.06%
controls:0.60%
57
75
1741
17897
43
38
1756
17944
15
12
1784
17970
16
0
1783
17982
34
5
1752
17895
53
26
1612
16921
73
78
1132
12911
Psychiatric monitoring contact
IGY02 [2001304322]
2.3e+00
2.4e+00
2.7e+00
1.0e+50
3.3e+00
3.4e+00
2.6e+00
cases:2.45%
controls:0.25%
cases:1.67%
controls:0.16%
cases:0.56%
controls:0.04%
cases:0.33%
controls:0.00%
cases:1.51%
controls:0.06%
cases:4.98%
controls:0.17%
cases:6.89%
controls:0.54%
44
45
1754
17927
30
28
1769
17954
10
7
1789
17975
6
0
1793
17982
27
10
1759
17890
83
29
1582
16918
83
70
1122
12919
General Practice
1 [38004446]
1.1e+00
1.4e+00
2.1e+00
6.6e+00
2.6e+00
1.6e+00
1.2e+00
cases:38.32%
controls:17.47%
cases:23.01%
controls:7.17%
cases:8.28%
controls:1.05%
cases:24.51%
controls:0.04%
cases:14.22%
controls:1.17%
cases:30.03%
controls:7.68%
cases:43.40%
controls:18.85%
689
3140
1109
14832
414
1289
1385
16693
149
188
1650
17794
441
8
1358
17974
254
209
1532
17691
500
1302
1165
15645
523
2449
682
10540
Delusional disorder
F22.0 [45581451]
2.1e+00
2.9e+00
—
1.0e+50
4.2e+00
4.1e+00
3.2e+00
cases:1.22%
controls:0.16%
cases:0.94%
controls:0.05%
—
—
cases:1.67%
controls:0.00%
cases:1.90%
controls:0.03%
cases:4.20%
controls:0.07%
cases:5.31%
controls:0.23%
22
28
1776
17944
17
9
1782
17973
—
30
0
1769
17982
34
5
1752
17895
70
12
1595
16935
64
30
1141
12959
Participation in compiling a psychiatric treatment plan
ICZ03 [2001304119]
2.1e+00
2.6e+00
2.5e+00
1.0e+50
3.4e+00
3.1e+00
2.9e+00
cases:2.67%
controls:0.35%
cases:2.33%
controls:0.17%
cases:0.39%
controls:0.03%
cases:1.06%
controls:0.00%
cases:1.12%
controls:0.04%
cases:4.44%
controls:0.21%
cases:7.80%
controls:0.45%
48
63
1750
17909
42
31
1757
17951
7
6
1792
17976
19
0
1780
17982
20
7
1766
17893
74
35
1591
16912
94
59
1111
12930
Poisoning by systemic antibiotics
T36 [45756588]
2.7e+00
3.1e+00
3.4e+00
1.0e+50
—
3.7e+00
3.4e+00
cases:4.62%
controls:0.32%
cases:2.67%
controls:0.13%
cases:0.83%
controls:0.03%
cases:0.33%
controls:0.00%
—
—
cases:3.36%
controls:0.08%
cases:6.47%
controls:0.24%
83
58
1715
17914
48
23
1751
17959
15
5
1784
17977
6
0
1793
17982
—
56
14
1609
16933
78
31
1127
12958
Dedicated profession-specific psychiatric intervention, individual
IEY05 [2001304224]
2.2e+00
2.7e+00
2.4e+00
—
3.0e+00
3.2e+00
2.6e+00
cases:2.67%
controls:0.31%
cases:3.00%
controls:0.20%
cases:1.11%
controls:0.11%
—
—
cases:2.69%
controls:0.13%
cases:6.01%
controls:0.25%
cases:8.80%
controls:0.68%
48
55
1750
17917
54
36
1745
17946
20
19
1779
17963
—
48
24
1738
17876
100
42
1565
16905
106
88
1099
12901
Undifferentiated schizophrenia continuous
F20.30 [2000501944]
1.9e+00
2.4e+00
3.2e+00
—
2.9e+00
2.9e+00
2.9e+00
cases:1.17%
controls:0.18%
cases:1.00%
controls:0.09%
cases:0.78%
controls:0.03%
—
—
cases:0.73%
controls:0.04%
cases:1.62%
controls:0.09%
cases:2.90%
controls:0.16%
21
32
1777
17940
18
17
1781
17965
14
6
1785
17976
—
13
7
1773
17893
27
15
1638
16932
35
21
1170
12968
aripiprazole; oral, parenteral
N05AX12 [21604562]
2.2e+00
2.4e+00
2.5e+00
—
2.6e+00
3.2e+00
3.1e+00
cases:5.39%
controls:0.61%
cases:4.56%
controls:0.42%
cases:2.06%
controls:0.18%
—
—
cases:2.52%
controls:0.19%
cases:9.91%
controls:0.44%
cases:14.27%
controls:0.73%
97
109
1701
17863
82
75
1717
17907
37
32
1762
17950
—
45
34
1741
17866
165
74
1500
16873
172
95
1033
12894
Schizoaffective disorder, unspecified
F25.9 [45605490]
2.8e+00
2.7e+00
3.1e+00
—
—
3.7e+00
3.7e+00
cases:1.33%
controls:0.08%
cases:1.11%
controls:0.07%
cases:0.61%
controls:0.03%
—
—
—
—
cases:1.68%
controls:0.04%
cases:3.73%
controls:0.10%
24
15
1774
17957
20
13
1779
17969
11
5
1788
17977
—
—
28
7
1637
16940
45
13
1160
12976
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
1.6e+00
2.4e+00
3.2e+00
1.0e+50
3.8e+00
2.9e+00
1.9e+00
cases:6.01%
controls:1.27%
cases:3.78%
controls:0.36%
cases:2.17%
controls:0.09%
cases:1.83%
controls:0.00%
cases:3.98%
controls:0.09%
cases:6.13%
controls:0.35%
cases:8.55%
controls:1.35%
108
228
1690
17744
68
64
1731
17918
39
16
1760
17966
33
0
1766
17982
71
16
1715
17884
102
59
1563
16888
103
175
1102
12814
Emotionally unstable personality disorder, impulsive
F60.30 [2000502022]
2.7e+00
3.0e+00
—
1.0e+50
3.4e+00
3.5e+00
3.2e+00
cases:2.28%
controls:0.16%
cases:1.83%
controls:0.09%
—
—
cases:0.83%
controls:0.00%
cases:1.12%
controls:0.04%
cases:2.58%
controls:0.08%
cases:3.82%
controls:0.15%
41
29
1757
17943
33
16
1766
17966
—
15
0
1784
17982
20
7
1766
17893
43
13
1622
16934
46
20
1159
12969
Schizophrenia, unspecified
F20.9 [45576533]
2.1e+00
2.0e+00
2.9e+00
1.0e+50
3.0e+00
2.9e+00
2.9e+00
cases:1.67%
controls:0.21%
cases:0.78%
controls:0.11%
cases:0.50%
controls:0.03%
cases:0.28%
controls:0.00%
cases:0.56%
controls:0.03%
cases:2.10%
controls:0.12%
cases:4.73%
controls:0.26%
30
38
1768
17934
14
19
1785
17963
9
5
1790
17977
5
0
1794
17982
10
5
1776
17895
35
21
1630
16926
57
34
1148
12955
chlorprothixene; oral, parenteral
N05AF03 [21604533]
2.6e+00
2.3e+00
2.8e+00
—
2.3e+00
2.8e+00
2.9e+00
cases:2.67%
controls:0.20%
cases:1.33%
controls:0.13%
cases:0.44%
controls:0.03%
—
—
cases:0.56%
controls:0.06%
cases:1.62%
controls:0.10%
cases:2.90%
controls:0.16%
48
36
1750
17936
24
24
1775
17958
8
5
1791
17977
—
10
10
1776
17890
27
17
1638
16930
35
21
1170
12968
Valproate [Moles/volume] in Serum or Plasma
14946-8 [3009466]
1.9e+00
1.8e+00
2.4e+00
—
4.0e+00
2.9e+00
2.6e+00
cases:2.22%
controls:0.32%
cases:1.22%
controls:0.21%
cases:0.44%
controls:0.04%
—
—
cases:1.46%
controls:0.03%
cases:3.12%
controls:0.18%
cases:5.73%
controls:0.46%
40
58
1758
17914
22
37
1777
17945
8
7
1791
17975
—
26
5
1760
17895
52
31
1613
16916
69
60
1136
12929
Recurrent depressive disorder, unspecified
F33.9 [45581458]
2.0e+00
2.6e+00
3.0e+00
1.0e+50
3.0e+00
3.1e+00
1.9e+00
cases:2.56%
controls:0.36%
cases:1.50%
controls:0.12%
cases:0.89%
controls:0.04%
cases:0.83%
controls:0.00%
cases:0.78%
controls:0.04%
cases:2.52%
controls:0.12%
cases:3.07%
controls:0.46%
46
64
1752
17908
27
21
1772
17961
16
8
1783
17974
15
0
1784
17982
14
7
1772
17893
42
20
1623
16927
37
60
1168
12929
Paranoid schizophrenia continuous
F20.00 [2000501920]
2.2e+00
2.3e+00
2.5e+00
1.0e+50
3.0e+00
2.9e+00
2.6e+00
cases:2.06%
controls:0.23%
cases:1.33%
controls:0.13%
cases:0.78%
controls:0.07%
cases:1.11%
controls:0.00%
cases:1.12%
controls:0.06%
cases:2.52%
controls:0.15%
cases:4.48%
controls:0.33%
37
41
1761
17931
24
24
1775
17958
14
12
1785
17970
20
0
1779
17982
20
10
1766
17890
42
25
1623
16922
54
43
1151
12946
perphenazine; oral, parenteral, rectal
N05AB03 [21604502]
2.1e+00
2.3e+00
2.7e+00
—
2.9e+00
2.6e+00
2.8e+00
cases:2.73%
controls:0.34%
cases:2.06%
controls:0.22%
cases:0.94%
controls:0.06%
—
—
cases:1.18%
controls:0.07%
cases:2.82%
controls:0.21%
cases:4.32%
controls:0.28%
49
61
1749
17911
37
39
1762
17943
17
11
1782
17971
—
21
12
1765
17888
47
36
1618
16911
52
36
1153
12953
Bipolar affective disorder, unspecified
F31.9 [45571758]
1.9e+00
2.3e+00
2.6e+00
1.0e+50
3.6e+00
2.7e+00
2.4e+00
cases:1.78%
controls:0.28%
cases:1.33%
controls:0.13%
cases:0.50%
controls:0.04%
cases:0.72%
controls:0.00%
cases:1.01%
controls:0.03%
cases:2.28%
controls:0.16%
cases:3.73%
controls:0.36%
32
50
1766
17922
24
24
1775
17958
9
7
1790
17975
13
0
1786
17982
18
5
1768
17895
38
27
1627
16920
45
47
1160
12942
Emergency Medicine
93 [38004510]
7.5e-01
1.3e+00
2.1e+00
7.0e+00
2.1e+00
1.3e+00
9.1e-01
cases:33.48%
controls:19.25%
cases:27.63%
controls:9.83%
cases:11.34%
controls:1.49%
cases:32.30%
controls:0.04%
cases:11.20%
controls:1.50%
cases:29.79%
controls:10.76%
cases:48.22%
controls:27.33%
602
3460
1196
14512
497
1767
1302
16215
204
268
1595
17714
581
8
1218
17974
200
268
1586
17632
496
1823
1169
15124
581
3550
624
9439
Geriatric Psychiatry
27 [38004470]
1.8e+00
2.9e+00
2.8e+00
1.0e+50
—
4.5e+00
3.3e+00
cases:1.67%
controls:0.28%
cases:1.06%
controls:0.06%
cases:0.67%
controls:0.04%
cases:2.45%
controls:0.00%
—
—
cases:6.01%
controls:0.07%
cases:4.15%
controls:0.16%
30
50
1768
17922
19
11
1780
17971
12
7
1787
17975
44
0
1755
17982
—
100
12
1565
16935
50
21
1155
12968
levomepromazine; oral, parenteral
N05AA02 [21604493]
2.5e+00
2.3e+00
2.1e+00
—
2.8e+00
2.6e+00
2.8e+00
cases:3.95%
controls:0.32%
cases:2.00%
controls:0.21%
cases:0.56%
controls:0.07%
—
—
cases:0.90%
controls:0.06%
cases:2.70%
controls:0.20%
cases:5.39%
controls:0.33%
71
58
1727
17914
36
38
1763
17944
10
12
1789
17970
—
16
10
1770
17890
45
34
1620
16913
65
43
1140
12946
Hospital outpatient
ZY010 [2001311599]
1.6e+00
2.0e+00
3.0e+00
—
3.1e+00
2.8e+00
2.6e+00
cases:3.84%
controls:0.78%
cases:2.22%
controls:0.30%
cases:1.17%
controls:0.06%
—
—
cases:2.13%
controls:0.10%
cases:4.02%
controls:0.25%
cases:5.81%
controls:0.44%
69
141
1729
17831
40
54
1759
17928
21
11
1778
17971
—
38
18
1748
17882
67
43
1598
16904
70
57
1135
12932
Inpatient Hospital
21 [8717]
8.1e-01
1.1e+00
1.9e+00
6.0e+00
2.9e+00
1.4e+00
1.0e+00
cases:49.05%
controls:30.07%
cases:22.90%
controls:9.10%
cases:7.67%
controls:1.27%
cases:23.79%
controls:0.08%
cases:16.63%
controls:1.13%
cases:26.85%
controls:8.20%
cases:41.41%
controls:19.88%
882
5404
916
12568
412
1636
1387
16346
138
229
1661
17753
428
14
1371
17968
297
202
1489
17698
447
1389
1218
15558
499
2582
706
10407
Social worker
Z2446 [2001311559]
1.7e+00
2.3e+00
2.2e+00
—
3.4e+00
2.6e+00
2.7e+00
cases:4.00%
controls:0.75%
cases:1.72%
controls:0.18%
cases:0.33%
controls:0.04%
—
—
cases:0.95%
controls:0.03%
cases:1.86%
controls:0.14%
cases:3.98%
controls:0.28%
72
134
1726
17838
31
32
1768
17950
6
7
1793
17975
—
17
6
1769
17894
31
23
1634
16924
48
37
1157
12952
Procedure duration 60 to 89 minutes
ZXE11 [2001311402]
1.3e+00
1.7e+00
3.0e+00
1.0e+50
3.2e+00
2.7e+00
2.9e+00
cases:3.06%
controls:0.86%
cases:1.50%
controls:0.29%
cases:0.56%
controls:0.03%
cases:0.72%
controls:0.00%
cases:1.18%
controls:0.05%
cases:3.12%
controls:0.21%
cases:5.06%
controls:0.28%
55
154
1743
17818
27
52
1772
17930
10
5
1789
17977
13
0
1786
17982
21
9
1765
17891
52
35
1613
16912
61
37
1144
12952
Other bipolar affective disorders
F31.8 [45586237]
2.0e+00
2.1e+00
2.6e+00
—
2.7e+00
2.9e+00
2.2e+00
cases:1.06%
controls:0.14%
cases:0.67%
controls:0.08%
cases:0.39%
controls:0.03%
—
—
cases:0.50%
controls:0.03%
cases:1.20%
controls:0.06%
cases:1.49%
controls:0.16%
19
25
1779
17947
12
15
1787
17967
7
5
1792
17977
—
9
6
1777
17894
20
11
1645
16936
18
21
1187
12968
Buprenorphine [Presence] in Urine by Screen method
93494-3 [1001926]
1.7e+00
2.0e+00
2.3e+00
1.0e+50
4.1e+00
2.6e+00
1.7e+00
cases:3.73%
controls:0.69%
cases:2.50%
controls:0.33%
cases:0.78%
controls:0.08%
cases:0.94%
controls:0.00%
cases:1.90%
controls:0.03%
cases:3.66%
controls:0.27%
cases:6.80%
controls:1.29%
67
124
1731
17848
45
60
1754
17922
14
14
1785
17968
17
0
1782
17982
34
6
1752
17894
61
46
1604
16901
82
168
1123
12821
Depressive episode, unspecified
F32.9 [45571760]
1.7e+00
2.1e+00
3.2e+00
—
3.1e+00
2.5e+00
1.8e+00
cases:8.29%
controls:1.59%
cases:4.95%
controls:0.61%
cases:2.17%
controls:0.09%
—
—
cases:2.58%
controls:0.12%
cases:7.27%
controls:0.62%
cases:10.62%
controls:2.01%
149
285
1649
17687
89
110
1710
17872
39
17
1760
17965
—
46
21
1740
17879
121
105
1544
16842
128
261
1077
12728
Psychological sympt/compl other
P29 [2002000823]
1.5e+00
2.3e+00
3.1e+00
—
3.0e+00
2.4e+00
1.9e+00
cases:4.12%
controls:0.94%
cases:3.22%
controls:0.32%
cases:2.00%
controls:0.09%
—
—
cases:1.51%
controls:0.07%
cases:4.32%
controls:0.40%
cases:8.13%
controls:1.28%
74
169
1724
17803
58
57
1741
17925
36
16
1763
17966
—
27
13
1759
17887
72
68
1593
16879
98
166
1107
12823
Schizophrenia
P72 [2002000866]
2.0e+00
2.3e+00
2.2e+00
—
2.3e+00
2.7e+00
3.0e+00
cases:1.39%
controls:0.19%
cases:0.94%
controls:0.10%
cases:0.33%
controls:0.04%
—
—
cases:0.39%
controls:0.04%
cases:1.56%
controls:0.11%
cases:4.65%
controls:0.25%
25
35
1773
17937
17
18
1782
17964
6
7
1793
17975
—
7
7
1779
17893
26
18
1639
16929
56
32
1149
12957
lithium; oral
N05AN01 [21604556]
2.0e+00
2.4e+00
2.4e+00
—
2.1e+00
2.6e+00
2.9e+00
cases:1.89%
controls:0.26%
cases:1.67%
controls:0.16%
cases:0.56%
controls:0.05%
—
—
cases:0.45%
controls:0.06%
cases:1.80%
controls:0.14%
cases:3.32%
controls:0.18%
34
47
1764
17925
30
29
1769
17953
10
9
1789
17973
—
8
10
1778
17890
30
23
1635
16924
40
24
1165
12965
Profession-specific psychiatric evaluation
IBZ01 [2001304075]
2.3e+00
2.7e+00
—
—
3.2e+00
3.4e+00
2.7e+00
cases:1.56%
controls:0.16%
cases:1.33%
controls:0.09%
—
—
—
—
cases:0.78%
controls:0.03%
cases:2.82%
controls:0.09%
cases:4.65%
controls:0.32%
28
29
1770
17943
24
16
1775
17966
—
—
14
6
1772
17894
47
16
1618
16931
56
41
1149
12948
Procedure duration 50 to 59 minutes
ZXE06 [2001311400]
1.5e+00
1.8e+00
2.4e+00
—
2.9e+00
2.8e+00
2.8e+00
cases:3.06%
controls:0.69%
cases:1.56%
controls:0.26%
cases:0.44%
controls:0.04%
—
—
cases:0.73%
controls:0.04%
cases:2.52%
controls:0.15%
cases:4.81%
controls:0.32%
55
124
1743
17848
28
47
1771
17935
8
7
1791
17975
—
13
7
1773
17893
42
26
1623
16921
58
41
1147
12948
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
1.9e+00
2.4e+00
2.8e+00
1.0e+50
2.5e+00
2.4e+00
2.0e+00
cases:3.11%
controls:0.47%
cases:2.33%
controls:0.21%
cases:0.94%
controls:0.06%
cases:0.72%
controls:0.00%
cases:0.84%
controls:0.07%
cases:2.64%
controls:0.25%
cases:4.23%
controls:0.61%
56
84
1742
17888
42
38
1757
17944
17
10
1782
17972
13
0
1786
17982
15
12
1771
17888
44
42
1621
16905
51
79
1154
12910
clozapine; oral, parenteral
N05AH02 [21604542]
2.0e+00
2.1e+00
2.2e+00
—
2.0e+00
2.6e+00
3.1e+00
cases:2.11%
controls:0.28%
cases:2.22%
controls:0.27%
cases:1.78%
controls:0.20%
—
—
cases:1.68%
controls:0.22%
cases:4.02%
controls:0.32%
cases:8.05%
controls:0.39%
38
51
1760
17921
40
49
1759
17933
32
36
1767
17946
—
30
40
1756
17860
67
54
1598
16893
97
51
1108
12938
lorazepam; oral, parenteral, sublingual
N05BA06 [21604571]
2.1e+00
2.1e+00
2.3e+00
—
2.3e+00
2.8e+00
2.4e+00
cases:5.78%
controls:0.77%
cases:4.45%
controls:0.54%
cases:1.78%
controls:0.18%
—
—
cases:2.02%
controls:0.21%
cases:8.05%
controls:0.55%
cases:11.12%
controls:1.13%
104
139
1694
17833
80
98
1719
17884
32
33
1767
17949
—
36
38
1750
17862
134
93
1531
16854
134
147
1071
12842
Amphetamines [Presence] in Urine
3349-8 [3027944]
1.4e+00
1.9e+00
2.5e+00
1.0e+50
4.1e+00
2.5e+00
1.5e+00
cases:3.45%
controls:0.85%
cases:2.33%
controls:0.37%
cases:0.83%
controls:0.07%
cases:1.06%
controls:0.00%
cases:1.96%
controls:0.03%
cases:3.60%
controls:0.31%
cases:6.89%
controls:1.60%
62
152
1736
17820
42
66
1757
17916
15
12
1784
17970
19
0
1780
17982
35
6
1751
17894
60
53
1605
16894
83
208
1122
12781
Bipolar disorder Depressive episode without somatic syndrome
F31.30 [2000501976]
2.0e+00
2.3e+00
2.3e+00
—
2.8e+00
2.4e+00
2.2e+00
cases:1.33%
controls:0.19%
cases:1.11%
controls:0.11%
cases:0.56%
controls:0.06%
—
—
cases:0.62%
controls:0.04%
cases:1.32%
controls:0.12%
cases:2.07%
controls:0.24%
24
34
1774
17938
20
20
1779
17962
10
10
1789
17972
—
11
7
1775
17893
22
21
1643
16926
25
31
1180
12958
Cocaine [Presence] in Urine
3397-7 [3016879]
1.6e+00
1.9e+00
2.4e+00
1.0e+50
3.8e+00
2.6e+00
1.6e+00
cases:3.78%
controls:0.79%
cases:2.45%
controls:0.39%
cases:0.83%
controls:0.08%
cases:1.11%
controls:0.00%
cases:2.02%
controls:0.04%
cases:3.78%
controls:0.29%
cases:7.05%
controls:1.46%
68
142
1730
17830
44
70
1755
17912
15
14
1784
17968
20
0
1779
17982
36
8
1750
17892
63
49
1602
16898
85
190
1120
12799
haloperidol; oral, parenteral
N05AD01 [21604516]
2.3e+00
2.0e+00
1.8e+00
—
3.5e+00
3.1e+00
2.9e+00
cases:2.17%
controls:0.22%
cases:1.17%
controls:0.16%
cases:0.28%
controls:0.04%
—
—
cases:1.40%
controls:0.04%
cases:3.06%
controls:0.14%
cases:5.23%
controls:0.29%
39
39
1759
17933
21
28
1778
17954
5
8
1794
17974
—
25
8
1761
17892
51
24
1614
16923
63
38
1142
12951
Parkinsonism
N87 [2002000787]
2.1e+00
2.4e+00
2.3e+00
—
2.8e+00
2.3e+00
1.9e+00
cases:1.39%
controls:0.18%
cases:1.11%
controls:0.11%
cases:0.39%
controls:0.04%
—
—
cases:0.78%
controls:0.05%
cases:1.56%
controls:0.15%
cases:1.58%
controls:0.23%
25
32
1773
17940
20
19
1779
17963
7
7
1792
17975
—
14
9
1772
17891
26
26
1639
16921
19
30
1186
12959
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
1.3e+00
1.7e+00
2.3e+00
—
4.5e+00
2.1e+00
1.7e+00
cases:7.73%
controls:2.19%
cases:4.56%
controls:0.84%
cases:1.17%
controls:0.12%
—
—
cases:4.98%
controls:0.06%
cases:5.95%
controls:0.77%
cases:14.94%
controls:3.22%
139
394
1659
17578
82
151
1717
17831
21
22
1778
17960
—
89
10
1697
17890
99
130
1566
16817
180
418
1025
12571
Chronic alcohol abuse
P15 [2002000811]
2.3e+00
2.4e+00
—
—
3.5e+00
2.8e+00
2.7e+00
cases:2.56%
controls:0.27%
cases:1.28%
controls:0.12%
—
—
—
—
cases:1.06%
controls:0.03%
cases:2.46%
controls:0.15%
cases:4.32%
controls:0.32%
46
49
1752
17923
23
22
1776
17960
—
—
19
6
1767
17894
41
25
1624
16922
52
41
1153
12948
Benzodiazepines [Presence] in Urine
3390-2 [3000764]
1.5e+00
1.9e+00
2.2e+00
1.0e+50
3.8e+00
2.5e+00
1.6e+00
cases:3.78%
controls:0.87%
cases:2.56%
controls:0.39%
cases:0.83%
controls:0.09%
cases:1.11%
controls:0.00%
cases:2.02%
controls:0.04%
cases:3.78%
controls:0.32%
cases:7.22%
controls:1.59%
68
157
1730
17815
46
70
1753
17912
15
16
1784
17966
20
0
1779
17982
36
8
1750
17892
63
55
1602
16892
87
207
1118
12782
Cannabinoids [Presence] in Urine
3427-2 [3028300]
1.5e+00
1.9e+00
2.2e+00
1.0e+50
3.8e+00
2.5e+00
1.6e+00
cases:3.78%
controls:0.88%
cases:2.56%
controls:0.39%
cases:0.83%
controls:0.09%
cases:1.11%
controls:0.00%
cases:2.02%
controls:0.04%
cases:3.78%
controls:0.32%
cases:7.22%
controls:1.61%
68
158
1730
17814
46
70
1753
17912
15
16
1784
17966
20
0
1779
17982
36
8
1750
17892
63
55
1602
16892
87
209
1118
12780
Parkinson disease
G20 [45538098]
2.1e+00
2.1e+00
2.5e+00
1.0e+50
3.1e+00
2.2e+00
1.5e+00
cases:4.39%
controls:0.57%
cases:3.89%
controls:0.49%
cases:1.89%
controls:0.16%
cases:3.00%
controls:0.00%
cases:2.91%
controls:0.14%
cases:4.68%
controls:0.55%
cases:3.49%
controls:0.76%
79
102
1719
17870
70
89
1729
17893
34
28
1765
17954
54
0
1745
17982
52
25
1734
17875
78
94
1587
16853
42
99
1163
12890
Opiates [Presence] in Urine
3879-4 [3027008]
1.5e+00
1.9e+00
2.2e+00
1.0e+50
3.8e+00
2.5e+00
1.5e+00
cases:3.73%
controls:0.88%
cases:2.56%
controls:0.39%
cases:0.83%
controls:0.09%
cases:1.11%
controls:0.00%
cases:2.02%
controls:0.04%
cases:3.72%
controls:0.32%
cases:7.14%
controls:1.61%
67
159
1731
17813
46
70
1753
17912
15
16
1784
17966
20
0
1779
17982
36
8
1750
17892
62
55
1603
16892
86
209
1119
12780
Severe psychotic and other severe mental disorders
112 [2001600112]
2.3e+00
3.1e+00
—
—
1.0e+50
4.7e+00
3.3e+00
cases:3.62%
controls:0.37%
cases:1.89%
controls:0.09%
—
—
—
—
cases:2.18%
controls:0.00%
cases:7.57%
controls:0.08%
cases:6.72%
controls:0.27%
65
66
1733
17906
34
16
1765
17966
—
—
39
0
1747
17900
126
13
1539
16934
81
35
1124
12954
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
N04BA03 [21604466]
2.2e+00
2.2e+00
2.5e+00
—
2.4e+00
2.2e+00
1.7e+00
cases:1.28%
controls:0.14%
cases:1.06%
controls:0.12%
cases:0.61%
controls:0.05%
—
—
cases:0.62%
controls:0.06%
cases:1.08%
controls:0.12%
cases:0.91%
controls:0.17%
23
26
1775
17946
19
22
1780
17960
11
9
1788
17973
—
11
10
1775
17890
18
20
1647
16927
11
22
1194
12967
Anxiety disorder, unspecified
F41.9 [45542849]
1.8e+00
2.3e+00
3.0e+00
—
2.5e+00
2.1e+00
1.6e+00
cases:6.06%
controls:1.04%
cases:4.28%
controls:0.47%
cases:1.89%
controls:0.10%
—
—
cases:1.62%
controls:0.14%
cases:4.68%
controls:0.59%
cases:8.13%
controls:1.82%
109
187
1689
17785
77
84
1722
17898
34
18
1765
17964
—
29
25
1757
17875
78
100
1587
16847
98
237
1107
12752
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 [45585661]
2.6e+00
3.2e+00
—
—
—
4.2e+00
3.2e+00
cases:3.39%
controls:0.26%
cases:1.95%
controls:0.08%
—
—
—
—
—
—
cases:3.00%
controls:0.05%
cases:4.65%
controls:0.21%
61
46
1737
17926
35
15
1764
17967
—
—
—
50
8
1615
16939
56
27
1149
12962
Drug abuse
P19 [2002000815]
2.2e+00
2.1e+00
2.5e+00
—
—
3.3e+00
2.9e+00
cases:1.11%
controls:0.12%
cases:0.61%
controls:0.07%
cases:0.33%
controls:0.03%
—
—
—
—
cases:1.26%
controls:0.05%
cases:1.91%
controls:0.11%
20
22
1778
17950
11
13
1788
17969
6
5
1793
17977
—
—
21
8
1644
16939
23
14
1182
12975
olanzapine and samidorphan
N05AH53 [955100]
2.5e+00
3.4e+00
—
—
—
4.0e+00
3.0e+00
cases:2.28%
controls:0.18%
cases:1.72%
controls:0.06%
—
—
—
—
—
—
cases:2.94%
controls:0.05%
cases:4.81%
controls:0.25%
41
33
1757
17939
31
11
1768
17971
—
—
—
49
9
1616
16938
58
33
1147
12956
Chronic viral hepatitis C
B18.2 [45590846]
3.0e+00
3.2e+00
—
1.0e+50
—
3.5e+00
3.1e+00
cases:1.84%
controls:0.09%
cases:1.11%
controls:0.04%
—
—
cases:0.33%
controls:0.00%
—
—
cases:1.20%
controls:0.04%
cases:2.49%
controls:0.12%
33
16
1765
17956
20
8
1779
17974
—
6
0
1793
17982
—
20
6
1645
16941
30
15
1175
12974
Norclozapine [Moles/volume] in Serum or Plasma
14851-0 [3008832]
2.0e+00
2.1e+00
1.5e+00
—
3.0e+00
2.8e+00
2.9e+00
cases:1.28%
controls:0.18%
cases:1.33%
controls:0.16%
cases:0.28%
controls:0.06%
—
—
cases:1.06%
controls:0.06%
cases:2.58%
controls:0.16%
cases:5.64%
controls:0.32%
23
33
1775
17939
24
29
1775
17953
5
11
1794
17971
—
19
10
1767
17890
43
27
1622
16920
68
42
1137
12947
clonazepam; oral, parenteral
N03AE01 [21604415]
1.7e+00
2.0e+00
2.6e+00
—
2.1e+00
2.0e+00
2.1e+00
cases:3.62%
controls:0.66%
cases:2.83%
controls:0.41%
cases:1.50%
controls:0.12%
—
—
cases:1.18%
controls:0.14%
cases:2.94%
controls:0.40%
cases:4.07%
controls:0.50%
65
118
1733
17854
51
74
1748
17908
27
21
1772
17961
—
21
25
1765
17875
49
67
1616
16880
49
65
1156
12924
cloZAPine [Moles/volume] in Serum or Plasma
14656-3 [3000081]
1.9e+00
2.1e+00
1.6e+00
—
2.8e+00
2.7e+00
2.9e+00
cases:1.28%
controls:0.20%
cases:1.50%
controls:0.18%
cases:0.33%
controls:0.07%
—
—
cases:1.23%
controls:0.07%
cases:2.82%
controls:0.19%
cases:5.89%
controls:0.33%
23
36
1775
17936
27
32
1772
17950
6
12
1793
17970
—
22
13
1764
17887
47
32
1618
16915
71
43
1134
12946
Mixed anxiety and depressive disorder
F41.2 [45566845]
1.5e+00
2.2e+00
2.8e+00
1.0e+50
2.6e+00
2.1e+00
1.2e+00
cases:3.89%
controls:0.87%
cases:2.78%
controls:0.32%
cases:1.06%
controls:0.07%
cases:1.00%
controls:0.00%
cases:1.29%
controls:0.10%
cases:3.06%
controls:0.38%
cases:4.81%
controls:1.52%
70
156
1728
17816
50
57
1749
17925
19
12
1780
17970
18
0
1781
17982
23
18
1763
17882
51
65
1614
16882
58
197
1147
12792
Urine methamphetamine measurement
313579004 [4198724]
2.5e+00
2.9e+00
—
1.0e+50
—
3.7e+00
3.2e+00
cases:1.61%
controls:0.13%
cases:1.11%
controls:0.06%
—
—
cases:0.67%
controls:0.00%
—
—
cases:1.68%
controls:0.04%
cases:2.32%
controls:0.10%
29
23
1769
17949
20
11
1779
17971
—
12
0
1787
17982
—
28
7
1637
16940
28
13
1177
12976
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
6.2e-01
1.1e+00
1.7e+00
5.2e+00
1.9e+00
1.1e+00
7.7e-01
cases:18.30%
controls:10.73%
cases:13.34%
controls:4.85%
cases:3.39%
controls:0.65%
cases:6.45%
controls:0.04%
cases:4.76%
controls:0.77%
cases:12.91%
controls:4.74%
cases:23.15%
controls:12.28%
329
1928
1469
16044
240
873
1559
17109
61
117
1738
17865
116
7
1683
17975
85
138
1701
17762
215
804
1450
16143
279
1595
926
11394
valproic acid; oral, parenteral, rectal
N03AG01 [21604422]
1.9e+00
1.9e+00
1.8e+00
—
2.0e+00
2.2e+00
2.5e+00
cases:5.06%
controls:0.82%
cases:4.00%
controls:0.61%
cases:1.56%
controls:0.25%
—
—
cases:1.34%
controls:0.19%
cases:5.65%
controls:0.65%
cases:9.71%
controls:0.89%
91
147
1707
17825
72
109
1727
17873
28
45
1771
17937
—
24
34
1762
17866
94
110
1571
16837
117
116
1088
12873
Bacteria [Presence] in Urine
87829-8 [36304419]
6.5e-01
1.1e+00
1.5e+00
5.1e+00
2.0e+00
1.1e+00
8.3e-01
cases:13.85%
controls:7.75%
cases:9.84%
controls:3.66%
cases:2.39%
controls:0.53%
cases:5.17%
controls:0.03%
cases:3.58%
controls:0.50%
cases:10.15%
controls:3.53%
cases:18.42%
controls:8.98%
249
1392
1549
16580
177
658
1622
17324
43
95
1756
17887
93
6
1706
17976
64
89
1722
17811
169
599
1496
16348
222
1166
983
11823
Internal Medicine
11 [38004456]
8.1e-01
9.6e-01
1.7e+00
5.3e+00
1.6e+00
1.1e+00
8.4e-01
cases:37.60%
controls:21.10%
cases:18.01%
controls:7.79%
cases:6.28%
controls:1.26%
cases:11.12%
controls:0.06%
cases:5.94%
controls:1.28%
cases:20.72%
controls:7.98%
cases:33.61%
controls:17.92%
676
3792
1122
14180
324
1400
1475
16582
113
227
1686
17755
200
11
1599
17971
106
229
1680
17671
345
1352
1320
15595
405
2327
800
10662
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
6.9e-01
1.1e+00
1.4e+00
5.3e+00
2.0e+00
1.0e+00
7.6e-01
cases:17.02%
controls:9.31%
cases:12.56%
controls:4.65%
cases:2.89%
controls:0.72%
cases:6.17%
controls:0.03%
cases:4.98%
controls:0.74%
cases:12.19%
controls:4.64%
cases:22.16%
controls:11.71%
306
1674
1492
16298
226
837
1573
17145
52
129
1747
17853
111
6
1688
17976
89
132
1697
17768
203
787
1462
16160
267
1521
938
11468
Alcohol intoxication UNS
F10.09 [2000501676]
2.2e+00
3.3e+00
—
—
—
3.4e+00
3.3e+00
cases:1.56%
controls:0.17%
cases:0.89%
controls:0.03%
—
—
—
—
—
—
cases:1.02%
controls:0.04%
cases:2.74%
controls:0.10%
28
31
1770
17941
16
6
1783
17976
—
—
—
17
6
1648
16941
33
13
1172
12976
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
6.4e-01
1.0e+00
1.6e+00
5.2e+00
1.9e+00
1.1e+00
8.0e-01
cases:14.18%
controls:8.01%
cases:10.34%
controls:4.04%
cases:2.67%
controls:0.56%
cases:5.50%
controls:0.03%
cases:3.98%
controls:0.59%
cases:10.45%
controls:3.89%
cases:19.25%
controls:9.65%
255
1440
1543
16532
186
726
1613
17256
48
100
1751
17882
99
6
1700
17976
71
105
1715
17795
174
660
1491
16287
232
1254
973
11735
Recurrent depressive disorder, current episode severe without psychotic symptoms
F33.2 [45547705]
1.8e+00
2.2e+00
2.2e+00
—
2.0e+00
2.2e+00
1.7e+00
cases:2.28%
controls:0.39%
cases:1.39%
controls:0.15%
cases:0.56%
controls:0.06%
—
—
cases:0.56%
controls:0.07%
cases:1.74%
controls:0.19%
cases:2.57%
controls:0.48%
41
70
1757
17902
25
27
1774
17955
10
11
1789
17971
—
10
13
1776
17887
29
33
1636
16914
31
62
1174
12927
Alcohol depence active use
F10.24 [2000501681]
2.4e+00
3.2e+00
—
1.0e+50
1.0e+50
3.4e+00
3.2e+00
cases:1.45%
controls:0.13%
cases:0.78%
controls:0.03%
—
—
cases:0.28%
controls:0.00%
cases:0.50%
controls:0.00%
cases:0.84%
controls:0.03%
cases:2.66%
controls:0.11%
26
23
1772
17949
14
6
1785
17976
—
5
0
1794
17982
9
0
1777
17900
14
5
1651
16942
32
14
1173
12975
Mixed personality disorders
F61.0 [2000502024]
2.4e+00
3.1e+00
—
—
—
3.2e+00
3.4e+00
cases:1.11%
controls:0.11%
cases:0.89%
controls:0.04%
—
—
—
—
—
—
cases:0.90%
controls:0.04%
cases:1.83%
controls:0.06%
20
19
1778
17953
16
7
1783
17975
—
—
—
15
6
1650
16941
22
8
1183
12981
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
6.0e-01
9.5e-01
1.3e+00
4.3e+00
2.8e+00
1.3e+00
8.6e-01
cases:27.31%
controls:17.13%
cases:17.12%
controls:7.39%
cases:3.78%
controls:1.05%
cases:2.45%
controls:0.03%
cases:12.88%
controls:0.89%
cases:22.34%
controls:7.37%
cases:40.66%
controls:22.47%
491
3078
1307
14894
308
1329
1491
16653
68
188
1731
17794
44
6
1755
17976
230
159
1556
17741
372
1249
1293
15698
490
2918
715
10071
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
4.9e-01
9.5e-01
1.6e+00
5.3e+00
1.9e+00
1.0e+00
7.7e-01
cases:32.20%
controls:22.62%
cases:24.46%
controls:11.13%
cases:8.67%
controls:1.82%
cases:12.28%
controls:0.07%
cases:10.41%
controls:1.72%
cases:25.77%
controls:11.18%
cases:43.40%
controls:26.14%
579
4066
1219
13906
440
2002
1359
15980
156
327
1643
17655
221
12
1578
17970
186
308
1600
17592
429
1895
1236
15052
523
3395
682
9594
Severe depressive episode with psychotic symptoms
F32.3 [45600739]
2.6e+00
2.7e+00
—
1.0e+50
—
4.0e+00
2.8e+00
cases:2.50%
controls:0.19%
cases:1.28%
controls:0.09%
—
—
cases:0.50%
controls:0.00%
—
—
cases:1.86%
controls:0.04%
cases:2.49%
controls:0.15%
45
34
1753
17938
23
16
1776
17966
—
9
0
1790
17982
—
31
6
1634
16941
30
20
1175
12969
Recurrent depression, moderate episode without somatic syndrome
F33.10 [2000501984]
1.5e+00
1.9e+00
2.8e+00
—
2.0e+00
2.2e+00
1.6e+00
cases:1.95%
controls:0.42%
cases:1.22%
controls:0.18%
cases:0.72%
controls:0.04%
—
—
cases:0.62%
controls:0.08%
cases:1.80%
controls:0.21%
cases:2.74%
controls:0.56%
35
76
1763
17896
22
33
1777
17949
13
8
1786
17974
—
11
15
1775
17885
30
35
1635
16912
33
73
1172
12916
Dedicated profession-specific psychiatric intervention, group
IER02 [2001304206]
2.2e+00
2.9e+00
—
1.0e+50
—
3.7e+00
3.3e+00
cases:0.67%
controls:0.08%
cases:0.61%
controls:0.03%
—
—
cases:0.33%
controls:0.00%
—
—
cases:1.62%
controls:0.04%
cases:2.74%
controls:0.11%
12
14
1786
17958
11
6
1788
17976
—
6
0
1793
17982
—
27
7
1638
16940
33
14
1172
12975
Leukocytes [#/volume] in Urine
30405-5 [3018095]
6.7e-01
1.0e+00
1.5e+00
5.1e+00
2.0e+00
1.0e+00
6.3e-01
cases:18.46%
controls:10.42%
cases:13.84%
controls:5.47%
cases:3.61%
controls:0.86%
cases:6.28%
controls:0.04%
cases:5.99%
controls:0.86%
cases:13.81%
controls:5.57%
cases:23.24%
controls:13.89%
332
1872
1466
16100
249
983
1550
16999
65
155
1734
17827
113
7
1686
17975
107
154
1679
17746
230
944
1435
16003
280
1804
925
11185
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
6.8e-01
9.5e-01
1.2e+00
4.3e+00
2.5e+00
1.3e+00
1.0e+00
cases:22.91%
controls:13.09%
cases:16.06%
controls:6.90%
cases:3.89%
controls:1.21%
cases:3.56%
controls:0.05%
cases:11.65%
controls:1.11%
cases:19.70%
controls:6.44%
cases:33.78%
controls:15.43%
412
2353
1386
15619
289
1241
1510
16741
70
218
1729
17764
64
9
1735
17973
208
198
1578
17702
328
1092
1337
15855
407
2004
798
10985
Inpatient Visit
IP [9201]
5.8e-01
8.5e-01
1.0e+00
4.9e+00
2.2e+00
1.3e+00
9.0e-01
cases:13.90%
controls:8.26%
cases:8.23%
controls:3.70%
cases:1.50%
controls:0.54%
cases:3.56%
controls:0.03%
cases:4.37%
controls:0.50%
cases:12.43%
controls:3.58%
cases:22.07%
controls:10.34%
250
1485
1548
16487
148
666
1651
17316
27
98
1772
17884
64
5
1735
17977
78
89
1708
17811
207
606
1458
16341
266
1343
939
11646
Psychiatric treatment plan, extended/prolonged
ICB02 [2001304099]
2.5e+00
2.8e+00
—
—
—
3.0e+00
3.5e+00
cases:0.95%
controls:0.08%
cases:0.78%
controls:0.05%
—
—
—
—
—
—
cases:1.14%
controls:0.06%
cases:2.99%
controls:0.09%
17
14
1781
17958
14
9
1785
17973
—
—
—
19
10
1646
16937
36
12
1169
12977
oxazepam; oral
N05BA04 [21604569]
1.2e+00
1.3e+00
1.6e+00
2.9e+00
1.8e+00
1.6e+00
1.4e+00
cases:15.24%
controls:5.09%
cases:9.89%
controls:2.99%
cases:4.11%
controls:0.90%
cases:0.50%
controls:0.03%
cases:4.98%
controls:0.89%
cases:13.57%
controls:3.07%
cases:21.16%
controls:6.19%
274
914
1524
17058
178
538
1621
17444
74
162
1725
17820
9
5
1790
17977
89
159
1697
17741
226
520
1439
16427
255
804
950
12185
Bacteria identified in Urine by Culture
630-4 [3026008]
6.6e-01
1.0e+00
1.5e+00
4.9e+00
2.0e+00
8.8e-01
7.4e-01
cases:17.07%
controls:9.65%
cases:11.90%
controls:4.60%
cases:3.22%
controls:0.76%
cases:4.28%
controls:0.03%
cases:4.82%
controls:0.68%
cases:11.59%
controls:5.15%
cases:23.57%
controls:12.77%
307
1734
1491
16238
214
827
1585
17155
58
137
1741
17845
77
6
1722
17976
86
122
1700
17778
193
873
1472
16074
284
1659
921
11330
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
6.7e-01
9.0e-01
1.3e+00
4.3e+00
2.5e+00
1.2e+00
8.8e-01
cases:25.08%
controls:14.68%
cases:17.57%
controls:8.00%
cases:4.72%
controls:1.38%
cases:4.22%
controls:0.06%
cases:13.33%
controls:1.28%
cases:21.80%
controls:7.87%
cases:35.85%
controls:18.83%
451
2638
1347
15334
316
1439
1483
16543
85
249
1714
17733
76
11
1723
17971
238
229
1548
17671
363
1334
1302
15613
432
2446
773
10543
Rehabilitative psychiatric group intervention, functional
IER04 [2001304208]
2.2e+00
2.6e+00
—
1.0e+50
—
3.7e+00
3.2e+00
cases:0.89%
controls:0.10%
cases:0.50%
controls:0.04%
—
—
cases:0.33%
controls:0.00%
—
—
cases:1.14%
controls:0.03%
cases:2.66%
controls:0.12%
16
18
1782
17954
9
7
1790
17975
—
6
0
1793
17982
—
19
5
1646
16942
32
15
1173
12974
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
1.5e+00
1.7e+00
2.3e+00
—
2.4e+00
1.9e+00
1.8e+00
cases:10.46%
controls:2.49%
cases:5.89%
controls:1.10%
cases:2.61%
controls:0.26%
—
—
cases:2.52%
controls:0.25%
cases:5.77%
controls:0.95%
cases:10.79%
controls:2.02%
188
447
1610
17525
106
198
1693
17784
47
46
1752
17936
—
45
44
1741
17856
96
161
1569
16786
130
263
1075
12726
Headache
R51.80 [2000503603]
1.2e+00
1.8e+00
2.7e+00
—
3.1e+00
1.6e+00
1.2e+00
cases:6.28%
controls:1.92%
cases:2.61%
controls:0.46%
cases:0.83%
controls:0.06%
—
—
cases:0.95%
controls:0.04%
cases:2.40%
controls:0.51%
cases:5.48%
controls:1.74%
113
345
1685
17627
47
82
1752
17900
15
10
1784
17972
—
17
8
1769
17892
40
86
1625
16861
66
226
1139
12763
Outpatient Hospital
22 [8756]
6.1e-01
8.5e-01
1.4e+00
4.4e+00
2.3e+00
1.2e+00
8.3e-01
cases:36.04%
controls:23.36%
cases:12.62%
controls:5.81%
cases:3.06%
controls:0.77%
cases:4.61%
controls:0.06%
cases:6.49%
controls:0.69%
cases:14.41%
controls:5.02%
cases:26.14%
controls:13.39%
648
4198
1150
13774
227
1045
1572
16937
55
139
1744
17843
83
11
1716
17971
116
123
1670
17777
240
850
1425
16097
315
1739
890
11250
pH of Serum or Plasma
2753-2 [3018418]
7.4e-01
9.1e-01
1.2e+00
4.0e+00
2.5e+00
1.1e+00
8.3e-01
cases:15.74%
controls:8.18%
cases:10.23%
controls:4.37%
cases:2.39%
controls:0.75%
cases:1.78%
controls:0.03%
cases:8.06%
controls:0.69%
cases:12.25%
controls:4.31%
cases:20.66%
controls:10.15%
283
1470
1515
16502
184
785
1615
17197
43
135
1756
17847
32
6
1767
17976
144
123
1642
17777
204
730
1461
16217
249
1319
956
11670
Addiction-induced dependence is currently independent but uses substitute intermittent medication
F11.22 [2000501716]
3.2e+00
2.4e+00
—
—
2.6e+00
—
3.1e+00
cases:0.78%
controls:0.03%
cases:0.50%
controls:0.04%
—
—
—
—
cases:0.39%
controls:0.03%
—
—
cases:1.33%
controls:0.06%
14
6
1784
17966
9
8
1790
17974
—
—
7
5
1779
17895
—
16
8
1189
12981
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
3.6e-01
7.8e-01
1.5e+00
5.0e+00
2.1e+00
9.5e-01
5.8e-01
cases:47.55%
controls:38.65%
cases:40.74%
controls:23.93%
cases:18.45%
controls:4.84%
cases:27.13%
controls:0.26%
cases:30.57%
controls:4.99%
cases:45.65%
controls:24.54%
cases:63.40%
controls:49.16%
855
6946
943
11026
733
4303
1066
13679
332
871
1467
17111
488
47
1311
17935
546
893
1240
17007
760
4158
905
12789
764
6385
441
6604
Accelerated psychiatric treatment contact
IGY01 [2001304321]
2.2e+00
2.8e+00
—
1.0e+50
—
3.5e+00
2.8e+00
cases:1.72%
controls:0.19%
cases:1.89%
controls:0.12%
—
—
cases:0.50%
controls:0.00%
—
—
cases:3.96%
controls:0.13%
cases:5.98%
controls:0.37%
31
35
1767
17937
34
22
1765
17960
—
9
0
1790
17982
—
66
22
1599
16925
72
48
1133
12941
Emotionally unstable personality disorder
F60.3 [45566852]
3.0e+00
2.8e+00
—
—
—
3.0e+00
2.4e+00
cases:0.78%
controls:0.04%
cases:0.56%
controls:0.03%
—
—
—
—
—
—
cases:0.60%
controls:0.03%
cases:1.16%
controls:0.11%
14
7
1784
17965
10
6
1789
17976
—
—
—
10
5
1655
16942
14
14
1191
12975
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
1.1e+00
1.3e+00
2.2e+00
1.0e+50
2.9e+00
2.3e+00
1.5e+00
cases:2.28%
controls:0.78%
cases:0.94%
controls:0.27%
cases:0.33%
controls:0.04%
cases:1.00%
controls:0.00%
cases:0.90%
controls:0.05%
cases:2.16%
controls:0.22%
cases:2.66%
controls:0.58%
41
141
1757
17831
17
48
1782
17934
6
7
1793
17975
18
0
1781
17982
16
9
1770
17891
36
38
1629
16909
32
75
1173
12914
Psychological disorders other
P99 [2002000880]
1.4e+00
2.1e+00
1.7e+00
—
2.5e+00
2.6e+00
2.6e+00
cases:1.56%
controls:0.37%
cases:1.17%
controls:0.14%
cases:0.39%
controls:0.07%
—
—
cases:0.73%
controls:0.06%
cases:2.10%
controls:0.17%
cases:5.23%
controls:0.42%
28
67
1770
17905
21
25
1778
17957
7
13
1792
17969
—
13
11
1773
17889
35
28
1630
16919
63
54
1142
12935
Psychosocial counselling and guidance
SPAT1307 [2001700408]
1.3e+00
1.8e+00
2.9e+00
—
2.5e+00
1.7e+00
9.6e-01
cases:3.28%
controls:0.92%
cases:1.83%
controls:0.31%
cases:0.61%
controls:0.03%
—
—
cases:0.67%
controls:0.06%
cases:1.62%
controls:0.30%
cases:2.49%
controls:0.97%
59
165
1739
17807
33
55
1766
17927
11
6
1788
17976
—
12
10
1774
17890
27
51
1638
16896
30
126
1175
12863
Child and Adolescent Psychiatry
OMOP4821986 [45756756]
1.1e+00
1.7e+00
2.2e+00
—
2.6e+00
2.0e+00
1.6e+00
cases:3.17%
controls:1.06%
cases:2.56%
controls:0.50%
cases:1.83%
controls:0.21%
—
—
cases:2.63%
controls:0.20%
cases:3.42%
controls:0.46%
cases:4.23%
controls:0.92%
57
190
1741
17782
46
90
1753
17892
33
38
1766
17944
—
47
35
1739
17865
57
78
1608
16869
51
120
1154
12869
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
7.1e-01
9.4e-01
1.5e+00
3.2e+00
2.4e+00
1.3e+00
1.0e+00
cases:14.74%
controls:7.85%
cases:8.23%
controls:3.38%
cases:2.11%
controls:0.47%
cases:0.67%
controls:0.03%
cases:4.98%
controls:0.45%
cases:11.29%
controls:3.28%
cases:23.82%
controls:10.17%
265
1411
1533
16561
148
607
1651
17375
38
84
1761
17898
12
5
1787
17977
89
81
1697
17819
188
556
1477
16391
287
1321
918
11668
Assessment of need for psychiatric treatment
IAA01 [2001304011]
2.4e+00
3.1e+00
—
1.0e+50
—
3.4e+00
2.2e+00
cases:2.39%
controls:0.21%
cases:2.50%
controls:0.11%
—
—
cases:2.72%
controls:0.00%
—
—
cases:3.78%
controls:0.14%
cases:4.81%
controls:0.57%
43
38
1755
17934
45
20
1754
17962
—
49
0
1750
17982
—
63
23
1602
16924
58
74
1147
12915
disulfiram; oral
N07BB01 [21604821]
2.4e+00
3.0e+00
—
—
—
3.1e+00
2.6e+00
cases:3.78%
controls:0.34%
cases:1.61%
controls:0.08%
—
—
—
—
—
—
cases:2.10%
controls:0.09%
cases:4.32%
controls:0.34%
68
62
1730
17910
29
15
1770
17967
—
—
—
35
16
1630
16931
52
44
1153
12945
levodopa and decarboxylase inhibitor; oral
N04BA02 [21604465]
1.8e+00
1.9e+00
2.1e+00
—
1.6e+00
1.8e+00
1.8e+00
cases:3.95%
controls:0.65%
cases:3.84%
controls:0.57%
cases:2.06%
controls:0.27%
—
—
cases:1.23%
controls:0.24%
cases:3.78%
controls:0.63%
cases:3.90%
controls:0.69%
71
116
1727
17856
69
103
1730
17879
37
48
1762
17934
—
22
43
1764
17857
63
106
1602
16841
47
89
1158
12900
zuclopenthixol; oral, parenteral
N05AF05 [21604535]
2.3e+00
2.0e+00
—
—
2.2e+00
2.3e+00
2.4e+00
cases:1.06%
controls:0.11%
cases:0.56%
controls:0.08%
—
—
—
—
cases:0.34%
controls:0.04%
cases:0.78%
controls:0.08%
cases:1.24%
controls:0.12%
19
19
1779
17953
10
14
1789
17968
—
—
6
7
1780
17893
13
14
1652
16933
15
15
1190
12974
Bipolar affective disorder, current episode mixed
F31.6 [45571757]
2.4e+00
3.2e+00
—
1.0e+50
—
2.8e+00
2.6e+00
cases:1.17%
controls:0.11%
cases:0.83%
controls:0.03%
—
—
cases:0.44%
controls:0.00%
—
—
cases:0.90%
controls:0.05%
cases:1.24%
controls:0.09%
21
20
1777
17952
15
6
1784
17976
—
8
0
1791
17982
—
15
9
1650
16938
15
12
1190
12977
Delirium, unspecified
F05.9 [45591078]
2.5e+00
2.5e+00
—
1.0e+50
—
3.4e+00
2.5e+00
cases:1.56%
controls:0.13%
cases:0.83%
controls:0.07%
—
—
cases:2.17%
controls:0.00%
—
—
cases:2.04%
controls:0.07%
cases:1.99%
controls:0.16%
28
24
1770
17948
15
12
1784
17970
—
39
0
1760
17982
—
34
12
1631
16935
24
21
1181
12968
Thorax X-ray examination
GD1AA [2001303617]
7.1e-01
8.9e-01
1.1e+00
4.8e+00
1.5e+00
1.0e+00
8.8e-01
cases:19.35%
controls:10.55%
cases:8.95%
controls:3.89%
cases:1.72%
controls:0.58%
cases:3.39%
controls:0.03%
cases:1.74%
controls:0.40%
cases:9.31%
controls:3.55%
cases:20.50%
controls:9.70%
348
1896
1450
16076
161
699
1638
17283
31
105
1768
17877
61
5
1738
17977
31
72
1755
17828
155
602
1510
16345
247
1260
958
11729
Psychiatric network contact
IGV01 [2001304319]
2.1e+00
2.5e+00
—
1.0e+50
—
3.0e+00
3.2e+00
cases:0.95%
controls:0.11%
cases:0.61%
controls:0.05%
—
—
cases:0.44%
controls:0.00%
—
—
cases:1.56%
controls:0.08%
cases:3.24%
controls:0.14%
17
20
1781
17952
11
9
1788
17973
—
8
0
1791
17982
—
26
13
1639
16934
39
18
1166
12971
Unspecified dementia
F03 [45566772]
6.5e-01
1.1e+00
2.7e+00
1.0e+50
3.5e+00
2.3e+00
1.3e+00
cases:0.95%
controls:0.50%
cases:0.94%
controls:0.32%
cases:0.72%
controls:0.05%
cases:1.56%
controls:0.00%
cases:1.57%
controls:0.05%
cases:2.40%
controls:0.25%
cases:3.07%
controls:0.85%
17
89
1781
17883
17
58
1782
17924
13
9
1786
17973
28
0
1771
17982
28
9
1758
17891
40
42
1625
16905
37
110
1168
12879
Disorientation, unspecified
R41.0 [45558469]
4.1e+00
—
1.0e+50
1.0e+50
—
3.2e+00
3.4e+00
cases:1.95%
controls:0.03%
—
—
cases:1.00%
controls:0.00%
cases:1.45%
controls:0.00%
—
—
cases:1.20%
controls:0.05%
cases:2.90%
controls:0.10%
35
6
1763
17966
—
18
0
1781
17982
26
0
1773
17982
—
20
8
1645
16939
35
13
1170
12976
Procedure not carried out because of patient's decision for other and unspecified reasons
Z53.2 [45605136]
2.0e+00
2.8e+00
—
—
—
3.1e+00
2.7e+00
cases:0.83%
controls:0.11%
cases:0.56%
controls:0.03%
—
—
—
—
—
—
cases:0.66%
controls:0.03%
cases:1.66%
controls:0.11%
15
20
1783
17952
10
6
1789
17976
—
—
—
11
5
1654
16942
20
14
1185
12975
Alcohol-related acute intoxication uncomplicated
F10.00 [2000501668]
2.1e+00
3.0e+00
—
—
—
2.9e+00
2.8e+00
cases:0.95%
controls:0.12%
cases:0.67%
controls:0.03%
—
—
—
—
—
—
cases:1.02%
controls:0.06%
cases:2.16%
controls:0.14%
17
22
1781
17950
12
6
1787
17976
—
—
—
17
10
1648
16937
26
18
1179
12971
Psychiatric treatment plan, standard
ICB01 [2001304098]
2.1e+00
2.7e+00
2.1e+00
1.0e+50
—
3.4e+00
2.4e+00
cases:2.17%
controls:0.28%
cases:2.00%
controls:0.14%
cases:0.28%
controls:0.03%
cases:0.72%
controls:0.00%
—
—
cases:4.26%
controls:0.14%
cases:6.97%
controls:0.65%
39
51
1759
17921
36
25
1763
17957
5
6
1794
17976
13
0
1786
17982
—
71
24
1594
16923
84
84
1121
12905
Other psychiatric network intervention
IEV99 [2001304218]
2.0e+00
2.2e+00
—
—
—
3.4e+00
3.0e+00
cases:0.67%
controls:0.09%
cases:0.39%
controls:0.04%
—
—
—
—
—
—
cases:1.26%
controls:0.04%
cases:1.83%
controls:0.09%
12
16
1786
17956
7
8
1792
17974
—
—
—
21
7
1644
16940
22
12
1183
12977
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
3.5e-01
6.7e-01
1.3e+00
4.8e+00
2.0e+00
8.3e-01
5.6e-01
cases:52.67%
controls:43.99%
cases:50.19%
controls:34.06%
cases:20.90%
controls:6.91%
cases:28.13%
controls:0.32%
cases:35.78%
controls:6.73%
cases:54.35%
controls:34.24%
cases:69.13%
controls:56.09%
947
7906
851
10066
903
6125
896
11857
376
1242
1423
16740
506
58
1293
17924
639
1205
1147
16695
905
5802
760
11145
833
7285
372
5704
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
8.8e-01
1.1e+00
1.2e+00
3.4e+00
1.8e+00
1.2e+00
1.0e+00
cases:13.40%
controls:6.01%
cases:5.95%
controls:2.11%
cases:0.94%
controls:0.30%
cases:0.83%
controls:0.03%
cases:1.79%
controls:0.31%
cases:7.39%
controls:2.40%
cases:18.01%
controls:7.24%
241
1081
1557
16891
107
379
1692
17603
17
54
1782
17928
15
5
1784
17977
32
56
1754
17844
123
406
1542
16541
217
940
988
12049
Person encountering health services in unspecified circumstances
Z76.9 [45609967]
1.3e+00
1.8e+00
2.6e+00
—
2.1e+00
1.7e+00
9.1e-01
cases:3.39%
controls:0.92%
cases:2.06%
controls:0.34%
cases:0.44%
controls:0.03%
—
—
cases:0.50%
controls:0.06%
cases:2.22%
controls:0.40%
cases:3.98%
controls:1.64%
61
166
1737
17806
37
62
1762
17920
8
6
1791
17976
—
9
11
1777
17889
37
67
1628
16880
48
213
1157
12776
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
3.4e-01
6.6e-01
1.3e+00
4.8e+00
2.0e+00
8.2e-01
5.5e-01
cases:52.89%
controls:44.34%
cases:50.42%
controls:34.50%
cases:20.90%
controls:6.95%
cases:27.79%
controls:0.33%
cases:35.89%
controls:6.80%
cases:54.47%
controls:34.48%
cases:69.13%
controls:56.32%
951
7968
847
10004
907
6204
892
11778
376
1250
1423
16732
500
59
1299
17923
641
1218
1145
16682
907
5844
758
11103
833
7315
372
5674
2-person team, doctor-nurse
ZXY51 [2001311525]
2.0e+00
2.2e+00
—
1.0e+50
—
2.8e+00
3.4e+00
cases:1.45%
controls:0.19%
cases:0.61%
controls:0.07%
—
—
cases:0.33%
controls:0.00%
—
—
cases:1.20%
controls:0.07%
cases:2.57%
controls:0.09%
26
35
1772
17937
11
12
1788
17970
—
6
0
1793
17982
—
20
12
1645
16935
31
12
1174
12977
thiamine (vit B1); oral, parenteral
A11DA01 [21600825]
1.7e+00
1.6e+00
—
—
2.3e+00
2.5e+00
2.3e+00
cases:0.78%
controls:0.14%
cases:0.56%
controls:0.12%
—
—
—
—
cases:0.45%
controls:0.04%
cases:1.26%
controls:0.10%
cases:1.91%
controls:0.19%
14
26
1784
17946
10
21
1789
17961
—
—
8
8
1778
17892
21
17
1644
16930
23
25
1182
12964
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
4.7e-01
8.2e-01
1.5e+00
4.2e+00
1.9e+00
8.6e-01
5.3e-01
cases:9.90%
controls:6.45%
cases:7.73%
controls:3.57%
cases:2.67%
controls:0.60%
cases:1.89%
controls:0.03%
cases:3.70%
controls:0.55%
cases:8.71%
controls:3.88%
cases:16.51%
controls:10.44%
178
1159
1620
16813
139
642
1660
17340
48
108
1751
17874
34
5
1765
17977
66
98
1720
17802
145
658
1520
16289
199
1356
1006
11633
Weakness/tiredness general
A04 [2002000145]
9.2e-01
1.3e+00
1.5e+00
2.9e+00
1.5e+00
1.3e+00
9.0e-01
cases:6.28%
controls:2.62%
cases:3.95%
controls:1.11%
cases:1.06%
controls:0.23%
cases:0.72%
controls:0.04%
cases:1.01%
controls:0.23%
cases:4.26%
controls:1.26%
cases:8.46%
controls:3.62%
113
470
1685
17502
71
199
1728
17783
19
41
1780
17941
13
7
1786
17975
18
42
1768
17858
71
213
1594
16734
102
470
1103
12519
pH of Urine
2756-5 [3015736]
4.7e-01
7.7e-01
1.4e+00
4.5e+00
1.8e+00
8.5e-01
4.6e-01
cases:17.07%
controls:11.39%
cases:11.56%
controls:5.71%
cases:3.95%
controls:0.98%
cases:3.89%
controls:0.04%
cases:5.38%
controls:0.92%
cases:12.97%
controls:5.99%
cases:24.65%
controls:17.11%
307
2047
1491
15925
208
1027
1591
16955
71
177
1728
17805
70
8
1729
17974
96
164
1690
17736
216
1015
1449
15932
297
2222
908
10767
Procedure duration 120 to 149 minutes
ZXE15 [2001311406]
1.2e+00
2.2e+00
—
—
1.0e+50
3.0e+00
3.8e+00
cases:0.89%
controls:0.26%
cases:0.72%
controls:0.08%
—
—
—
—
cases:0.45%
controls:0.00%
cases:0.96%
controls:0.05%
cases:1.66%
controls:0.04%
16
47
1782
17925
13
14
1786
17968
—
—
8
0
1778
17900
16
8
1649
16939
20
5
1185
12984
Remote contact by phone
ZYC01 [2001311579]
1.4e+00
1.2e+00
2.3e+00
1.0e+50
2.1e+00
1.9e+00
1.2e+00
cases:2.61%
controls:0.64%
cases:1.17%
controls:0.35%
cases:0.33%
controls:0.03%
cases:0.28%
controls:0.00%
cases:0.56%
controls:0.07%
cases:2.22%
controls:0.33%
cases:3.40%
controls:1.04%
47
115
1751
17857
21
63
1778
17919
6
6
1793
17976
5
0
1794
17982
10
12
1776
17888
37
56
1628
16891
41
135
1164
12854
Post-traumatic stress disorder
F43.1 [45595909]
1.9e+00
2.3e+00
1.6e+00
1.0e+50
2.0e+00
2.2e+00
1.9e+00
cases:1.33%
controls:0.21%
cases:0.94%
controls:0.10%
cases:0.28%
controls:0.06%
cases:0.39%
controls:0.00%
cases:0.45%
controls:0.06%
cases:1.32%
controls:0.14%
cases:2.32%
controls:0.37%
24
38
1774
17934
17
18
1782
17964
5
10
1794
17972
7
0
1792
17982
8
11
1778
17889
22
24
1643
16923
28
48
1177
12941
Specific gravity of Urine by Refractometry
5810-7 [3019150]
4.4e-01
7.3e-01
1.5e+00
4.4e+00
1.8e+00
7.7e-01
5.5e-01
cases:10.85%
controls:7.23%
cases:7.34%
controls:3.66%
cases:3.06%
controls:0.68%
cases:2.95%
controls:0.04%
cases:3.70%
controls:0.62%
cases:8.47%
controls:4.09%
cases:17.18%
controls:10.66%
195
1300
1603
16672
132
659
1667
17323
55
123
1744
17859
53
7
1746
17975
66
111
1720
17789
141
693
1524
16254
207
1385
998
11604
lamotrigine; oral
N03AX09 [21604431]
2.0e+00
1.9e+00
1.8e+00
—
1.0e+00
2.0e+00
2.5e+00
cases:3.23%
controls:0.45%
cases:1.78%
controls:0.28%
cases:0.50%
controls:0.08%
—
—
cases:0.39%
controls:0.14%
cases:2.34%
controls:0.32%
cases:6.22%
controls:0.53%
58
81
1740
17891
32
50
1767
17932
9
15
1790
17967
—
7
25
1779
17875
39
54
1626
16893
75
69
1130
12920
SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94759-8 [586526]
1.2e+00
1.6e+00
3.1e+00
1.0e+50
1.9e+00
1.4e+00
1.1e+00
cases:2.84%
controls:0.91%
cases:1.83%
controls:0.39%
cases:0.83%
controls:0.04%
cases:0.28%
controls:0.00%
cases:0.62%
controls:0.09%
cases:1.86%
controls:0.48%
cases:5.23%
controls:1.81%
51
164
1747
17808
33
71
1766
17911
15
7
1784
17975
5
0
1794
17982
11
16
1775
17884
31
81
1634
16866
63
235
1142
12754
Moderate depressive episode without somatic syndrome
F32.10 [2000501980]
1.3e+00
1.9e+00
1.6e+00
—
2.2e+00
2.0e+00
1.2e+00
cases:2.78%
controls:0.80%
cases:2.11%
controls:0.32%
cases:0.50%
controls:0.11%
—
—
cases:0.78%
controls:0.08%
cases:2.34%
controls:0.31%
cases:3.49%
controls:1.11%
50
143
1748
17829
38
58
1761
17924
9
19
1790
17963
—
14
15
1772
17885
39
53
1626
16894
42
144
1163
12845
Acetaminophen [Moles/volume] in Serum or Plasma
14581-3 [3020485]
1.9e+00
2.9e+00
—
—
—
2.4e+00
2.9e+00
cases:0.67%
controls:0.10%
cases:0.50%
controls:0.03%
—
—
—
—
—
—
cases:0.72%
controls:0.06%
cases:1.99%
controls:0.11%
12
18
1786
17954
9
5
1790
17977
—
—
—
12
11
1653
16936
24
14
1181
12975
Other and unspecified symptoms and signs involving cognitive functions and awareness
R41.8 [45534452]
2.0e+00
2.6e+00
—
1.0e+50
—
3.2e+00
2.2e+00
cases:3.89%
controls:0.53%
cases:3.28%
controls:0.24%
—
—
cases:1.28%
controls:0.00%
—
—
cases:6.61%
controls:0.28%
cases:7.30%
controls:0.85%
70
95
1728
17877
59
43
1740
17939
—
23
0
1776
17982
—
110
48
1555
16899
88
110
1117
12879
Other psychiatric treatment contact
IGY99 [2001304323]
2.0e+00
2.3e+00
—
1.0e+50
—
3.2e+00
2.6e+00
cases:1.89%
controls:0.26%
cases:1.06%
controls:0.11%
—
—
cases:0.28%
controls:0.00%
—
—
cases:2.46%
controls:0.10%
cases:4.32%
controls:0.32%
34
47
1764
17925
19
20
1780
17962
—
5
0
1794
17982
—
41
17
1624
16930
52
42
1153
12947
Bacteria identified in Blood by Culture
600-7 [3023368]
7.3e-01
1.0e+00
1.2e+00
3.2e+00
2.0e+00
1.0e+00
9.1e-01
cases:12.51%
controls:6.43%
cases:7.73%
controls:2.99%
cases:1.33%
controls:0.41%
cases:0.83%
controls:0.03%
cases:2.46%
controls:0.33%
cases:7.87%
controls:3.06%
cases:19.75%
controls:9.01%
225
1155
1573
16817
139
537
1660
17445
24
73
1775
17909
15
6
1784
17976
44
59
1742
17841
131
518
1534
16429
238
1170
967
11819
Psychiatric treatment plan, monitoring
ICB03 [2001304100]
1.9e+00
2.4e+00
1.0e+50
—
1.0e+50
3.1e+00
2.7e+00
cases:1.22%
controls:0.18%
cases:1.00%
controls:0.09%
cases:0.33%
controls:0.00%
—
—
cases:0.45%
controls:0.00%
cases:2.10%
controls:0.09%
cases:3.73%
controls:0.27%
22
33
1776
17939
18
17
1781
17965
6
0
1793
17982
—
8
0
1778
17900
35
16
1630
16931
45
35
1160
12954
buspirone; oral
N05BE01 [21604601]
2.2e+00
2.3e+00
—
—
—
3.2e+00
2.4e+00
cases:1.00%
controls:0.12%
cases:0.44%
controls:0.04%
—
—
—
—
—
—
cases:0.96%
controls:0.04%
cases:1.74%
controls:0.15%
18
21
1780
17951
8
8
1791
17974
—
—
—
16
7
1649
16940
21
20
1184
12969
Unspecified mood [affective] disorder
F39 [45591137]
2.1e+00
2.5e+00
—
—
—
3.0e+00
2.5e+00
cases:1.17%
controls:0.14%
cases:0.72%
controls:0.06%
—
—
—
—
—
—
cases:1.26%
controls:0.06%
cases:1.91%
controls:0.16%
21
26
1777
17946
13
11
1786
17971
—
—
—
21
11
1644
16936
23
21
1182
12968
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
7.0e-01
8.7e-01
1.1e+00
3.8e+00
1.5e+00
1.1e+00
8.7e-01
cases:25.31%
controls:14.38%
cases:15.45%
controls:7.09%
cases:4.06%
controls:1.37%
cases:2.95%
controls:0.07%
cases:5.88%
controls:1.32%
cases:18.62%
controls:7.17%
cases:33.36%
controls:17.28%
455
2584
1343
15388
278
1275
1521
16707
73
247
1726
17735
53
12
1746
17970
105
236
1681
17664
310
1215
1355
15732
402
2244
803
10745
Withdrawal symptoms caused by alcohol UNS
F10.39 [2000501687]
2.9e+00
—
—
—
—
3.4e+00
3.7e+00
cases:1.28%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.84%
controls:0.03%
cases:1.91%
controls:0.05%
23
13
1775
17959
—
—
—
—
14
5
1651
16942
23
6
1182
12983
sertraline; oral
N06AB06 [21604714]
1.4e+00
1.6e+00
1.8e+00
—
1.7e+00
1.7e+00
1.7e+00
cases:5.34%
controls:1.35%
cases:3.84%
controls:0.77%
cases:1.45%
controls:0.25%
—
—
cases:1.34%
controls:0.24%
cases:4.26%
controls:0.80%
cases:8.05%
controls:1.59%
96
243
1702
17729
69
138
1730
17844
26
45
1773
17937
—
24
43
1762
17857
71
135
1594
16812
97
207
1108
12782
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
8.0e-01
1.4e+00
2.1e+00
—
2.8e+00
1.7e+00
1.2e+00
cases:4.78%
controls:2.21%
cases:3.28%
controls:0.82%
cases:0.67%
controls:0.08%
—
—
cases:0.90%
controls:0.06%
cases:4.14%
controls:0.77%
cases:7.39%
controls:2.46%
86
397
1712
17575
59
147
1740
17835
12
15
1787
17967
—
16
10
1770
17890
69
131
1596
16816
89
319
1116
12670
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
3.8e-01
7.2e-01
1.4e+00
4.5e+00
1.6e+00
6.7e-01
5.5e-01
cases:12.79%
controls:9.10%
cases:9.28%
controls:4.74%
cases:3.50%
controls:0.86%
cases:3.45%
controls:0.04%
cases:3.75%
controls:0.78%
cases:9.01%
controls:4.81%
cases:19.34%
controls:12.13%
230
1636
1568
16336
167
852
1632
17130
63
155
1736
17827
62
7
1737
17975
67
140
1719
17760
150
815
1515
16132
233
1575
972
11414
Other specified anxiety disorders
F41.8 [45595908]
1.7e+00
1.9e+00
—
—
2.2e+00
2.1e+00
1.9e+00
cases:1.33%
controls:0.25%
cases:0.89%
controls:0.13%
—
—
—
—
cases:0.39%
controls:0.04%
cases:1.20%
controls:0.15%
cases:2.32%
controls:0.34%
24
45
1774
17927
16
23
1783
17959
—
—
7
8
1779
17892
20
25
1645
16922
28
44
1177
12945
Bipolar affective disorder, current episode severe depression without psychotic symptoms
F31.4 [45581456]
1.9e+00
2.9e+00
—
—
—
2.7e+00
2.3e+00
cases:0.61%
controls:0.09%
cases:0.78%
controls:0.04%
—
—
—
—
—
—
cases:0.78%
controls:0.05%
cases:1.08%
controls:0.11%
11
16
1787
17956
14
8
1785
17974
—
—
—
13
9
1652
16938
13
14
1192
12975
Bipolar affective disorder
F31 [45595902]
2.3e+00
2.6e+00
—
—
—
2.8e+00
2.1e+00
cases:1.11%
controls:0.12%
cases:0.39%
controls:0.03%
—
—
—
—
—
—
cases:0.48%
controls:0.03%
cases:1.00%
controls:0.12%
20
21
1778
17951
7
5
1792
17977
—
—
—
8
5
1657
16942
12
16
1193
12973
paliperidone; oral, parenteral
N05AX13 [21604563]
1.8e+00
2.2e+00
—
—
—
2.9e+00
2.8e+00
cases:0.44%
controls:0.07%
cases:0.56%
controls:0.06%
—
—
—
—
—
—
cases:1.20%
controls:0.06%
cases:2.16%
controls:0.13%
8
13
1790
17959
10
11
1789
17971
—
—
—
20
11
1645
16936
26
17
1179
12972
Dizziness and giddiness
R42 [45568132]
1.8e+00
2.1e+00
2.5e+00
—
—
1.9e+00
1.6e+00
cases:9.40%
controls:1.75%
cases:4.45%
controls:0.58%
cases:0.72%
controls:0.06%
—
—
—
—
cases:3.90%
controls:0.63%
cases:10.12%
controls:2.18%
169
315
1629
17657
80
105
1719
17877
13
11
1786
17971
—
—
65
107
1600
16840
122
283
1083
12706
Fear of mental disorder
P27 [2002000821]
2.5e+00
2.7e+00
1.0e+50
—
1.0e+50
2.7e+00
1.9e+00
cases:1.28%
controls:0.11%
cases:0.50%
controls:0.03%
cases:0.44%
controls:0.00%
—
—
cases:0.45%
controls:0.00%
cases:0.54%
controls:0.04%
cases:1.24%
controls:0.19%
23
20
1775
17952
9
6
1790
17976
8
0
1791
17982
—
8
0
1778
17900
9
6
1656
16941
15
25
1190
12964
Psychiatric family contact
IGP01 [2001304317]
2.1e+00
2.1e+00
—
—
—
3.0e+00
2.5e+00
cases:0.95%
controls:0.12%
cases:0.44%
controls:0.06%
—
—
—
—
—
—
cases:1.20%
controls:0.06%
cases:1.74%
controls:0.14%
17
21
1781
17951
8
10
1791
17972
—
—
—
20
10
1645
16937
21
18
1184
12971
Procedure duration 90 to 119 minutes
ZXE13 [2001311404]
1.5e+00
1.7e+00
—
1.0e+50
—
3.6e+00
3.0e+00
cases:2.17%
controls:0.50%
cases:0.94%
controls:0.17%
—
—
cases:0.72%
controls:0.00%
—
—
cases:2.22%
controls:0.06%
cases:3.15%
controls:0.17%
39
89
1759
17883
17
30
1782
17952
—
13
0
1786
17982
—
37
11
1628
16936
38
22
1167
12967
venlafaxine; oral
N06AX16 [21604745]
1.4e+00
1.6e+00
1.7e+00
—
1.8e+00
1.7e+00
1.6e+00
cases:6.90%
controls:1.85%
cases:5.45%
controls:1.11%
cases:2.56%
controls:0.48%
—
—
cases:2.18%
controls:0.37%
cases:5.77%
controls:1.12%
cases:9.38%
controls:2.12%
124
332
1674
17640
98
200
1701
17782
46
86
1753
17896
—
39
67
1747
17833
96
189
1569
16758
113
275
1092
12714
Lithium [Moles/volume] in Serum or Plasma
14334-7 [3024666]
2.3e+00
2.3e+00
—
—
—
2.3e+00
2.8e+00
cases:1.33%
controls:0.14%
cases:0.89%
controls:0.09%
—
—
—
—
—
—
cases:0.96%
controls:0.09%
cases:2.16%
controls:0.13%
24
25
1774
17947
16
16
1783
17966
—
—
—
16
16
1649
16931
26
17
1179
12972
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
3.7e-01
7.1e-01
1.3e+00
4.4e+00
1.6e+00
7.6e-01
5.8e-01
cases:30.70%
controls:23.40%
cases:20.40%
controls:11.19%
cases:6.28%
controls:1.87%
cases:6.61%
controls:0.09%
cases:8.01%
controls:1.65%
cases:21.32%
controls:11.26%
cases:40.08%
controls:27.27%
552
4206
1246
13766
367
2012
1432
15970
113
336
1686
17646
119
16
1680
17966
143
295
1643
17605
355
1908
1310
15039
483
3542
722
9447
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
3.8e-01
7.7e-01
1.3e+00
4.3e+00
1.7e+00
7.0e-01
4.5e-01
cases:20.36%
controls:14.82%
cases:16.06%
controls:8.12%
cases:5.39%
controls:1.46%
cases:5.67%
controls:0.08%
cases:6.89%
controls:1.34%
cases:16.22%
controls:8.80%
cases:31.70%
controls:22.91%
366
2663
1432
15309
289
1461
1510
16521
97
262
1702
17720
102
14
1697
17968
123
239
1663
17661
270
1492
1395
15455
382
2976
823
10013
Drugs identified in Urine by Screen method Nominal
12286-1 [3011288]
1.8e+00
1.9e+00
1.9e+00
1.0e+50
—
2.4e+00
1.7e+00
cases:3.50%
controls:0.62%
cases:2.22%
controls:0.33%
cases:0.39%
controls:0.06%
cases:0.67%
controls:0.00%
—
—
cases:2.70%
controls:0.25%
cases:6.72%
controls:1.26%
63
111
1735
17861
40
60
1759
17922
7
11
1792
17971
12
0
1787
17982
—
45
42
1620
16905
81
164
1124
12825
Ethanol [Moles/volume] in Serum or Plasma
14719-9 [3020191]
1.9e+00
2.4e+00
—
—
—
3.0e+00
2.4e+00
cases:0.78%
controls:0.12%
cases:0.67%
controls:0.06%
—
—
—
—
—
—
cases:0.84%
controls:0.04%
cases:2.24%
controls:0.21%
14
22
1784
17950
12
11
1787
17971
—
—
—
14
7
1651
16940
27
27
1178
12962
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
4.0e-01
7.7e-01
1.3e+00
4.3e+00
1.7e+00
7.0e-01
4.3e-01
cases:19.91%
controls:14.29%
cases:15.79%
controls:7.99%
cases:5.34%
controls:1.46%
cases:5.61%
controls:0.08%
cases:6.83%
controls:1.33%
cases:16.16%
controls:8.70%
cases:30.95%
controls:22.55%
358
2569
1440
15403
284
1436
1515
16546
96
263
1703
17719
101
14
1698
17968
122
238
1664
17662
269
1474
1396
15473
373
2929
832
10060
Generalized anxiety disorder
F41.1 [45571764]
1.1e+00
1.2e+00
1.9e+00
—
2.2e+00
1.9e+00
1.3e+00
cases:1.45%
controls:0.48%
cases:0.89%
controls:0.27%
cases:0.56%
controls:0.08%
—
—
cases:0.73%
controls:0.08%
cases:1.92%
controls:0.28%
cases:2.99%
controls:0.79%
26
86
1772
17886
16
49
1783
17933
10
15
1789
17967
—
13
15
1773
17885
32
48
1633
16899
36
103
1169
12886
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
3.8e-01
7.5e-01
1.3e+00
4.3e+00
1.7e+00
7.0e-01
4.2e-01
cases:20.19%
controls:14.71%
cases:15.79%
controls:8.12%
cases:5.45%
controls:1.47%
cases:5.56%
controls:0.08%
cases:6.83%
controls:1.32%
cases:16.22%
controls:8.80%
cases:31.12%
controls:22.86%
363
2643
1435
15329
284
1461
1515
16521
98
265
1701
17717
100
14
1699
17968
122
236
1664
17664
270
1492
1395
15455
375
2969
830
10020
trazodone; oral
N06AX05 [21604734]
1.9e+00
2.1e+00
—
—
—
3.4e+00
2.1e+00
cases:1.17%
controls:0.17%
cases:0.56%
controls:0.07%
—
—
—
—
—
—
cases:1.26%
controls:0.04%
cases:1.66%
controls:0.20%
21
31
1777
17941
10
12
1789
17970
—
—
—
21
7
1644
16940
20
26
1185
12963
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
2.8e-01
5.5e-01
1.1e+00
4.6e+00
1.8e+00
7.0e-01
3.9e-01
cases:54.17%
controls:47.20%
cases:51.97%
controls:38.43%
cases:22.46%
controls:8.47%
cases:27.79%
controls:0.37%
cases:36.56%
controls:8.37%
cases:56.10%
controls:38.83%
cases:69.71%
controls:60.86%
974
8483
824
9489
935
6911
864
11071
404
1523
1395
16459
500
66
1299
17916
653
1499
1133
16401
934
6580
731
10367
840
7905
365
5084
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6.0e-01
7.8e-01
9.9e-01
3.8e+00
1.7e+00
8.9e-01
7.8e-01
cases:38.54%
controls:25.58%
cases:27.13%
controls:14.58%
cases:6.84%
controls:2.65%
cases:4.11%
controls:0.10%
cases:13.89%
controls:2.80%
cases:29.73%
controls:14.74%
cases:49.21%
controls:30.70%
693
4598
1105
13374
488
2621
1311
15361
123
477
1676
17505
74
18
1725
17964
248
502
1538
17398
495
2498
1170
14449
593
3987
612
9002
Alcohol dependence currently independent
F10.20 [2000501677]
2.8e+00
3.5e+00
—
1.0e+50
—
—
3.2e+00
cases:1.61%
controls:0.10%
cases:0.94%
controls:0.03%
—
—
cases:0.28%
controls:0.00%
—
—
—
—
cases:2.32%
controls:0.10%
29
18
1769
17954
17
5
1782
17977
—
5
0
1794
17982
—
—
28
13
1177
12976
Alcohol dependence periodic alcoholism
F10.26 [2000501683]
2.8e+00
3.2e+00
—
1.0e+50
—
—
3.5e+00
cases:1.56%
controls:0.10%
cases:0.78%
controls:0.03%
—
—
cases:0.33%
controls:0.00%
—
—
—
—
cases:2.82%
controls:0.08%
28
18
1770
17954
14
6
1785
17976
—
6
0
1793
17982
—
—
34
11
1171
12978
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
F19.1 [45552459]
3.0e+00
3.3e+00
—
1.0e+50
—
—
3.1e+00
cases:1.33%
controls:0.07%
cases:0.72%
controls:0.03%
—
—
cases:0.44%
controls:0.00%
—
—
—
—
cases:1.58%
controls:0.07%
24
12
1774
17960
13
5
1786
17977
—
8
0
1791
17982
—
—
19
9
1186
12980
Feeling anxious/nervous/tense
P01 [2002000798]
1.2e+00
1.4e+00
2.3e+00
—
2.0e+00
1.4e+00
9.8e-01
cases:5.56%
controls:1.67%
cases:3.34%
controls:0.82%
cases:1.22%
controls:0.12%
—
—
cases:1.01%
controls:0.14%
cases:2.76%
controls:0.67%
cases:6.39%
controls:2.49%
100
301
1698
17671
60
148
1739
17834
22
22
1777
17960
—
18
25
1768
17875
46
114
1619
16833
77
323
1128
12666
rasagiline; oral
N04BD02 [21604484]
2.4e+00
2.7e+00
2.5e+00
—
—
1.8e+00
—
cases:1.11%
controls:0.10%
cases:1.06%
controls:0.07%
cases:0.33%
controls:0.03%
—
—
—
—
cases:0.42%
controls:0.07%
—
—
20
18
1778
17954
19
13
1780
17969
6
5
1793
17977
—
—
7
12
1658
16935
—
Hospital inpatient
ZY000 [2001311598]
2.8e+00
3.2e+00
—
1.0e+50
—
—
3.4e+00
cases:1.39%
controls:0.09%
cases:0.83%
controls:0.03%
—
—
cases:1.00%
controls:0.00%
—
—
—
—
cases:2.41%
controls:0.08%
25
16
1773
17956
15
6
1784
17976
—
18
0
1781
17982
—
—
29
11
1176
12978
Psychiatric pharmacotherapy plan, not specified
IFA01 [2001304251]
1.7e+00
2.3e+00
—
—
—
2.8e+00
2.5e+00
cases:1.00%
controls:0.18%
cases:0.78%
controls:0.08%
—
—
—
—
—
—
cases:1.68%
controls:0.11%
cases:2.74%
controls:0.22%
18
32
1780
17940
14
14
1785
17968
—
—
—
28
18
1637
16929
33
29
1172
12960
magnesium hydroxide; oral
A02AA04 [21600052]
1.5e+00
1.7e+00
1.4e+00
—
1.5e+00
1.6e+00
1.7e+00
cases:2.17%
controls:0.50%
cases:1.78%
controls:0.34%
cases:0.67%
controls:0.17%
—
—
cases:0.84%
controls:0.18%
cases:2.28%
controls:0.47%
cases:3.98%
controls:0.79%
39
90
1759
17882
32
61
1767
17921
12
30
1787
17952
—
15
33
1771
17867
38
79
1627
16868
48
102
1157
12887
magnesium hydroxide; oral
G04BX01 [21602658]
1.5e+00
1.7e+00
1.4e+00
—
1.5e+00
1.6e+00
1.7e+00
cases:2.17%
controls:0.50%
cases:1.78%
controls:0.34%
cases:0.67%
controls:0.17%
—
—
cases:0.84%
controls:0.18%
cases:2.28%
controls:0.47%
cases:3.98%
controls:0.79%
39
90
1759
17882
32
61
1767
17921
12
30
1787
17952
—
15
33
1771
17867
38
79
1627
16868
48
102
1157
12887
ropinirole; oral
N04BC04 [21604476]
2.4e+00
2.5e+00
2.7e+00
—
—
1.8e+00
1.5e+00
cases:1.33%
controls:0.13%
cases:1.22%
controls:0.10%
cases:0.56%
controls:0.04%
—
—
—
—
cases:0.42%
controls:0.07%
cases:0.50%
controls:0.12%
24
23
1774
17949
22
18
1777
17964
10
7
1789
17975
—
—
7
12
1658
16935
6
15
1199
12974
Cerebral infarction, unspecified
I63.9 [45596216]
7.4e-01
1.4e+00
2.1e+00
—
3.0e+00
1.4e+00
7.5e-01
cases:2.89%
controls:1.40%
cases:2.00%
controls:0.51%
cases:0.44%
controls:0.06%
—
—
cases:1.18%
controls:0.06%
cases:1.92%
controls:0.50%
cases:2.99%
controls:1.43%
52
251
1746
17721
36
91
1763
17891
8
10
1791
17972
—
21
11
1765
17889
32
85
1633
16862
36
186
1169
12803
temazepam; oral
N05CD07 [21604642]
1.3e+00
1.3e+00
1.6e+00
—
1.6e+00
1.7e+00
1.8e+00
cases:12.07%
controls:3.78%
cases:7.89%
controls:2.29%
cases:3.17%
controls:0.65%
—
—
cases:3.42%
controls:0.69%
cases:10.21%
controls:2.02%
cases:16.02%
controls:3.14%
217
679
1581
17293
142
412
1657
17570
57
117
1742
17865
—
61
124
1725
17776
170
342
1495
16605
193
408
1012
12581
Diagnostic and symptom-mapping evaluation
IBA01 [2001304043]
1.6e+00
2.5e+00
—
—
—
3.1e+00
2.0e+00
cases:1.06%
controls:0.21%
cases:0.83%
controls:0.07%
—
—
—
—
—
—
cases:1.74%
controls:0.08%
cases:2.32%
controls:0.32%
19
38
1779
17934
15
12
1784
17970
—
—
—
29
14
1636
16933
28
41
1177
12948
Emergency Room and Inpatient Visit
ERIP [262]
8.6e-01
1.3e+00
2.0e+00
—
2.6e+00
1.4e+00
9.4e-01
cases:16.63%
controls:7.80%
cases:14.34%
controls:4.23%
cases:4.56%
controls:0.65%
—
—
cases:9.13%
controls:0.71%
cases:17.06%
controls:4.80%
cases:28.46%
controls:13.40%
299
1401
1499
16571
258
760
1541
17222
82
116
1717
17866
—
163
127
1623
17773
284
814
1381
16133
343
1740
862
11249
Pure hypercholesterolaemia
E78.01 [2000501514]
4.2e-01
5.9e-01
1.3e+00
4.8e+00
1.5e+00
5.9e-01
1.3e-01
cases:6.79%
controls:4.56%
cases:3.84%
controls:2.16%
cases:1.39%
controls:0.40%
cases:3.28%
controls:0.03%
cases:2.02%
controls:0.47%
cases:4.26%
controls:2.41%
cases:6.56%
controls:5.81%
122
820
1676
17152
69
388
1730
17594
25
72
1774
17910
59
5
1740
17977
36
84
1750
17816
71
408
1594
16539
79
755
1126
12234
Methylenedioxymethamphetamine [Presence] in Urine by Screen method
19568-5 [3002148]
2.4e+00
2.4e+00
—
—
1.0e+50
2.8e+00
1.6e+00
cases:0.83%
controls:0.08%
cases:0.56%
controls:0.05%
—
—
—
—
cases:0.28%
controls:0.00%
cases:0.84%
controls:0.05%
cases:1.24%
controls:0.26%
15
14
1783
17958
10
9
1789
17973
—
—
5
0
1781
17900
14
9
1651
16938
15
34
1190
12955
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
6.1e-01
7.6e-01
1.0e+00
2.7e+00
2.2e+00
1.0e+00
7.7e-01
cases:20.58%
controls:12.29%
cases:12.56%
controls:6.32%
cases:3.00%
controls:1.07%
cases:0.67%
controls:0.04%
cases:8.29%
controls:0.99%
cases:15.86%
controls:6.41%
cases:28.63%
controls:15.61%
370
2209
1428
15763
226
1136
1573
16846
54
193
1745
17789
12
8
1787
17974
148
177
1638
17723
264
1086
1401
15861
345
2027
860
10962
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
2.2e-01
5.0e-01
1.1e+00
4.6e+00
1.7e+00
6.3e-01
3.9e-01
cases:38.21%
controls:33.12%
cases:38.58%
controls:27.67%
cases:16.06%
controls:6.27%
cases:20.62%
controls:0.26%
cases:26.76%
controls:6.09%
cases:42.28%
controls:28.00%
cases:56.27%
controls:46.45%
687
5953
1111
12019
694
4976
1105
13006
289
1128
1510
16854
371
47
1428
17935
478
1091
1308
16809
704
4746
961
12201
678
6033
527
6956
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
3.1e-01
6.7e-01
1.3e+00
4.3e+00
1.5e+00
5.8e-01
3.9e-01
cases:15.91%
controls:12.19%
cases:11.28%
controls:6.13%
cases:3.78%
controls:1.08%
cases:4.84%
controls:0.07%
cases:4.48%
controls:1.04%
cases:10.99%
controls:6.44%
cases:23.15%
controls:16.99%
286
2190
1512
15782
203
1102
1596
16880
68
194
1731
17788
87
12
1712
17970
80
187
1706
17713
183
1092
1482
15855
279
2207
926
10782
Bipolar affective disorder, current episode hypomanic
F31.0 [45542840]
2.0e+00
2.6e+00
—
—
—
2.2e+00
2.2e+00
cases:0.67%
controls:0.09%
cases:0.39%
controls:0.03%
—
—
—
—
—
—
cases:0.36%
controls:0.04%
cases:0.91%
controls:0.10%
12
16
1786
17956
7
5
1792
17977
—
—
—
6
7
1659
16940
11
13
1194
12976
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
7.1e-01
1.1e+00
1.5e+00
—
3.5e+00
1.2e+00
1.0e+00
cases:11.79%
controls:6.19%
cases:4.34%
controls:1.55%
cases:0.83%
controls:0.19%
—
—
cases:4.09%
controls:0.13%
cases:4.38%
controls:1.32%
cases:10.21%
controls:3.86%
212
1113
1586
16859
78
278
1721
17704
15
34
1784
17948
—
73
23
1713
17877
73
223
1592
16724
123
502
1082
12487
Recurrent depression, severe episode without somatic syndrome
F33.30 [2000501986]
3.3e+00
—
—
—
—
2.7e+00
3.1e+00
cases:1.17%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.42%
controls:0.03%
cases:1.49%
controls:0.07%
21
8
1777
17964
—
—
—
—
7
5
1658
16942
18
9
1187
12980
OLANZapine [Moles/volume] in Serum or Plasma
39484-1 [3040370]
2.5e+00
—
—
—
—
3.5e+00
3.0e+00
cases:0.67%
controls:0.06%
—
—
—
—
—
—
—
—
cases:1.56%
controls:0.05%
cases:2.90%
controls:0.15%
12
10
1786
17962
—
—
—
—
26
8
1639
16939
35
19
1170
12970
Psychiatric treatment plan, permanent discontinuation
ICC04 [2001304105]
1.5e+00
2.2e+00
—
—
—
2.9e+00
2.5e+00
cases:0.83%
controls:0.19%
cases:0.39%
controls:0.04%
—
—
—
—
—
—
cases:1.38%
controls:0.08%
cases:3.73%
controls:0.32%
15
35
1783
17937
7
8
1792
17974
—
—
—
23
13
1642
16934
45
42
1160
12947
Psychologist
Z2445 [2001311558]
1.5e+00
1.7e+00
—
—
—
3.3e+00
2.4e+00
cases:2.50%
controls:0.55%
cases:0.89%
controls:0.16%
—
—
—
—
—
—
cases:1.92%
controls:0.07%
cases:2.74%
controls:0.25%
45
98
1753
17874
16
29
1783
17953
—
—
—
32
12
1633
16935
33
32
1172
12957
Functional capacity evaluation
443351003 [40481051]
7.0e-01
1.2e+00
1.3e+00
1.9e+00
1.7e+00
1.1e+00
1.0e+00
cases:8.18%
controls:4.25%
cases:5.39%
controls:1.64%
cases:1.61%
controls:0.45%
cases:0.61%
controls:0.09%
cases:2.13%
controls:0.39%
cases:5.77%
controls:1.93%
cases:10.37%
controls:4.07%
147
764
1651
17208
97
295
1702
17687
29
81
1770
17901
11
16
1788
17966
38
70
1748
17830
96
327
1569
16620
125
529
1080
12460
Alcohol dependence continuous use
F10.25 [2000501682]
2.9e+00
2.9e+00
—
1.0e+50
1.0e+50
—
3.2e+00
cases:1.72%
controls:0.10%
cases:0.94%
controls:0.05%
—
—
cases:0.28%
controls:0.00%
cases:0.50%
controls:0.00%
—
—
cases:2.32%
controls:0.10%
31
18
1767
17954
17
9
1782
17973
—
5
0
1794
17982
9
0
1777
17900
—
28
13
1177
12976
Office Visit
OMOP4822458 [581477]
6.6e-01
1.1e+00
2.1e+00
—
2.5e+00
1.6e+00
1.0e+00
cases:15.85%
controls:8.91%
cases:6.17%
controls:2.19%
cases:1.89%
controls:0.24%
—
—
cases:3.75%
controls:0.31%
cases:9.19%
controls:1.96%
cases:14.27%
controls:5.70%
285
1601
1513
16371
111
394
1688
17588
34
43
1765
17939
—
67
56
1719
17844
153
332
1512
16615
172
741
1033
12248
Counselling/guidance promoting independent living
SPAT1222 [2001700323]
7.6e-01
1.2e+00
1.5e+00
1.6e+00
1.5e+00
1.4e+00
9.6e-01
cases:7.56%
controls:3.69%
cases:5.61%
controls:1.79%
cases:3.00%
controls:0.66%
cases:0.94%
controls:0.20%
cases:2.80%
controls:0.64%
cases:6.91%
controls:1.72%
cases:9.21%
controls:3.74%
136
663
1662
17309
101
321
1698
17661
54
118
1745
17864
17
36
1782
17946
50
115
1736
17785
115
292
1550
16655
111
486
1094
12503
Geriatric Medicine
38 [38004478]
5.5e-01
1.3e+00
1.9e+00
—
2.9e+00
1.8e+00
1.0e+00
cases:1.72%
controls:1.00%
cases:2.28%
controls:0.61%
cases:0.61%
controls:0.09%
—
—
cases:1.46%
controls:0.08%
cases:3.84%
controls:0.64%
cases:4.40%
controls:1.61%
31
180
1767
17792
41
110
1758
17872
11
17
1788
17965
—
26
15
1760
17885
64
108
1601
16839
53
209
1152
12780
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
8.2e-01
1.0e+00
1.8e+00
—
3.3e+00
1.2e+00
8.2e-01
cases:10.85%
controls:5.07%
cases:8.84%
controls:3.37%
cases:2.67%
controls:0.47%
—
—
cases:9.24%
controls:0.36%
cases:10.87%
controls:3.68%
cases:21.91%
controls:10.99%
195
911
1603
17061
159
606
1640
17376
48
85
1751
17897
—
165
64
1621
17836
181
623
1484
16324
264
1427
941
11562
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
2.1e-01
4.6e-01
1.1e+00
4.5e+00
1.8e+00
6.4e-01
2.9e-01
cases:55.67%
controls:50.53%
cases:53.25%
controls:41.88%
cases:24.01%
controls:9.59%
cases:28.35%
controls:0.46%
cases:38.30%
controls:9.42%
cases:58.14%
controls:42.39%
cases:71.87%
controls:65.68%
1001
9082
797
8890
958
7530
841
10452
432
1724
1367
16258
510
82
1289
17900
684
1687
1102
16213
968
7183
697
9764
866
8531
339
4458
Platelets [#/volume] in Blood
26515-7 [3007461]
2.1e-01
4.6e-01
1.1e+00
4.5e+00
1.8e+00
6.2e-01
2.9e-01
cases:55.67%
controls:50.44%
cases:53.31%
controls:41.80%
cases:24.01%
controls:9.56%
cases:28.29%
controls:0.46%
cases:38.19%
controls:9.41%
cases:57.84%
controls:42.35%
cases:71.78%
controls:65.54%
1001
9065
797
8907
959
7517
840
10465
432
1719
1367
16263
509
82
1290
17900
682
1685
1104
16215
963
7177
702
9770
865
8513
340
4476
Leukocytes [#/volume] in Blood
26464-8 [3010813]
2.1e-01
4.6e-01
1.1e+00
4.5e+00
1.8e+00
6.3e-01
2.9e-01
cases:55.78%
controls:50.60%
cases:53.36%
controls:41.86%
cases:24.01%
controls:9.59%
cases:28.35%
controls:0.46%
cases:38.19%
controls:9.45%
cases:58.08%
controls:42.44%
cases:71.95%
controls:65.72%
1003
9093
795
8879
960
7528
839
10454
432
1725
1367
16257
510
82
1289
17900
682
1691
1104
16209
967
7192
698
9755
867
8537
338
4452
MCH [Entitic mass]
28539-5 [3035941]
2.1e-01
4.6e-01
1.1e+00
4.5e+00
1.8e+00
6.3e-01
2.9e-01
cases:55.62%
controls:50.51%
cases:53.25%
controls:41.84%
cases:24.01%
controls:9.55%
cases:28.35%
controls:0.46%
cases:38.19%
controls:9.41%
cases:58.02%
controls:42.34%
cases:71.78%
controls:65.63%
1000
9077
798
8895
958
7524
841
10458
432
1717
1367
16265
510
82
1289
17900
682
1685
1104
16215
966
7176
699
9771
865
8525
340
4464
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
2.1e-01
4.6e-01
1.1e+00
4.5e+00
1.8e+00
6.3e-01
2.9e-01
cases:55.67%
controls:50.55%
cases:53.31%
controls:41.84%
cases:24.01%
controls:9.57%
cases:28.35%
controls:0.46%
cases:38.19%
controls:9.41%
cases:58.02%
controls:42.39%
cases:71.78%
controls:65.62%
1001
9084
797
8888
959
7523
840
10459
432
1721
1367
16261
510
82
1289
17900
682
1684
1104
16216
966
7183
699
9764
865
8524
340
4465
Memory disturbance
P20 [2002000816]
6.5e-01
1.1e+00
1.7e+00
1.7e+00
1.7e+00
1.2e+00
9.7e-01
cases:6.17%
controls:3.33%
cases:4.89%
controls:1.66%
cases:1.56%
controls:0.29%
cases:0.44%
controls:0.08%
cases:1.74%
controls:0.34%
cases:5.59%
controls:1.79%
cases:10.46%
controls:4.23%
111
599
1687
17373
88
298
1711
17684
28
53
1771
17929
8
15
1791
17967
31
60
1755
17840
93
304
1572
16643
126
550
1079
12439
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
2.1e-01
4.6e-01
1.1e+00
4.5e+00
1.8e+00
6.3e-01
2.9e-01
cases:55.67%
controls:50.53%
cases:53.31%
controls:41.90%
cases:24.01%
controls:9.58%
cases:28.35%
controls:0.46%
cases:38.19%
controls:9.42%
cases:58.02%
controls:42.40%
cases:71.87%
controls:65.67%
1001
9082
797
8890
959
7535
840
10447
432
1722
1367
16260
510
82
1289
17900
682
1686
1104
16214
966
7186
699
9761
866
8530
339
4459
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
3.0e-01
4.9e-01
1.1e+00
4.3e+00
1.7e+00
6.6e-01
3.3e-01
cases:39.49%
controls:32.49%
cases:36.91%
controls:26.39%
cases:15.62%
controls:5.97%
cases:20.62%
controls:0.34%
cases:25.98%
controls:5.87%
cases:40.90%
controls:26.30%
cases:51.95%
controls:43.84%
710
5840
1088
12132
664
4746
1135
13236
281
1073
1518
16909
371
61
1428
17921
464
1050
1322
16850
681
4457
984
12490
626
5694
579
7295
Alcohol dependence currently abstinent, but staying in restrictive environment
F10.21 [2000501678]
2.5e+00
2.8e+00
—
—
—
—
3.6e+00
cases:0.61%
controls:0.05%
cases:0.56%
controls:0.03%
—
—
—
—
—
—
—
—
cases:1.91%
controls:0.05%
11
9
1787
17963
10
6
1789
17976
—
—
—
—
23
7
1182
12982
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
2.1e-01
4.6e-01
1.1e+00
4.5e+00
1.8e+00
6.3e-01
2.9e-01
cases:55.73%
controls:50.62%
cases:53.36%
controls:41.96%
cases:24.07%
controls:9.63%
cases:28.52%
controls:0.46%
cases:38.19%
controls:9.46%
cases:58.20%
controls:42.48%
cases:71.87%
controls:65.73%
1002
9098
796
8874
960
7545
839
10437
433
1731
1366
16251
513
83
1286
17899
682
1694
1104
16206
969
7199
696
9748
866
8538
339
4451
Epilepsy, unspecified
G40.9 [45562083]
1.6e+00
1.3e+00
—
1.0e+50
2.6e+00
1.8e+00
1.6e+00
cases:1.67%
controls:0.34%
cases:0.67%
controls:0.18%
—
—
cases:0.39%
controls:0.00%
cases:0.45%
controls:0.03%
cases:1.32%
controls:0.23%
cases:2.24%
controls:0.45%
30
62
1768
17910
12
32
1787
17950
—
7
0
1792
17982
8
6
1778
17894
22
39
1643
16908
27
59
1178
12930
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
3.7e-01
6.0e-01
8.6e-01
3.3e+00
2.4e+00
7.8e-01
5.8e-01
cases:44.05%
controls:35.18%
cases:31.63%
controls:20.28%
cases:6.56%
controls:2.90%
cases:1.89%
controls:0.07%
cases:21.67%
controls:2.45%
cases:35.74%
controls:20.29%
cases:59.09%
controls:44.72%
792
6322
1006
11650
569
3646
1230
14336
118
521
1681
17461
34
13
1765
17969
387
439
1399
17461
595
3438
1070
13509
712
5809
493
7180
Assessment of need for services (elderly/care support)
SPAT1217 [2001700318]
7.7e-01
1.4e+00
1.8e+00
—
2.7e+00
1.3e+00
9.5e-01
cases:4.17%
controls:1.98%
cases:2.67%
controls:0.69%
cases:0.83%
controls:0.14%
—
—
cases:1.06%
controls:0.07%
cases:3.66%
controls:1.04%
cases:5.23%
controls:2.09%
75
355
1723
17617
48
124
1751
17858
15
26
1784
17956
—
19
13
1767
17887
61
176
1604
16771
63
272
1142
12717
Other and unspecified convulsions
R56.8 [45602033]
1.4e+00
2.3e+00
—
—
—
2.9e+00
2.3e+00
cases:1.95%
controls:0.48%
cases:1.22%
controls:0.13%
—
—
—
—
—
—
cases:1.98%
controls:0.11%
cases:3.65%
controls:0.39%
35
87
1763
17885
22
23
1777
17959
—
—
—
33
19
1632
16928
44
51
1161
12938
Supine thorax X-ray examination
GD1QA [2001303648]
1.1e+00
1.3e+00
2.2e+00
—
1.8e+00
1.3e+00
1.0e+00
cases:7.06%
controls:2.46%
cases:4.17%
controls:1.15%
cases:1.39%
controls:0.16%
—
—
cases:1.01%
controls:0.16%
cases:5.11%
controls:1.40%
cases:11.20%
controls:4.32%
127
442
1671
17530
75
207
1724
17775
25
28
1774
17954
—
18
29
1768
17871
85
238
1580
16709
135
561
1070
12428
Depressive episode
F32 [45595904]
1.5e+00
1.5e+00
2.9e+00
—
—
1.4e+00
1.4e+00
cases:2.39%
controls:0.53%
cases:0.72%
controls:0.16%
cases:0.50%
controls:0.03%
—
—
—
—
cases:0.78%
controls:0.19%
cases:2.07%
controls:0.51%
43
95
1755
17877
13
29
1786
17953
9
5
1790
17977
—
—
13
32
1652
16915
25
66
1180
12923
Fear of other disease NOS
A27 [2002000161]
9.9e-01
1.3e+00
2.6e+00
—
2.3e+00
1.5e+00
7.2e-01
cases:1.95%
controls:0.73%
cases:0.94%
controls:0.26%
cases:0.39%
controls:0.03%
—
—
cases:0.39%
controls:0.04%
cases:1.14%
controls:0.25%
cases:1.66%
controls:0.82%
35
132
1763
17840
17
46
1782
17936
7
5
1792
17977
—
7
7
1779
17893
19
43
1646
16904
20
106
1185
12883
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
3.6e-01
7.6e-01
1.2e+00
4.0e+00
1.7e+00
6.8e-01
1.6e-01
cases:8.12%
controls:5.80%
cases:6.89%
controls:3.34%
cases:1.83%
controls:0.57%
cases:2.11%
controls:0.04%
cases:3.08%
controls:0.55%
cases:7.51%
controls:3.94%
cases:13.03%
controls:11.29%
146
1042
1652
16930
124
601
1675
17381
33
103
1766
17879
38
7
1761
17975
55
99
1731
17801
125
668
1540
16279
157
1467
1048
11522
Therapeutic discussion
SPAT1240 [2001700341]
1.0e+00
1.5e+00
1.6e+00
—
1.9e+00
1.6e+00
1.1e+00
cases:5.17%
controls:1.88%
cases:2.72%
controls:0.63%
cases:0.83%
controls:0.17%
—
—
cases:1.18%
controls:0.17%
cases:2.94%
controls:0.61%
cases:5.56%
controls:1.93%
93
338
1705
17634
49
113
1750
17869
15
31
1784
17951
—
21
31
1765
17869
49
103
1616
16844
67
251
1138
12738
Body temperature
8310-5 [3020891]
8.9e-01
1.2e+00
2.2e+00
—
2.3e+00
1.4e+00
7.4e-01
cases:2.22%
controls:0.93%
cases:1.78%
controls:0.52%
cases:0.33%
controls:0.04%
—
—
cases:0.50%
controls:0.05%
cases:1.92%
controls:0.48%
cases:3.57%
controls:1.73%
40
167
1758
17805
32
94
1767
17888
6
7
1793
17975
—
9
9
1777
17891
32
81
1633
16866
43
225
1162
12764
biperiden; oral, parenteral
N04AA02 [21604447]
1.8e+00
1.6e+00
2.3e+00
—
—
2.2e+00
3.1e+00
cases:1.06%
controls:0.17%
cases:0.56%
controls:0.11%
cases:0.28%
controls:0.03%
—
—
—
—
cases:0.96%
controls:0.11%
cases:2.74%
controls:0.12%
19
31
1779
17941
10
20
1789
17962
5
5
1794
17977
—
—
16
19
1649
16928
33
16
1172
12973
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]
4.1e-01
6.1e-01
8.3e-01
3.1e+00
2.3e+00
7.8e-01
6.3e-01
cases:34.71%
controls:26.14%
cases:22.96%
controls:13.95%
cases:4.45%
controls:1.99%
cases:1.00%
controls:0.04%
cases:14.56%
controls:1.64%
cases:26.19%
controls:13.94%
cases:48.30%
controls:33.14%
624
4697
1174
13275
413
2508
1386
15474
80
358
1719
17624
18
8
1781
17974
260
294
1526
17606
436
2363
1229
14584
582
4305
623
8684
Other depressive episodes
F32.8 [45571759]
2.0e+00
2.1e+00
—
—
—
2.5e+00
2.1e+00
cases:0.61%
controls:0.08%
cases:0.50%
controls:0.06%
—
—
—
—
—
—
cases:0.36%
controls:0.03%
cases:1.00%
controls:0.12%
11
15
1787
17957
9
11
1790
17971
—
—
—
6
5
1659
16942
12
16
1193
12973
Addiction caused by alcohol UNS
F10.29 [2000501684]
2.9e+00
3.1e+00
—
1.0e+50
—
—
2.7e+00
cases:2.28%
controls:0.12%
cases:0.94%
controls:0.04%
—
—
cases:0.44%
controls:0.00%
—
—
—
—
cases:2.32%
controls:0.16%
41
22
1757
17950
17
8
1782
17974
—
8
0
1791
17982
—
—
28
21
1177
12968
Observation for suspected mental and behavioural disorders
Z03.2 [45552060]
1.6e+00
2.6e+00
—
—
—
2.1e+00
2.5e+00
cases:0.78%
controls:0.16%
cases:0.50%
controls:0.04%
—
—
—
—
—
—
cases:0.42%
controls:0.05%
cases:1.00%
controls:0.08%
14
29
1784
17943
9
7
1790
17975
—
—
—
7
9
1658
16938
12
11
1193
12978
Mental disorder, not otherwise specified
F99 [45605525]
2.4e+00
—
—
1.0e+50
1.0e+50
3.2e+00
3.1e+00
cases:1.28%
controls:0.12%
—
—
—
—
cases:0.44%
controls:0.00%
cases:0.62%
controls:0.00%
cases:1.02%
controls:0.04%
cases:1.49%
controls:0.07%
23
22
1775
17950
—
—
8
0
1791
17982
11
0
1775
17900
17
7
1648
16940
18
9
1187
12980
Procedure duration 10 to 19 minutes
ZXE02 [2001311396]
1.1e+00
2.0e+00
—
1.0e+50
—
2.8e+00
2.7e+00
cases:2.17%
controls:0.74%
cases:1.11%
controls:0.15%
—
—
cases:0.44%
controls:0.00%
—
—
cases:2.46%
controls:0.15%
cases:3.40%
controls:0.24%
39
133
1759
17839
20
27
1779
17955
—
8
0
1791
17982
—
41
25
1624
16922
41
31
1164
12958
Psychiatric pharmacotherapy consultation
IAB01 [2001304018]
2.5e+00
—
—
—
1.0e+50
3.6e+00
2.5e+00
cases:0.56%
controls:0.04%
—
—
—
—
—
—
cases:0.28%
controls:0.00%
cases:1.32%
controls:0.04%
cases:1.16%
controls:0.10%
10
8
1788
17964
—
—
—
5
0
1781
17900
22
6
1643
16941
14
13
1191
12976
selegiline; oral
N04BD01 [21604483]
2.2e+00
2.3e+00
—
—
2.5e+00
1.6e+00
9.0e-01
cases:1.61%
controls:0.18%
cases:1.11%
controls:0.11%
—
—
—
—
cases:0.34%
controls:0.03%
cases:0.54%
controls:0.11%
cases:0.41%
controls:0.17%
29
33
1769
17939
20
20
1779
17962
—
—
6
5
1780
17895
9
18
1656
16929
5
22
1200
12967
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
8.2e-01
1.1e+00
2.0e+00
—
2.0e+00
1.5e+00
1.2e+00
cases:2.78%
controls:1.24%
cases:1.72%
controls:0.59%
cases:0.33%
controls:0.04%
—
—
cases:0.50%
controls:0.07%
cases:2.16%
controls:0.50%
cases:5.23%
controls:1.69%
50
223
1748
17749
31
106
1768
17876
6
8
1793
17974
—
9
12
1777
17888
36
85
1629
16862
63
219
1142
12770
Home Visit
OMOP4822459 [581476]
8.6e-01
1.0e+00
1.3e+00
1.3e+00
1.5e+00
1.4e+00
1.1e+00
cases:20.47%
controls:9.85%
cases:16.29%
controls:6.56%
cases:9.01%
controls:2.59%
cases:4.00%
controls:1.09%
cases:11.59%
controls:2.75%
cases:24.26%
controls:7.32%
cases:34.36%
controls:14.70%
368
1771
1430
16201
293
1179
1506
16803
162
466
1637
17516
72
196
1727
17786
207
493
1579
17407
404
1241
1261
15706
414
1909
791
11080
Syncope and collapse
R55 [45568141]
8.0e-01
1.1e+00
1.9e+00
1.0e+50
2.7e+00
1.0e+00
9.3e-01
cases:3.23%
controls:1.48%
cases:1.22%
controls:0.39%
cases:0.39%
controls:0.06%
cases:0.28%
controls:0.00%
cases:0.56%
controls:0.04%
cases:1.38%
controls:0.50%
cases:3.82%
controls:1.54%
58
266
1740
17706
22
71
1777
17911
7
10
1792
17972
5
0
1794
17982
10
7
1776
17893
23
84
1642
16863
46
200
1159
12789
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
8.2e-01
1.0e+00
2.0e+00
—
2.1e+00
1.4e+00
1.1e+00
cases:2.73%
controls:1.22%
cases:1.67%
controls:0.61%
cases:0.33%
controls:0.04%
—
—
cases:0.56%
controls:0.07%
cases:2.16%
controls:0.53%
cases:5.39%
controls:1.86%
49
220
1749
17752
30
110
1769
17872
6
8
1793
17974
—
10
12
1776
17888
36
89
1629
16858
65
241
1140
12748
Bipolar affective disorder, currently in remission
F31.7 [45581457]
1.9e+00
2.2e+00
—
1.0e+50
—
2.1e+00
2.3e+00
cases:1.22%
controls:0.19%
cases:0.72%
controls:0.08%
—
—
cases:0.28%
controls:0.00%
—
—
cases:0.96%
controls:0.12%
cases:1.99%
controls:0.21%
22
34
1776
17938
13
14
1786
17968
—
5
0
1794
17982
—
16
20
1649
16927
24
27
1181
12962
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
8.1e-01
1.0e+00
2.0e+00
—
2.1e+00
1.4e+00
1.1e+00
cases:2.78%
controls:1.25%
cases:1.72%
controls:0.61%
cases:0.33%
controls:0.04%
—
—
cases:0.56%
controls:0.07%
cases:2.04%
controls:0.54%
cases:5.39%
controls:1.79%
50
225
1748
17747
31
110
1768
17872
6
8
1793
17974
—
10
12
1776
17888
34
91
1631
16856
65
233
1140
12756
Psychosis NOS/other
P98 [2002000879]
1.7e+00
2.9e+00
—
1.0e+50
—
—
3.9e+00
cases:0.44%
controls:0.08%
cases:0.50%
controls:0.03%
—
—
cases:0.33%
controls:0.00%
—
—
—
—
cases:2.24%
controls:0.05%
8
15
1790
17957
9
5
1790
17977
—
6
0
1793
17982
—
—
27
6
1178
12983
CBC panel - Blood by Automated count
58410-2 [40761511]
2.2e-01
3.9e-01
1.1e+00
4.3e+00
1.7e+00
5.6e-01
3.0e-01
cases:47.39%
controls:41.88%
cases:35.24%
controls:26.95%
cases:13.67%
controls:5.19%
cases:16.73%
controls:0.28%
cases:21.56%
controls:4.93%
cases:38.86%
controls:26.59%
cases:58.09%
controls:50.68%
852
7527
946
10445
634
4846
1165
13136
246
934
1553
17048
301
51
1498
17931
385
882
1401
17018
647
4506
1018
12441
700
6583
505
6406
Progressive vascular leukoencephalopathy
I67.3 [45538402]
1.6e+00
2.2e+00
—
1.0e+50
2.5e+00
2.2e+00
1.1e+00
cases:0.50%
controls:0.10%
cases:0.39%
controls:0.04%
—
—
cases:0.33%
controls:0.00%
cases:0.34%
controls:0.03%
cases:0.78%
controls:0.09%
cases:0.58%
controls:0.20%
9
18
1789
17954
7
8
1792
17974
—
6
0
1793
17982
6
5
1780
17895
13
15
1652
16932
7
26
1198
12963
INR in Blood by Coagulation assay
34714-6 [3032080]
6.3e-01
7.6e-01
7.4e-01
3.8e+00
9.6e-01
8.9e-01
6.4e-01
cases:24.42%
controls:14.63%
cases:15.84%
controls:8.11%
cases:5.73%
controls:2.82%
cases:5.61%
controls:0.13%
cases:6.55%
controls:2.61%
cases:17.12%
controls:7.79%
cases:26.80%
controls:16.24%
439
2629
1359
15343
285
1459
1514
16523
103
507
1696
17475
101
23
1698
17959
117
468
1669
17432
285
1321
1380
15626
323
2110
882
10879
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
2.1e-01
3.9e-01
1.2e+00
4.4e+00
1.7e+00
5.5e-01
1.1e-01
cases:41.32%
controls:36.36%
cases:36.30%
controls:27.87%
cases:16.95%
controls:5.89%
cases:19.23%
controls:0.28%
cases:25.59%
controls:6.05%
cases:40.36%
controls:28.12%
cases:50.95%
controls:48.20%
743
6535
1055
11437
653
5011
1146
12971
305
1059
1494
16923
346
50
1453
17932
457
1083
1329
16817
672
4766
993
12181
614
6261
591
6728
Other Alzheimer disease
G30.8 [45605532]
—
8.3e-01
2.5e+00
1.0e+50
3.0e+00
1.8e+00
1.2e+00
—
—
cases:0.44%
controls:0.19%
cases:0.39%
controls:0.03%
cases:0.33%
controls:0.00%
cases:0.56%
controls:0.03%
cases:1.68%
controls:0.29%
cases:2.07%
controls:0.65%
—
8
35
1791
17947
7
6
1792
17976
6
0
1793
17982
10
5
1776
17895
28
49
1637
16898
25
85
1180
12904
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
8.6e-01
1.3e+00
1.6e+00
—
2.0e+00
1.5e+00
1.1e+00
cases:4.23%
controls:1.83%
cases:2.95%
controls:0.82%
cases:0.67%
controls:0.13%
—
—
cases:0.95%
controls:0.13%
cases:3.90%
controls:0.87%
cases:7.55%
controls:2.72%
76
328
1722
17644
53
147
1746
17835
12
24
1787
17958
—
17
23
1769
17877
65
147
1600
16800
91
353
1114
12636
Malaise and fatigue
R53 [45553741]
1.0e+00
1.6e+00
1.9e+00
—
1.6e+00
1.4e+00
9.7e-01
cases:9.40%
controls:3.63%
cases:6.61%
controls:1.46%
cases:1.67%
controls:0.26%
—
—
cases:1.12%
controls:0.23%
cases:6.49%
controls:1.71%
cases:13.69%
controls:5.70%
169
652
1629
17320
119
263
1680
17719
30
47
1769
17935
—
20
41
1766
17859
108
290
1557
16657
165
740
1040
12249
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
X44 [45756400]
2.8e+00
—
—
—
—
2.5e+00
3.0e+00
cases:1.50%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.36%
controls:0.03%
cases:1.58%
controls:0.08%
27
16
1771
17956
—
—
—
—
6
5
1659
16942
19
10
1186
12979
Phosphatidylethanol [Mass/volume] in Blood
74661-0 [44816559]
2.0e+00
2.1e+00
—
—
—
2.6e+00
1.7e+00
cases:2.39%
controls:0.34%
cases:2.11%
controls:0.26%
—
—
—
—
—
—
cases:3.00%
controls:0.22%
cases:5.81%
controls:1.15%
43
61
1755
17911
38
47
1761
17935
—
—
—
50
38
1615
16909
70
150
1135
12839
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
7.5e-01
7.3e-01
1.8e+00
—
3.3e+00
1.4e+00
1.2e+00
cases:3.00%
controls:1.44%
cases:1.28%
controls:0.62%
cases:0.39%
controls:0.07%
—
—
cases:1.01%
controls:0.04%
cases:1.80%
controls:0.46%
cases:5.23%
controls:1.63%
54
258
1744
17714
23
111
1776
17871
7
12
1792
17970
—
18
7
1768
17893
30
78
1635
16869
63
212
1142
12777
Oxygen saturation in Venous blood
2711-0 [3024928]
9.8e-01
1.8e+00
—
1.0e+50
2.6e+00
1.5e+00
1.5e+00
cases:1.17%
controls:0.44%
cases:1.11%
controls:0.18%
—
—
cases:0.33%
controls:0.00%
cases:0.45%
controls:0.03%
cases:0.72%
controls:0.17%
cases:3.07%
controls:0.72%
21
79
1777
17893
20
33
1779
17949
—
6
0
1793
17982
8
6
1778
17894
12
28
1653
16919
37
93
1168
12896
Nursing episode
950 [44777714]
6.8e-01
1.0e+00
1.3e+00
1.6e+00
1.4e+00
1.2e+00
1.0e+00
cases:6.12%
controls:3.20%
cases:5.56%
controls:2.02%
cases:2.83%
controls:0.77%
cases:0.83%
controls:0.16%
cases:3.30%
controls:0.80%
cases:6.97%
controls:2.26%
cases:11.37%
controls:4.43%
110
575
1688
17397
100
363
1699
17619
51
138
1748
17844
15
29
1784
17953
59
144
1727
17756
116
383
1549
16564
137
575
1068
12414
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
8.4e-01
1.3e+00
1.4e+00
1.0e+50
2.3e+00
1.4e+00
1.1e+00
cases:15.24%
controls:7.21%
cases:8.89%
controls:2.64%
cases:1.50%
controls:0.36%
cases:2.56%
controls:0.00%
cases:3.42%
controls:0.34%
cases:9.19%
controls:2.54%
cases:20.58%
controls:8.31%
274
1295
1524
16677
160
474
1639
17508
27
65
1772
17917
46
0
1753
17982
61
61
1725
17839
153
430
1512
16517
248
1079
957
11910
Ammonium ion [Moles/volume] in Plasma
1845-7 [3023183]
1.8e+00
1.8e+00
—
1.0e+50
—
2.7e+00
2.0e+00
cases:1.67%
controls:0.29%
cases:0.78%
controls:0.13%
—
—
cases:0.67%
controls:0.00%
—
—
cases:1.32%
controls:0.09%
cases:2.57%
controls:0.35%
30
52
1768
17920
14
23
1785
17959
—
12
0
1787
17982
—
22
15
1643
16932
31
46
1174
12943
Nonorganic insomnia
F51.0 [45552492]
1.2e+00
1.2e+00
2.3e+00
1.0e+50
1.8e+00
1.2e+00
7.3e-01
cases:5.62%
controls:1.84%
cases:2.72%
controls:0.85%
cases:1.06%
controls:0.11%
cases:0.72%
controls:0.00%
cases:0.73%
controls:0.12%
cases:2.88%
controls:0.91%
cases:5.98%
controls:2.97%
101
331
1697
17641
49
152
1750
17830
19
20
1780
17962
13
0
1786
17982
13
22
1773
17878
48
155
1617
16792
72
386
1133
12603
topiramate; oral
N03AX11 [21604433]
1.3e+00
1.7e+00
2.3e+00
—
—
1.6e+00
1.4e+00
cases:1.17%
controls:0.31%
cases:1.06%
controls:0.19%
cases:0.78%
controls:0.08%
—
—
—
—
cases:1.02%
controls:0.22%
cases:1.74%
controls:0.45%
21
56
1777
17916
19
35
1780
17947
14
14
1785
17968
—
—
17
37
1648
16910
21
59
1184
12930
Unspecified fall
W19 [45756257]
9.3e-01
8.9e-01
2.1e+00
—
1.8e+00
1.3e+00
1.2e+00
cases:3.06%
controls:1.22%
cases:1.00%
controls:0.41%
cases:0.39%
controls:0.05%
—
—
cases:0.45%
controls:0.07%
cases:2.04%
controls:0.55%
cases:5.56%
controls:1.71%
55
220
1743
17752
18
74
1781
17908
7
9
1792
17973
—
8
13
1778
17887
34
94
1631
16853
67
222
1138
12767
Urinary tract infection, site not specified
N39.0 [45548665]
7.5e-01
1.2e+00
2.1e+00
—
2.3e+00
1.2e+00
6.7e-01
cases:5.39%
controls:2.62%
cases:3.34%
controls:1.01%
cases:0.56%
controls:0.07%
—
—
cases:1.23%
controls:0.12%
cases:3.30%
controls:1.07%
cases:6.80%
controls:3.60%
97
470
1701
17502
60
182
1739
17800
10
12
1789
17970
—
22
22
1764
17878
55
181
1610
16766
82
468
1123
12521
Concussion
S06.0 [45582805]
1.2e+00
1.5e+00
2.0e+00
—
2.6e+00
1.7e+00
1.2e+00
cases:4.23%
controls:1.30%
cases:1.61%
controls:0.37%
cases:0.28%
controls:0.04%
—
—
cases:0.39%
controls:0.03%
cases:1.98%
controls:0.36%
cases:4.90%
controls:1.57%
76
233
1722
17739
29
67
1770
17915
5
7
1794
17975
—
7
5
1779
17895
33
61
1632
16886
59
204
1146
12785
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
8.0e-01
1.3e+00
1.4e+00
—
2.5e+00
1.3e+00
1.0e+00
cases:4.28%
controls:1.96%
cases:4.17%
controls:1.17%
cases:0.61%
controls:0.16%
—
—
cases:1.68%
controls:0.15%
cases:4.62%
controls:1.33%
cases:10.79%
controls:4.27%
77
353
1721
17619
75
210
1724
17772
11
28
1788
17954
—
30
26
1756
17874
77
225
1588
16722
130
555
1075
12434
clopenthixol; oral, parenteral
N05AF02 [21604532]
2.7e+00
2.0e+00
—
—
—
2.8e+00
2.7e+00
cases:0.72%
controls:0.05%
cases:0.28%
controls:0.04%
—
—
—
—
—
—
cases:0.60%
controls:0.04%
cases:0.91%
controls:0.06%
13
9
1785
17963
5
7
1794
17975
—
—
—
10
6
1655
16941
11
8
1194
12981
Essential (primary) hypertension
I10 [45591453]
3.1e-01
5.5e-01
9.9e-01
4.5e+00
1.2e+00
6.1e-01
1.6e-01
cases:29.76%
controls:23.68%
cases:18.73%
controls:11.75%
cases:5.56%
controls:2.13%
cases:8.95%
controls:0.11%
cases:7.17%
controls:2.32%
cases:19.82%
controls:11.89%
cases:28.88%
controls:25.78%
535
4255
1263
13717
337
2112
1462
15870
100
383
1699
17599
161
19
1638
17963
128
415
1658
17485
330
2015
1335
14932
348
3348
857
9641
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
2.8e-01
6.4e-01
1.1e+00
4.3e+00
1.4e+00
4.9e-01
1.9e-01
cases:10.34%
controls:8.02%
cases:7.28%
controls:3.97%
cases:1.95%
controls:0.68%
cases:3.17%
controls:0.04%
cases:2.69%
controls:0.67%
cases:6.61%
controls:4.16%
cases:13.53%
controls:11.50%
186
1442
1612
16530
131
714
1668
17268
35
123
1764
17859
57
8
1742
17974
48
120
1738
17780
110
705
1555
16242
163
1494
1042
11495
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
2.9e-01
5.1e-01
8.7e-01
3.7e+00
1.8e+00
6.1e-01
4.0e-01
cases:51.78%
controls:44.43%
cases:44.69%
controls:32.70%
cases:12.84%
controls:5.82%
cases:6.89%
controls:0.19%
cases:26.65%
controls:5.67%
cases:47.21%
controls:32.67%
cases:67.14%
controls:57.73%
931
7985
867
9987
804
5880
995
12102
231
1047
1568
16935
124
34
1675
17948
476
1015
1310
16885
786
5536
879
11411
809
7499
396
5490
Short blood count panel - Blood
55429-5 [40758558]
5.4e-01
5.1e-01
6.9e-01
3.4e+00
1.7e+00
8.6e-01
5.1e-01
cases:11.68%
controls:7.16%
cases:6.06%
controls:3.73%
cases:1.67%
controls:0.85%
cases:0.94%
controls:0.03%
cases:3.86%
controls:0.74%
cases:8.59%
controls:3.82%
cases:13.61%
controls:8.65%
210
1287
1588
16685
109
671
1690
17311
30
152
1769
17830
17
6
1782
17976
69
132
1717
17768
143
647
1522
16300
164
1124
1041
11865
Creatine kinase.MB [Mass/volume] in Serum or Plasma
13969-1 [3005785]
7.8e-01
9.1e-01
2.5e+00
1.0e+50
1.8e+00
1.2e+00
9.9e-01
cases:4.84%
controls:2.28%
cases:2.06%
controls:0.84%
cases:0.83%
controls:0.07%
cases:0.50%
controls:0.00%
cases:0.95%
controls:0.16%
cases:2.46%
controls:0.73%
cases:5.15%
controls:1.98%
87
410
1711
17562
37
151
1762
17831
15
13
1784
17969
9
0
1790
17982
17
29
1769
17871
41
123
1624
16824
62
257
1143
12732
Disturbance of activity and attention
F90.0 [45542870]
1.5e+00
1.4e+00
1.6e+00
1.0e+50
1.5e+00
1.1e+00
9.5e-01
cases:1.56%
controls:0.36%
cases:1.50%
controls:0.37%
cases:0.61%
controls:0.12%
cases:0.67%
controls:0.00%
cases:0.78%
controls:0.17%
cases:1.38%
controls:0.45%
cases:2.41%
controls:0.95%
28
65
1770
17907
27
67
1772
17915
11
22
1788
17960
12
0
1787
17982
14
30
1772
17870
23
76
1642
16871
29
123
1176
12866
Sequelae of cerebral infarction
I69.3 [45533476]
8.0e-01
1.1e+00
1.8e+00
—
1.8e+00
1.5e+00
1.0e+00
cases:2.34%
controls:1.07%
cases:2.17%
controls:0.71%
cases:0.83%
controls:0.13%
—
—
cases:0.78%
controls:0.13%
cases:3.24%
controls:0.74%
cases:4.65%
controls:1.71%
42
192
1756
17780
39
128
1760
17854
15
24
1784
17958
—
14
23
1772
17877
54
125
1611
16822
56
222
1149
12767
fluoxetine; oral
N06AB03 [21604711]
1.3e+00
1.1e+00
1.6e+00
—
1.7e+00
1.4e+00
9.1e-01
cases:3.62%
controls:1.04%
cases:1.72%
controls:0.56%
cases:0.61%
controls:0.12%
—
—
cases:0.56%
controls:0.10%
cases:2.34%
controls:0.57%
cases:2.66%
controls:1.09%
65
187
1733
17785
31
101
1768
17881
11
22
1788
17960
—
10
18
1776
17882
39
96
1626
16851
32
141
1173
12848
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
7.7e-01
8.8e-01
1.7e+00
—
2.4e+00
1.3e+00
1.0e+00
cases:4.95%
controls:2.36%
cases:2.28%
controls:0.96%
cases:0.44%
controls:0.08%
—
—
cases:1.06%
controls:0.10%
cases:2.64%
controls:0.74%
cases:7.14%
controls:2.66%
89
424
1709
17548
41
173
1758
17809
8
14
1791
17968
—
19
18
1767
17882
44
125
1621
16822
86
346
1119
12643
propranolol; oral, parenteral
C07AA05 [21601670]
1.2e+00
1.3e+00
1.7e+00
—
1.2e+00
1.4e+00
1.3e+00
cases:11.18%
controls:3.78%
cases:7.56%
controls:2.09%
cases:2.11%
controls:0.40%
—
—
cases:1.46%
controls:0.44%
cases:7.99%
controls:2.07%
cases:14.36%
controls:4.53%
201
680
1597
17292
136
376
1663
17606
38
72
1761
17910
—
26
79
1760
17821
133
350
1532
16597
173
589
1032
12400
12 lead EKG panel
34534-8 [3044889]
3.9e-01
5.7e-01
8.0e-01
3.4e+00
1.8e+00
7.0e-01
3.9e-01
cases:31.87%
controls:24.05%
cases:19.40%
controls:11.95%
cases:3.28%
controls:1.50%
cases:0.94%
controls:0.03%
cases:7.28%
controls:1.28%
cases:19.94%
controls:11.02%
cases:36.43%
controls:27.89%
573
4322
1225
13650
349
2149
1450
15833
59
270
1740
17712
17
6
1782
17976
130
229
1656
17671
332
1867
1333
15080
439
3623
766
9366
Anxiety disorder/anxiety state
P74 [2002000868]
1.7e+00
2.3e+00
—
—
—
2.3e+00
1.7e+00
cases:1.84%
controls:0.36%
cases:1.45%
controls:0.14%
—
—
—
—
—
—
cases:1.14%
controls:0.11%
cases:2.82%
controls:0.54%
33
64
1765
17908
26
26
1773
17956
—
—
—
19
19
1646
16928
34
70
1171
12919
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
8.0e-01
1.3e+00
1.4e+00
—
2.4e+00
1.3e+00
7.5e-01
cases:4.23%
controls:1.95%
cases:3.61%
controls:1.01%
cases:0.72%
controls:0.17%
—
—
cases:1.62%
controls:0.15%
cases:3.60%
controls:1.01%
cases:7.55%
controls:3.72%
76
350
1722
17622
65
182
1734
17800
13
31
1786
17951
—
29
27
1757
17873
60
171
1605
16776
91
483
1114
12506
Social phobias
F40.1 [45595907]
1.4e+00
1.5e+00
2.2e+00
1.0e+50
—
1.6e+00
1.3e+00
cases:0.89%
controls:0.21%
cases:0.67%
controls:0.14%
cases:0.33%
controls:0.04%
cases:0.28%
controls:0.00%
—
—
cases:0.60%
controls:0.12%
cases:1.16%
controls:0.33%
16
38
1782
17934
12
26
1787
17956
6
7
1793
17975
5
0
1794
17982
—
10
21
1655
16926
14
43
1191
12946
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
1.6e+00
2.1e+00
—
1.0e+50
—
2.7e+00
1.6e+00
cases:3.89%
controls:0.81%
cases:1.72%
controls:0.22%
—
—
cases:1.50%
controls:0.00%
—
—
cases:3.48%
controls:0.24%
cases:3.90%
controls:0.83%
70
145
1728
17827
31
40
1768
17942
—
27
0
1772
17982
—
58
41
1607
16906
47
108
1158
12881
Normoblasts [#/volume] in Blood
715-3 [3021589]
4.6e-01
4.4e-01
7.1e-01
3.6e+00
1.5e+00
7.1e-01
5.3e-01
cases:19.35%
controls:13.18%
cases:14.79%
controls:10.04%
cases:5.06%
controls:2.54%
cases:4.95%
controls:0.14%
cases:9.46%
controls:2.30%
cases:18.56%
controls:10.10%
cases:27.14%
controls:17.91%
348
2369
1450
15603
266
1806
1533
16176
91
457
1708
17525
89
26
1710
17956
169
412
1617
17488
309
1712
1356
15235
327
2326
878
10663
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
7.6e-01
1.2e+00
1.8e+00
—
2.2e+00
1.1e+00
8.0e-01
cases:8.23%
controls:4.01%
cases:7.06%
controls:2.17%
cases:1.61%
controls:0.27%
—
—
cases:3.08%
controls:0.34%
cases:6.37%
controls:2.30%
cases:11.78%
controls:5.64%
148
721
1650
17251
127
391
1672
17591
29
48
1770
17934
—
55
60
1731
17840
106
389
1559
16558
142
733
1063
12256
Supplier / Service Provider
OMOP5117446 [33004]
-3.0e-01
-3.4e-01
-3.4e-01
-1.0e+50
3.1e+00
2.2e+00
2.9e+00
cases:19.80%
controls:25.02%
cases:5.39%
controls:7.41%
cases:0.56%
controls:0.78%
cases:0.00%
controls:0.03%
cases:1.12%
controls:0.05%
cases:5.11%
controls:0.60%
cases:19.25%
controls:1.30%
356
4497
1442
13475
97
1333
1702
16649
10
140
1789
17842
0
5
1799
17977
20
9
1766
17891
85
102
1580
16845
232
169
973
12820
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
7.3e-01
1.2e+00
1.8e+00
—
2.2e+00
1.1e+00
8.2e-01
cases:7.68%
controls:3.86%
cases:7.17%
controls:2.32%
cases:1.72%
controls:0.28%
—
—
cases:3.02%
controls:0.34%
cases:6.97%
controls:2.42%
cases:13.20%
controls:6.26%
138
693
1660
17279
129
418
1670
17564
31
51
1768
17931
—
54
61
1732
17839
116
410
1549
16537
159
813
1046
12176
Atrial fibrillation and flutter
I48 [45596206]
5.4e-01
6.2e-01
8.0e-01
3.8e+00
1.4e+00
6.9e-01
3.2e-01
cases:14.29%
controls:8.86%
cases:8.06%
controls:4.49%
cases:1.89%
controls:0.86%
cases:2.28%
controls:0.05%
cases:3.08%
controls:0.82%
cases:8.41%
controls:4.39%
cases:11.04%
controls:8.27%
257
1592
1541
16380
145
808
1654
17174
34
155
1765
17827
41
9
1758
17973
55
146
1731
17754
140
744
1525
16203
133
1074
1072
11915
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
6.0e-01
1.1e+00
1.4e+00
—
2.7e+00
1.1e+00
9.5e-01
cases:15.02%
controls:8.84%
cases:10.95%
controls:4.10%
cases:2.45%
controls:0.62%
—
—
cases:7.50%
controls:0.54%
cases:11.17%
controls:3.88%
cases:23.57%
controls:10.64%
270
1588
1528
16384
197
737
1602
17245
44
111
1755
17871
—
134
97
1652
17803
186
657
1479
16290
284
1382
921
11607
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
6.6e-01
9.0e-01
1.5e+00
—
2.9e+00
1.1e+00
7.8e-01
cases:21.19%
controls:12.16%
cases:13.23%
controls:5.83%
cases:3.39%
controls:0.76%
—
—
cases:11.25%
controls:0.70%
cases:15.38%
controls:5.84%
cases:30.62%
controls:16.78%
381
2185
1417
15787
238
1048
1561
16934
61
136
1738
17846
—
201
126
1585
17774
256
989
1409
15958
369
2179
836
10810
Acute alcohol abuse
P16 [2002000812]
2.2e+00
2.6e+00
—
—
—
—
3.0e+00
cases:1.45%
controls:0.16%
cases:0.39%
controls:0.03%
—
—
—
—
—
—
—
—
cases:1.74%
controls:0.09%
26
29
1772
17943
7
5
1792
17977
—
—
—
—
21
12
1184
12977
Glucose [Moles/volume] in Cerebral spinal fluid
14744-7 [3020044]
1.4e+00
2.3e+00
—
1.0e+50
—
2.5e+00
1.6e+00
cases:1.28%
controls:0.33%
cases:0.72%
controls:0.07%
—
—
cases:0.28%
controls:0.00%
—
—
cases:1.08%
controls:0.09%
cases:1.33%
controls:0.28%
23
60
1775
17912
13
13
1786
17969
—
5
0
1794
17982
—
18
15
1647
16932
16
36
1189
12953
Administration of medicine
SPAT1254 [2001700355]
7.7e-01
1.1e+00
1.4e+00
1.0e+00
1.2e+00
1.4e+00
8.9e-01
cases:7.68%
controls:3.71%
cases:5.67%
controls:1.89%
cases:3.00%
controls:0.78%
cases:1.11%
controls:0.40%
cases:2.74%
controls:0.87%
cases:6.91%
controls:1.86%
cases:9.29%
controls:4.03%
138
667
1660
17305
102
340
1697
17642
54
140
1745
17842
20
72
1779
17910
49
155
1737
17745
115
316
1550
16631
112
524
1093
12465
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
8.1e-01
1.0e+00
1.8e+00
—
1.7e+00
1.3e+00
1.0e+00
cases:4.00%
controls:1.83%
cases:2.50%
controls:0.90%
cases:0.44%
controls:0.07%
—
—
cases:0.62%
controls:0.11%
cases:3.12%
controls:0.85%
cases:7.39%
controls:2.85%
72
328
1726
17644
45
161
1754
17821
8
13
1791
17969
—
11
20
1775
17880
52
144
1613
16803
89
370
1116
12619
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
8.0e-01
1.0e+00
1.6e+00
—
2.0e+00
1.3e+00
9.2e-01
cases:5.90%
controls:2.74%
cases:3.89%
controls:1.40%
cases:0.83%
controls:0.17%
—
—
cases:1.34%
controls:0.18%
cases:4.50%
controls:1.23%
cases:10.37%
controls:4.43%
106
493
1692
17479
70
252
1729
17730
15
31
1784
17951
—
24
33
1762
17867
75
209
1590
16738
125
575
1080
12414
Oxygen saturation in Arterial blood
2708-6 [3016502]
8.4e-01
1.0e+00
1.7e+00
—
1.8e+00
1.2e+00
1.0e+00
cases:4.51%
controls:2.00%
cases:2.61%
controls:0.97%
cases:0.44%
controls:0.08%
—
—
cases:0.73%
controls:0.12%
cases:3.06%
controls:0.91%
cases:8.05%
controls:3.11%
81
359
1717
17613
47
174
1752
17808
8
14
1791
17968
—
13
21
1773
17879
51
154
1614
16793
97
404
1108
12585
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
8.2e-01
1.3e+00
1.2e+00
—
2.3e+00
1.4e+00
7.6e-01
cases:5.01%
controls:2.26%
cases:4.34%
controls:1.26%
cases:0.78%
controls:0.23%
—
—
cases:1.74%
controls:0.18%
cases:4.68%
controls:1.26%
cases:8.63%
controls:4.24%
90
407
1708
17565
78
227
1721
17755
14
42
1785
17940
—
31
33
1755
17867
78
213
1587
16734
104
551
1101
12438
Leukocytes [#/volume] in Cerebral spinal fluid
26465-5 [3016543]
1.4e+00
2.0e+00
—
—
—
2.6e+00
1.6e+00
cases:1.33%
controls:0.32%
cases:0.72%
controls:0.10%
—
—
—
—
—
—
cases:1.08%
controls:0.08%
cases:1.41%
controls:0.28%
24
57
1774
17915
13
18
1786
17964
—
—
—
18
14
1647
16933
17
36
1188
12953
Outpatient Visit
OP [9202]
5.7e-01
3.3e-01
6.2e-01
3.5e+00
1.0e+00
8.2e-01
8.1e-01
cases:87.04%
controls:79.17%
cases:66.48%
controls:58.84%
cases:19.01%
controls:11.25%
cases:15.12%
controls:0.54%
cases:26.93%
controls:11.74%
cases:73.93%
controls:55.57%
cases:91.12%
controls:81.98%
1565
14228
233
3744
1196
10581
603
7401
342
2023
1457
15959
272
98
1527
17884
481
2102
1305
15798
1231
9417
434
7530
1098
10649
107
2340
Guidance related to psychoactive substances / risk behaviour
SPAT1309 [2001700410]
1.8e+00
2.5e+00
—
—
—
1.9e+00
1.5e+00
cases:1.72%
controls:0.30%
cases:0.83%
controls:0.07%
—
—
—
—
—
—
cases:0.78%
controls:0.11%
cases:1.49%
controls:0.35%
31
54
1767
17918
15
13
1784
17969
—
—
—
13
19
1652
16928
18
45
1187
12944
Base excess in Arterial blood by calculation
1925-7 [3003396]
8.4e-01
1.1e+00
1.6e+00
1.0e+50
1.8e+00
1.3e+00
1.0e+00
cases:5.12%
controls:2.28%
cases:3.00%
controls:1.01%
cases:0.50%
controls:0.11%
cases:0.33%
controls:0.00%
cases:0.78%
controls:0.13%
cases:3.48%
controls:1.01%
cases:8.63%
controls:3.31%
92
410
1706
17562
54
181
1745
17801
9
19
1790
17963
6
0
1793
17982
14
23
1772
17877
58
171
1607
16776
104
430
1101
12559
EKG study
11524-6 [3013512]
1.6e-01
5.2e-01
7.2e-01
4.1e+00
1.6e+00
3.5e-01
3.0e-01
cases:11.96%
controls:10.33%
cases:8.78%
controls:5.42%
cases:1.83%
controls:0.90%
cases:2.33%
controls:0.04%
cases:3.47%
controls:0.73%
cases:7.75%
controls:5.59%
cases:16.27%
controls:12.61%
215
1856
1583
16116
158
974
1641
17008
33
162
1766
17820
42
7
1757
17975
62
130
1724
17770
129
947
1536
16000
196
1638
1009
11351
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
5.4e-01
5.9e-01
7.4e-01
2.6e+00
1.5e+00
8.5e-01
7.5e-01
cases:25.81%
controls:16.83%
cases:16.84%
controls:10.09%
cases:4.95%
controls:2.42%
cases:1.06%
controls:0.08%
cases:9.63%
controls:2.31%
cases:20.36%
controls:9.87%
cases:35.68%
controls:20.73%
464
3025
1334
14947
303
1814
1496
16168
89
436
1710
17546
19
14
1780
17968
172
413
1614
17487
339
1672
1326
15275
430
2693
775
10296
Limited function/disability NOS
A28 [2002000162]
7.7e-01
9.4e-01
1.2e+00
1.3e+00
1.4e+00
1.1e+00
8.3e-01
cases:8.79%
controls:4.28%
cases:7.06%
controls:2.89%
cases:4.17%
controls:1.26%
cases:2.00%
controls:0.54%
cases:5.15%
controls:1.33%
cases:10.09%
controls:3.55%
cases:13.94%
controls:6.63%
158
769
1640
17203
127
519
1672
17463
75
226
1724
17756
36
98
1763
17884
92
238
1694
17662
168
601
1497
16346
168
861
1037
12128
Erythrocytes [#/volume] in Cerebral spinal fluid
26454-9 [3027475]
1.4e+00
2.0e+00
—
—
—
2.6e+00
1.6e+00
cases:1.33%
controls:0.32%
cases:0.72%
controls:0.10%
—
—
—
—
—
—
cases:1.14%
controls:0.09%
cases:1.41%
controls:0.29%
24
57
1774
17915
13
18
1786
17964
—
—
—
19
15
1646
16932
17
38
1188
12951
pH of Venous blood
2746-6 [3012544]
8.2e-01
1.3e+00
1.2e+00
—
2.1e+00
1.4e+00
7.5e-01
cases:5.12%
controls:2.32%
cases:4.22%
controls:1.25%
cases:0.72%
controls:0.22%
—
—
cases:1.51%
controls:0.18%
cases:4.92%
controls:1.23%
cases:8.55%
controls:4.22%
92
417
1706
17555
76
224
1723
17758
13
40
1786
17942
—
27
32
1759
17868
82
209
1583
16738
103
548
1102
12441
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
7.3e-01
1.1e+00
1.9e+00
1.0e+50
2.1e+00
8.9e-01
8.7e-01
cases:7.06%
controls:3.53%
cases:3.45%
controls:1.21%
cases:0.89%
controls:0.13%
cases:0.67%
controls:0.00%
cases:0.95%
controls:0.12%
cases:2.58%
controls:1.07%
cases:7.47%
controls:3.26%
127
635
1671
17337
62
217
1737
17765
16
24
1783
17958
12
0
1787
17982
17
21
1769
17879
43
182
1622
16765
90
424
1115
12565
In Home Supportive Care Agency
253Z00000X [38004206]
1.1e+00
8.9e-01
1.3e+00
1.2e+00
1.3e+00
1.4e+00
1.4e+00
cases:1.84%
controls:0.61%
cases:1.28%
controls:0.53%
cases:1.17%
controls:0.31%
cases:0.56%
controls:0.17%
cases:1.12%
controls:0.30%
cases:2.46%
controls:0.59%
cases:4.32%
controls:1.06%
33
109
1765
17863
23
95
1776
17887
21
56
1778
17926
10
31
1789
17951
20
53
1766
17847
41
100
1624
16847
52
138
1153
12851
General symptom/complaint other
A29 [2002000163]
6.8e-01
6.5e-01
1.0e+00
2.3e+00
1.1e+00
1.0e+00
7.6e-01
cases:4.95%
controls:2.58%
cases:2.39%
controls:1.26%
cases:0.78%
controls:0.28%
cases:0.33%
controls:0.03%
cases:0.78%
controls:0.27%
cases:3.42%
controls:1.25%
cases:7.30%
controls:3.56%
89
464
1709
17508
43
226
1756
17756
14
50
1785
17932
6
6
1793
17976
14
48
1772
17852
57
212
1608
16735
88
462
1117
12527
Paranoid schizophrenia with partial recurrence
F20.04 [2000501924]
1.9e+00
—
—
—
—
2.7e+00
2.9e+00
cases:0.39%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.42%
controls:0.03%
cases:1.00%
controls:0.05%
7
10
1791
17962
—
—
—
—
7
5
1658
16942
12
7
1193
12982
pH of Arterial blood
2744-1 [3019977]
8.5e-01
1.1e+00
1.6e+00
1.0e+50
1.8e+00
1.2e+00
1.0e+00
cases:5.17%
controls:2.28%
cases:3.00%
controls:1.03%
cases:0.50%
controls:0.11%
cases:0.33%
controls:0.00%
cases:0.78%
controls:0.13%
cases:3.42%
controls:1.04%
cases:8.55%
controls:3.33%
93
410
1705
17562
54
185
1745
17797
9
19
1790
17963
6
0
1793
17982
14
23
1772
17877
57
177
1608
16770
103
432
1102
12557
Acute cystitis
N30.0 [45601724]
8.2e-01
1.1e+00
1.8e+00
1.0e+50
1.9e+00
1.2e+00
7.3e-01
cases:6.34%
controls:2.90%
cases:3.34%
controls:1.15%
cases:0.72%
controls:0.12%
cases:1.11%
controls:0.00%
cases:0.84%
controls:0.13%
cases:4.32%
controls:1.32%
cases:8.13%
controls:4.10%
114
521
1684
17451
60
207
1739
17775
13
22
1786
17960
20
0
1779
17982
15
23
1771
17877
72
223
1593
16724
98
532
1107
12457
melatonin; oral
N05CH01 [21604659]
8.7e-01
9.9e-01
1.2e+00
—
1.6e+00
1.5e+00
1.2e+00
cases:7.62%
controls:3.35%
cases:5.73%
controls:2.20%
cases:2.45%
controls:0.72%
—
—
cases:3.70%
controls:0.74%
cases:11.41%
controls:2.67%
cases:17.18%
controls:5.83%
137
602
1661
17370
103
395
1696
17587
44
129
1755
17853
—
66
133
1720
17767
190
452
1475
16495
207
757
998
12232

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
178
174
11.24
162.41
7.5
5.4
368.02
361.16
umol/l
0.20
159
151
232
332
7.87
157.28
5.0
3.1
—
—
—
0
0
951
4417
3.44
145.09
2.2
1.7
19.41
20.11
nmol/l
0.62
864
3695
289
611
5.44
132.13
2.4
1.7
0.32
0.29
mg/l
0.45
158
273
112
72
16.52
130.95
3.2
2.1
—
—
—
0
0
1315
7747
3.58
130.09
8.3
7.3
1.21
1.21
mmol/l
0.84
1182
6651
914
4406
3.18
126.22
3.5
2.1
272.35
231.87
u/l
0.52
878
4152
1210
6897
3.30
123.90
7.9
6.8
1.21
1.21
mmol/l
1.56
1149
6345
633
2684
3.09
105.64
2.0
1.8
1178.01
1169.18
nmol/l
0.08
488
2024
262
623
4.75
103.30
4.9
2.2
—
—
—
0
0
1142
6749
2.89
100.94
2.8
2.1
93.18
95.66
pmol/l
1.02
687
3524
237
533
4.97
99.85
6.1
3.1
—
—
—
0
0
958
5317
2.71
93.19
3.2
3.4
2.35
2.36
mmol/l
1.35
871
4796
870
4613
2.71
92.61
4.2
4.2
7.40
7.40
ph
2.38
649
3310
1114
6780
2.68
88.08
5.1
5.1
34.97
35.35
g/l
1.37
1045
6352
268
733
4.12
87.52
4.9
2.2
—
—
—
0
0
863
4683
2.62
85.85
3.7
2.5
53.36
79.38
u/l
0.88
800
4323
1223
7877
2.72
84.77
7.2
6.4
10.95
12.14
umol/l
2.68
1168
7481
1323
8898
2.83
83.49
7.6
5.1
6.59
6.74
mmol/l
1.70
1290
8372
905
5087
2.57
82.73
4.7
3.4
—
—
—
0
0
273
788
3.90
82.47
4.9
2.2
—
—
—
0
0
273
796
3.86
81.24
4.9
2.2
—
—
—
0
0
271
791
3.86
80.48
4.9
2.2
—
—
—
0
0
811
4410
2.53
78.44
5.0
4.2
—
—
—
0
0
79
70
11.76
76.33
12.7
11.1
0.60
0.63
mmol/l
0.42
71
62
864
4887
2.48
76.07
4.7
3.2
40.94
34.44
u/l
0.57
823
4603
1102
6961
2.50
75.96
18.1
16.2
1.27
1.29
inr
0.50
938
5776
144
275
5.60
72.54
2.0
3.4
29.84
35.04
umol/l
2.00
122
252
259
786
3.68
72.31
4.7
2.1
—
—
—
0
0
862
5002
2.39
69.98
4.9
3.3
48.70
88.66
e6/l
1.23
693
3804
1513
11350
3.08
69.86
10.1
8.0
81.62
80.78
u/l
0.29
1450
10701
1402
10120
2.74
69.61
8.1
4.8
3193.37
2058.51
e6/l
0.20
30
155
71
67
10.99
65.73
5.3
3.8
167.47
121.26
umol/l
0.58
36
42
1509
11457
2.95
65.05
5.8
4.3
14.90
14.92
pmol/l
0.12
1411
10401
1168
7959
2.33
62.20
9.3
6.5
0.19
0.19
e9/l
0.09
1003
6893
1060
6943
2.28
62.00
2.8
2.5
71.91
77.08
nmol/l
7.21
966
6232
398
1690
2.74
61.99
4.7
3.9
5.90
5.85
kpa
0.43
382
1643
759
4336
2.30
61.86
2.7
2.4
3.01
2.88
mg/l
0.63
660
3721
1142
7721
2.31
61.78
9.2
6.2
0.04
0.04
e9/l
0.48
959
6595
755
4325
2.28
60.89
4.6
3.2
0.50
0.44
e6/l
0.39
583
3181
1137
7713
2.28
60.42
9.2
6.2
0.60
0.59
e9/l
1.56
954
6579
395
1695
2.70
60.09
4.6
4.0
7.38
7.38
ph
0.15
216
1000
354
1436
2.82
60.04
4.2
3.5
4.52
4.51
kpa
0.05
338
1395
1323
9605
2.42
59.33
6.2
3.2
50.90
48.29
u/l
0.46
1270
8984
1150
7907
2.26
58.13
9.2
6.3
1.90
1.90
e9/l
0.06
990
6927
380
1630
2.69
57.63
4.7
4.0
2.06
1.77
mmol/l
0.88
342
1392
402
1776
2.63
57.43
6.8
8.0
1.24
0.94
mmol/l
0.77
344
1456
1228
8701
2.29
57.26
15.8
9.3
4.42
4.15
e9/l
3.19
1044
7541
347
1439
2.75
56.12
6.7
7.8
1.37
1.35
mmol/l
0.07
341
1413
843
5178
2.18
55.90
7.5
6.4
—
—
—
0
0
903
5736
2.15
54.48
6.3
3.8
96.30
81.04
ng/l
0.09
709
4115
905
5779
2.14
53.56
6.0
3.9
117.13
128.03
e6/l
0.10
697
4008
395
1784
2.55
53.55
7.1
8.1
7.42
7.41
ph
0.52
230
966
543
2832
2.31
53.41
5.3
3.7
495.81
460.90
ng/l
0.05
427
2227
367
1611
2.60
52.71
7.1
8.4
95.41
95.38
%
0.03
358
1553
513
2635
2.32
52.11
4.1
2.9
1.94
1.24
e6/l
0.79
292
1381
75
103
7.55
51.94
2.6
1.4
1.23
1.33
promille
0.17
58
83
1052
7166
2.12
51.89
8.9
6.5
8.79
8.90
%
0.54
993
6701
1049
7142
2.12
51.76
8.9
6.4
2.66
2.79
%
1.15
992
6677
623
3479
2.21
51.60
3.6
2.7
7.32
6.21
e6/l
1.07
576
3159
390
1790
2.50
50.85
6.9
8.1
5.16
5.13
kpa
0.18
375
1712
389
1790
2.50
50.39
6.9
8.1
11.48
12.12
kpa
1.82
374
1717
1043
7137
2.10
50.12
9.0
6.5
0.65
0.66
%
0.34
987
6676
1065
7355
2.10
49.79
8.9
6.4
26.92
27.43
%
0.76
1010
6971
494
2541
2.30
49.67
3.2
3.5
0.80
0.82
mmol/l
2.39
457
2393
1047
7194
2.09
49.51
8.8
6.3
57.48
57.59
%
0.11
1005
6863
341
1489
2.59
49.24
7.5
8.8
121.98
119.75
g/l
1.23
334
1448
559
3070
2.19
47.58
3.1
3.0
2.46
2.46
mmol/l
0.40
493
2744
1631
13566
3.13
47.19
7.7
5.2
1.93
1.96
mu/l
0.35
1543
12476
1408
10966
2.30
46.39
5.1
4.3
13.78
12.91
mm/h
1.28
1329
10183
325
1425
2.56
46.32
7.9
8.9
—
—
—
0
0
576
3255
2.13
45.15
1.9
1.8
13996383.04
31655915.08
pmol/l
0.53
493
2682
253
991
2.81
45.05
4.4
4.4
24.69
24.09
mmol/l
2.72
248
984
468
2439
2.24
45.00
4.3
3.0
4.37
2.65
e6/l
2.50
237
1176
955
6489
2.00
44.86
5.2
3.6
6.36
6.26
ph
1.85
532
3576
547
3042
2.15
44.61
3.9
2.9
515.37
533.03
mosm/kgh2o
0.99
482
2654
429
2169
2.28
44.30
2.1
2.5
29.79
29.72
s
0.09
420
2106
109
251
4.56
43.93
1.2
1.5
3.63
3.75
mmol/l
0.73
100
239
470
2483
2.21
43.50
2.4
2.5
2.36
2.31
g/l
0.93
421
2276
493
2662
2.17
43.14
2.5
2.6
11.17
12.58
umol/l
4.64
454
2466
115
282
4.29
42.76
1.2
1.5
477.22
527.54
mg/l
0.54
109
272
248
993
2.74
42.21
3.9
3.3
128.50
127.16
g/l
0.42
242
966
1120
8187
1.97
41.01
6.1
4.0
0.01
0.01
estimate
0.13
244
1726
606
3602
2.03
40.63
6.3
4.1
1.02
1.02
kg/l
1.35
443
2339
1109
8125
1.95
39.78
6.1
4.0
0.06
5.48
estimate
1.76
251
1828
1099
8034
1.94
39.61
6.0
4.0
0.00
0.00
estimate
0.50
248
1791
411
2132
2.20
39.34
4.5
6.0
1.04
1.06
mmol/l
0.79
383
1976
1695
14762
3.50
38.24
35.6
19.0
139.56
139.54
mmol/l
0.13
1679
14436
104
259
4.20
37.86
1.2
1.6
1070.97
1259.59
e6/l
0.08
78
199
429
2295
2.14
37.79
2.5
2.6
19.85
22.22
%
2.93
388
2123
103
255
4.22
37.79
1.2
1.6
17.18
66.36
e6/l
0.80
76
189
1695
14780
3.47
37.78
35.5
19.2
3.95
3.97
mmol/l
3.98
1679
14423
93
220
4.40
36.19
1.2
1.6
—
—
—
0
0
39
37
10.75
35.84
1.0
1.0
703.47
567.13
ng/l
0.90
30
16
1607
13718
2.58
35.59
6.5
5.0
6.04
5.93
mmol/l
2.59
1491
12463
696
4503
1.89
35.22
8.7
6.2
—
—
—
0
0
363
1870
2.18
34.93
2.4
2.8
1.79
1.77
%
0.13
314
1666
38
37
10.47
34.30
1.0
1.0
302.39
249.50
ng/l
0.69
31
16
294
1410
2.30
33.59
2.1
2.1
395.46
390.18
nmol/l
0.14
274
1293
311
1531
2.25
33.36
2.1
2.4
0.20
0.20
g/l
0.69
287
1430
940
6790
1.80
32.42
17.3
11.5
0.00
0.00
e9/l
0.18
761
5529
293
1424
2.26
32.35
4.9
7.3
7.95
10.18
mmol/l
7.84
278
1365
221
948
2.52
32.34
7.5
6.9
25.01
24.38
mmol/l
1.63
212
899
1667
14635
2.86
32.07
30.4
15.9
22.72
25.56
mg/l
3.72
1507
12123
294
1439
2.25
31.89
3.6
2.4
29.48
69.43
u/l
0.63
258
1216
720
4822
1.82
31.79
3.7
3.4
1308.09
1574.33
ng/l
1.71
613
4175
107
314
3.56
30.85
1.9
1.3
—
—
—
0
0
261
1237
2.30
30.49
2.9
2.3
6.57
7.43
ug/l
0.25
221
1068
144
514
2.96
30.09
2.4
1.7
631.17
283.51
mu/l
6.75
132
459
328
1718
2.11
29.83
2.9
2.9
8.11
8.78
umol/l
0.26
265
1506
119
382
3.26
29.80
2.8
3.7
60.53
60.19
%
0.05
114
377
583
3746
1.82
28.88
5.8
4.3
86.66
88.25
%
0.79
565
3661
973
7278
1.73
28.13
3.5
3.1
137.12
120.60
ug/l
0.44
899
6762
569
3671
1.80
27.56
5.6
3.9
0.20
0.08
—
5
49
253
1234
2.22
27.44
3.2
2.4
0.37
0.63
e6/l
1.11
244
1176
749
5246
1.73
27.16
4.3
3.5
6.89
7.38
mmol/l
2.14
646
4425
34
9
38.49
27.13
3.9
1.8
—
—
—
0
0
203
926
2.34
25.74
7.4
10.1
24.88
24.28
mmol/l
1.62
197
904
1539
13343
2.05
25.53
7.7
6.3
39.33
39.23
mmol/mol
0.16
1441
12402
332
1841
1.98
25.50
2.0
1.7
—
—
—
0
0
28
27
10.52
25.38
2.8
2.0
15.89
16.26
umol/l
0.05
28
27
137
523
2.75
25.22
4.8
3.8
1.37
1.39
mmol/l
0.05
132
515
1702
15446
2.84
24.21
36.5
20.7
76.83
78.05
umol/l
0.89
1688
15232
823
6080
1.65
23.30
6.4
4.0
2.49
0.39
estimate
0.40
202
1471
656
4575
1.68
23.20
6.4
4.1
0.00
0.01
estimate
1.54
230
1636
271
1444
2.03
23.13
2.2
2.8
69.85
68.66
e9/l
0.23
189
1077
1682
15275
2.52
22.09
17.2
11.6
26.08
25.42
u/l
0.72
1651
14807
52
117
4.55
21.57
1.3
1.9
—
—
—
0
0
51
116
4.50
20.87
1.2
1.8
—
—
—
0
0
112
426
2.74
20.75
5.2
6.7
1.28
1.35
mmol/l
0.42
102
365
494
3277
1.70
20.62
1.9
1.8
1.18
1.36
mg/l
0.57
387
2505
155
696
2.34
20.27
4.9
5.2
1.72
1.53
%
1.38
145
653
179
855
2.21
20.22
8.2
10.8
16.36
15.72
%
2.39
174
818
160
734
2.29
19.91
4.5
3.1
25.43
25.29
mmol/l
0.19
153
706
309
1815
1.85
19.52
2.0
1.6
—
—
—
0
0
312
1860
1.82
18.73
5.3
3.1
4.71
4.97
e9/l
0.26
266
1597
208
1086
2.03
18.60
5.0
4.3
5.31
5.15
kpa
1.60
199
1043
204
1063
2.04
18.33
4.9
4.3
7.42
7.41
ph
0.54
179
894
1638
14986
2.02
16.64
26.0
14.3
—
—
—
0
0
71
240
3.04
16.33
1.2
1.1
—
—
—
0
0
1573
14224
1.83
16.27
6.3
5.5
2.55
2.67
mmol/l
6.34
1460
13127
220
1225
1.91
16.26
3.2
3.4
192.44
249.59
ng/l
1.64
198
1117
77
284
2.79
15.16
6.2
8.4
11.69
11.19
mmol/l
0.60
71
250
77
284
2.79
15.16
6.2
8.4
105.87
105.11
mmol/l
0.70
71
250
149
742
2.10
15.08
2.6
2.0
—
—
—
0
0
136
654
2.17
15.06
1.8
1.9
1.32
1.48
ug/l
0.09
117
578
340
2204
1.67
14.89
2.2
2.0
—
—
—
0
0
577
4242
1.53
14.81
4.2
3.1
0.14
0.06
0.25
14
142
1705
15945
2.29
14.58
46.7
24.0
247.57
250.58
e9/l
1.10
1680
15602
132
636
2.16
14.54
5.4
5.5
0.90
0.88
%
0.22
123
594
1705
15949
2.28
14.50
46.5
24.0
91.25
90.88
fl
2.52
1692
15757
1705
15951
2.28
14.46
46.5
23.9
30.22
30.22
pg
0.05
1692
15756
1705
15951
2.28
14.46
47.4
24.5
39.34
40.22
%
2.31
1694
15749
1705
15951
2.28
14.46
46.6
24.0
4.37
4.47
e12/l
12.21
1671
15557
1387
12247
1.58
14.35
37.5
19.4
13.94
13.65
%
11.59
1375
12069
1705
15958
2.27
14.32
47.1
24.2
130.76
133.99
g/l
15.93
1693
15768
657
4993
1.50
14.27
2.8
2.5
—
—
—
0
0
216
1248
1.83
14.16
3.2
3.9
78.95
90.97
ng/l
1.47
175
1063
1473
13209
1.63
14.10
4.6
4.1
1.36
1.28
mmol/l
3.65
1348
12044
1704
15959
2.25
14.05
46.9
24.0
7.10
6.82
e9/l
6.22
1671
15565
165
883
1.96
13.67
2.9
3.4
4.33
4.56
pmol/l
2.01
146
788
53
168
3.22
13.62
2.3
1.6
650.30
346.19
mu/l
1.27
43
137
1539
13987
1.69
13.59
5.6
4.8
4.38
4.58
mmol/l
11.99
1432
12971
22
15
14.83
13.58
1.1
1.7
—
—
—
0
0
1529
13883
1.67
13.42
5.4
4.7
1.38
1.46
mmol/l
11.59
1413
12779
18
7
25.95
13.37
1.3
1.6
24.27
66.04
nmol/l
—
18
7
115
543
2.19
13.33
3.6
3.1
25.82
24.88
mmol/l
1.62
110
535
51
161
3.23
13.20
2.6
4.0
9.99
10.54
%
0.32
51
161
218
1291
1.78
13.14
3.9
3.7
1.23
1.23
mmol/l
0.10
187
1098
39
1197
0.31
13.01
1.2
1.3
—
—
—
0
0
87
372
2.41
12.72
1.7
1.3
—
—
—
0
0
66
247
2.74
12.68
1.1
1.1
—
—
—
0
0
427
3029
1.54
12.59
2.7
2.1
—
—
—
0
0
77
313
2.53
12.55
1.5
1.5
50.00
59.94
mmol/l
1.51
60
252
92
412
2.30
12.12
2.9
3.4
3.38
2.68
index
0.14
53
211
205
1223
1.76
12.02
1.9
1.5
—
—
—
0
0
20
15
13.47
11.94
1.2
1.5
—
—
—
0
0
91
410
2.28
11.83
2.4
1.9
—
—
—
0
0
861
7094
1.41
11.35
3.0
2.8
—
—
estimate
—
0
0
82
360
2.34
11.33
5.3
3.9
—
—
—
0
0
211
1323
1.67
10.30
5.7
4.6
0.07
0.12
%
0.48
57
334
207
1298
1.67
10.09
2.1
2.9
65.93
66.09
g/l
0.09
177
1194
220
1402
1.65
10.08
5.4
4.3
0.86
0.94
%
0.15
76
427
224
1443
1.63
9.82
2.4
2.1
0.00
0.02
estimate
0.78
40
309
51
194
2.68
9.56
18.6
5.9
6.73
7.17
mmol/l
0.49
43
164
103
533
1.99
9.43
1.9
3.7
33.15
55.79
mg/l
1.80
89
463
451
3403
1.43
9.39
7.0
4.6
—
—
—
0
0
470
3582
1.42
9.24
1.4
1.4
1.55
1.78
u/ml
0.16
114
944
258
1748
1.56
9.13
1.5
1.5
—
—
—
0
0
102
533
1.97
9.09
1.9
3.7
36.93
164.95
mg/l
0.69
88
460
68
1399
0.47
9.03
1.9
1.9
3.75
3.55
ratio
0.47
54
1067
72
331
2.22
8.98
5.9
4.3
2.57
2.84
mmol/l
0.31
48
219
84
412
2.09
8.91
4.0
3.4
0.83
0.84
nmol/l
0.06
68
345
206
1335
1.61
8.80
4.9
4.1
0.53
0.68
%
0.57
72
399
25
66
3.83
8.52
1.2
1.3
148.20
139.45
nmol/l
0.30
25
66
605
4871
1.36
8.43
4.0
4.2
8.16
9.77
mg/mmol
0.54
385
3060
206
1349
1.60
8.42
5.5
4.3
0.18
0.12
%
0.29
62
372
78
381
2.09
8.38
2.7
2.4
129.15
128.13
g/l
0.13
60
309
45
1052
0.41
8.33
1.5
1.7
3.75
3.50
mmol/l
0.45
29
722
15
14
10.79
8.29
3.9
1.1
—
—
—
0
0
552
4396
1.37
8.19
5.5
3.5
1.28
0.21
estimate
0.39
196
1405
274
1925
1.50
8.15
1.3
1.2
—
—
—
0
0
184
1186
1.61
8.03
2.6
3.0
10.94
10.89
g/l
0.05
158
1079
11
5
22.12
8.01
2.2
1.8
231.44
369.40
ug/l
—
11
5
108
602
1.84
7.95
4.2
2.3
2962.93
4996.35
u/l
0.31
30
250
589
4757
1.35
7.94
3.3
3.5
39.02
51.05
mg/l
1.23
396
3086
127
746
1.76
7.86
1.6
1.9
1.54
1.56
g/l
0.10
104
651
214
1441
1.55
7.75
4.8
4.4
7.38
7.35
ph
1.26
165
1032
34
117
2.94
7.72
1.2
1.3
33.43
36.44
mmol/l
0.27
29
103
130
778
1.72
7.54
1.3
1.2
—
—
—
0
0
84
439
1.96
7.53
1.3
1.4
281.94
284.83
ug/g
0.04
43
260
90
487
1.89
7.28
1.9
3.5
1.33
4.12
ratio
1.50
55
283
107
616
1.78
7.11
5.3
4.8
25.04
24.69
mmol/l
0.60
101
578
126
761
1.71
7.08
2.4
2.4
—
—
—
0
0
12
10
12.07
7.08
5.1
3.2
—
—
—
0
0
406
3142
1.38
7.05
1.5
1.5
2.66
2.37
g/l
1.58
213
1924
420
5274
0.73
6.95
3.8
3.1
—
—
—
0
0
21
57
3.72
6.92
3.0
2.2
60.29
49.61
umol/l
0.93
21
51
471
3755
1.34
6.72
2.8
2.9
346.57
346.74
umol/l
0.01
392
3310
24
73
3.32
6.70
1.1
1.3
0.48
0.55
ratio
1.07
16
35
330
2491
1.40
6.62
2.2
1.7
—
—
—
0
0
123
756
1.67
6.50
5.1
4.6
—
—
—
0
0
127
791
1.65
6.38
1.3
1.3
79.43
58.73
au/ml
—
6
61
18
36
5.04
6.18
1.6
1.2
—
—
—
0
0
41
175
2.37
6.16
1.4
1.5
279.46
278.95
mosm/kgh2o
0.04
24
125
13
478
0.27
6.13
1.2
1.1
1.59
1.51
g/l
0.26
13
478
28
101
2.80
5.90
1.0
1.0
—
—
—
0
0
264
1957
1.41
5.85
2.2
2.6
184.86
130.92
ug/g
1.53
207
1548
89
516
1.76
5.82
2.3
2.7
—
—
—
0
0
22
595
0.36
5.75
1.6
1.6
—
—
—
0
0
91
533
1.74
5.75
1.9
2.9
20.18
21.22
s
1.66
85
487
177
1220
1.50
5.75
4.4
2.8
6.11
6.11
ph
0.01
138
848
74
410
1.84
5.63
1.7
2.0
2.76
18.27
iu/l
0.58
30
167
46
216
2.16
5.56
4.2
6.1
13.05
11.96
mg/l
0.52
40
202
92
547
1.72
5.53
2.2
2.7
11.15
10.69
g/l
0.24
79
487
92
554
1.70
5.29
1.3
1.2
—
—
—
0
0
133
878
1.56
5.29
2.5
2.4
20.33
20.88
au/ml
—
6
87
112
1708
0.63
5.23
1.4
1.5
—
—
—
0
0
265
2006
1.38
5.17
1.4
1.3
417.60
517.05
titre
0.44
50
421
22
75
2.96
5.15
3.8
2.7
—
—
—
0
0
32
133
2.43
5.14
2.0
2.6
20.48
22.47
nmol/l
0.32
26
123
26
100
2.62
4.90
2.3
2.4
6.93
8.41
mmol/l
1.91
26
100
174
1237
1.45
4.86
1.3
1.2
—
—
—
0
0
18
491
0.36
4.84
1.4
1.2
1.03
0.90
g/l
0.80
18
491
82
491
1.70
4.84
1.5
1.3
173.96
231.60
miu/ml
0.67
19
240
667
5775
1.25
4.70
1.9
1.9
1.52
1.35
mmol/l
3.39
561
4851
37
172
2.18
4.64
1.4
1.6
22.82
31.14
ng/l
0.56
37
172
19
64
2.99
4.56
1.3
5.7
67.40
76.22
mg/l
—
10
50
65
373
1.77
4.48
1.6
1.6
18355.90
14508.20
e6/l
0.20
41
274
46
242
1.92
4.18
1.1
1.1
6.13
136.16
iu/ml
—
10
50
57
326
1.77
4.00
2.6
2.2
0.94
0.86
nmol/l
0.28
46
272
38
190
2.02
3.99
1.4
1.6
—
—
—
0
0
38
190
2.02
3.99
1.4
1.6
—
—
—
0
0
38
190
2.02
3.99
1.4
1.6
—
—
—
0
0
38
190
2.02
3.99
1.4
1.6
—
—
—
0
0
71
433
1.67
3.97
1.3
1.3
62.00
86.49
titre
—
5
37
144
1032
1.43
3.89
1.3
1.2
101.00
138.08
u/ml
0.51
40
401
45
242
1.88
3.85
1.2
1.8
0.51
0.88
g/l
3.01
35
192
133
950
1.43
3.67
1.7
1.9
1.09
1.48
g/l
2.49
116
864
82
531
1.57
3.63
1.2
1.2
0.69
0.89
u/ml
—
10
38
71
449
1.61
3.48
1.5
1.6
7.35
7.95
u/l
0.22
60
344
67
418
1.63
3.47
1.2
1.3
—
5.94
—
0
7
11
309
0.35
3.25
1.5
1.5
—
—
—
0
0
107
753
1.45
3.23
2.2
2.1
0.00
1.08
estimate
0.51
33
235
36
193
1.88
3.16
1.3
1.3
0.17
0.46
nmol/l
—
7
14
106
748
1.44
3.16
1.2
1.2
134.00
163.33
titre
—
5
18
110
783
1.43
3.13
5.5
3.6
1.02
1.02
ratio
0.04
101
716
170
1301
1.34
3.13
6.4
4.1
—
—
—
0
0
68
438
1.57
3.12
13.6
10.9
—
—
—
0
0
25
118
2.13
3.10
1.0
1.2
—
—
—
0
0
45
261
1.74
3.08
1.4
1.4
—
—
—
0
0
42
239
1.78
3.07
2.0
2.1
1.09
0.88
%
1.14
30
169
24
117
2.07
2.77
1.4
1.4
30.24
32.97
%
0.13
14
77
13
312
0.41
2.75
1.5
1.6
—
—
—
0
0
31
167
1.87
2.72
1.6
1.4
19.24
19.96
u/l
0.05
25
142
13
48
2.72
2.72
1.4
1.3
66.18
113.76
nmol/l
—
5
37
8
19
4.22
2.68
1.4
1.3
54.75
68.26
ug/l
—
8
19
34
193
1.78
2.55
1.2
1.3
3.42
5.29
u/ml
0.44
19
92
125
947
1.34
2.50
1.2
1.2
—
—
—
0
0
196
1581
1.27
2.48
1.3
1.4
—
—
—
0
0
26
137
1.91
2.46
1.2
1.3
2.65
2.84
g/l
0.22
19
99
26
137
1.91
2.46
1.2
1.3
6.02
7.00
g/l
0.90
19
100
26
137
1.91
2.46
1.2
1.3
0.40
0.43
g/l
0.11
19
97
26
138
1.90
2.41
1.2
1.3
—
—
—
0
0
12
46
2.62
2.36
2.3
2.8
0.60
0.62
mmol/l
0.33
12
46
19
91
2.10
2.33
1.2
1.3
—
—
—
0
0
26
140
1.87
2.32
2.2
2.3
—
—
—
0
0
73
512
1.44
2.32
1.5
1.7
47.74
13.92
u/ml
—
7
116
54
356
1.53
2.31
3.0
2.9
55.21
57.96
%
0.83
54
356
32
185
1.74
2.29
1.4
1.4
300.52
321.46
pmol/l
0.19
27
161
181
1465
1.26
2.24
1.8
1.6
—
—
—
0
0
5
9
5.57
2.21
3.6
1.0
2.12
2.03
nmol/l
—
5
9
16
73
2.20
2.21
1.0
1.1
—
—
—
0
0
10
35
2.87
2.21
1.0
1.1
—
14.67
%
—
0
6
15
67
2.25
2.17
1.7
2.3
1.79
1.99
umol/l
0.64
15
60
23
123
1.88
2.12
1.5
1.2
98.30
107.83
pmol/l
0.37
23
123
72
514
1.42
2.11
4.4
4.9
1.38
1.53
mg/l
1.03
67
468
12
49
2.46
2.10
1.2
1.1
0.53
16.54
u/ml
—
5
30
204
1688
1.24
2.09
2.1
1.9
—
—
—
0
0
13
56
2.33
2.05
1.0
1.4
161.38
163.12
mmol/24h
0.02
13
56
6
15
4.01
2.04
4.2
8.0
0.13
0.19
%
—
6
15
427
3793
1.16
2.01
5.2
5.5
1.88
3.14
ug/l
2.94
370
3421
74
536
1.40
2.01
1.6
1.5
18.60
20.97
iu/l
0.27
54
438
27
156
1.74
1.97
1.6
1.7
—
—
—
0
0
16
77
2.09
1.96
1.0
1.3
0.87
1.12
nmol/l
—
8
49
27
159
1.71
1.85
1.3
1.3
—
—
nmol/l
—
0
0
24
137
1.76
1.83
1.4
1.3
22714.94
95936.73
e6/l
0.79
17
93
119
945
1.28
1.77
1.4
1.3
179.53
341.83
u/ml
0.78
112
875
6
18
3.34
1.74
3.0
1.2
3.27
5.47
nmol/l
—
6
18
38
250
1.53
1.71
2.9
3.6
0.77
1.70
%
2.30
31
226
0
46
0.00
1.70
0.0
2.8
—
43.33
—
0
46
0
46
0.00
1.70
0.0
5.7
—
7.85
—
0
46
10
41
2.45
1.64
1.1
1.4
27.80
28.46
s
—
10
41
10
42
2.39
1.61
1.4
1.1
—
—
—
0
0
10
42
2.39
1.61
1.1
1.6
78.90
99.40
nmol/24h
—
10
42
15
275
0.54
1.60
1.1
1.1
—
—
—
0
0
15
275
0.54
1.60
1.1
1.1
—
—
—
0
0
6
20
3.01
1.58
1.3
1.5
—
—
—
0
0
11
51
2.16
1.50
1.7
1.6
2.18
2.31
%
0.04
11
42
85
667
1.29
1.43
1.2
1.3
—
—
—
0
0
55
406
1.37
1.41
1.3
1.1
—
—
—
0
0
26
165
1.58
1.40
1.3
1.6
62.00
58.41
%
0.14
11
113
48
351
1.38
1.32
1.4
1.6
—
—
—
0
0
16
91
1.77
1.29
1.6
1.7
76.98
109.22
ng/l
1.38
16
91
8
35
2.29
1.27
1.3
1.3
—
—
—
0
0
13
70
1.86
1.24
1.2
1.0
1726.08
1574.26
miu/ml
0.22
13
70
5
19
2.64
1.21
1.0
1.1
—
—
—
0
0
5
19
2.64
1.21
3.2
1.8
2.20
2.29
%
—
5
19
52
400
1.31
1.07
1.2
1.2
—
—
—
0
0
24
161
1.50
1.07
1.1
1.2
—
—
—
0
0
71
571
1.25
1.04
3.7
3.4
367.23
382.20
mg/l
0.04
31
259
24
162
1.49
1.04
1.8
1.5
—
—
—
0
0
13
75
1.74
1.02
1.7
2.4
29.50
29.02
umol/l
0.08
13
68
73
591
1.25
1.02
1.6
1.7
4.04
7.88
iu/ml
0.78
16
134
30
214
1.41
1.00
4.0
2.9
—
—
—
0
0
52
406
1.29
0.98
7.3
4.5
—
—
—
0
0
283
2573
1.12
0.97
1.4
1.3
23.37
33.28
iu/ml
1.23
74
771
23
157
1.47
0.96
2.1
2.3
0.86
1.48
u/field
0.96
14
83
25
174
1.44
0.95
1.6
1.4
65791.00
67556.07
e6/l
0.01
18
101
20
133
1.51
0.94
2.6
2.3
575.90
1091.54
mg
1.32
20
133
15
93
1.62
0.94
2.3
2.8
16.29
16.44
%
0.07
15
93
198
1766
1.14
0.93
5.0
4.7
31.38
32.74
%
0.96
138
1143
46
357
1.30
0.92
5.2
3.7
33.33
26.64
mg/l
0.57
36
262
600
5675
1.09
0.91
2.1
2.2
—
—
—
0
0
15
94
1.60
0.90
1.3
1.4
7.19
7.40
ph
—
10
66
28
202
1.39
0.89
1.1
1.2
—
—
—
0
0
42
329
1.28
0.81
2.4
2.4
206.64
99.11
ug/min
0.43
23
200
10
60
1.67
0.72
1.3
1.3
—
1.92
—
0
13
10
60
1.67
0.72
1.1
1.8
38.56
40.47
g/l
—
10
60
13
194
0.67
0.71
2.2
1.6
—
—
—
0
0
470
4449
1.08
0.70
1.4
1.5
—
—
—
0
0
5
27
1.85
0.68
1.6
1.1
—
—
—
0
0
206
2250
0.90
0.68
3.3
3.2
0.68
0.79
ug/l
1.00
144
1422
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
258
2390
1.09
0.65
1.4
1.3
17.05
12.85
u/ml
0.32
91
893
22
293
0.75
0.65
1.2
1.1
0.68
1.62
u/ml
0.77
15
138
19
137
1.39
0.64
1.2
1.2
—
326.00
—
0
5
41
333
1.24
0.62
1.3
1.5
—
—
—
0
0
5
30
1.67
0.61
1.8
1.7
—
—
—
0
0
15
105
1.43
0.60
1.2
1.0
—
—
—
0
0
10
64
1.57
0.58
1.1
1.1
589.90
218.53
iu/ml
—
10
64
26
202
1.29
0.57
1.8
1.4
40336.30
1647.64
e6/l
0.58
20
146
11
161
0.68
0.57
1.0
1.1
—
—
—
0
0
128
1155
1.12
0.56
2.4
2.2
11.04
13.01
nmol/l
1.52
113
1047
11
73
1.51
0.56
1.6
1.4
—
—
—
0
0
12
82
1.47
0.54
1.4
2.9
1233.67
1359.15
u/ml
0.09
12
82
15
205
0.73
0.54
1.1
1.1
0.46
0.27
u/ml
—
9
72
51
599
0.85
0.53
1.1
1.1
—
—
—
0
0
22
283
0.77
0.53
1.3
1.1
0.28
1.90
u/ml
3.04
13
157
6
39
1.54
0.53
1.2
1.5
—
—
—
0
0
6
40
1.50
0.51
1.8
1.3
138.00
138.43
mmol/l
—
6
30
23
179
1.29
0.51
2.1
2.4
0.40
1.32
g/24h
—
9
108
21
162
1.30
0.50
2.7
2.3
—
—
—
0
0
20
154
1.30
0.48
1.2
2.1
—
—
—
0
0
18
234
0.77
0.48
1.2
1.1
1.07
4.61
u/ml
—
10
125
37
308
1.21
0.48
1.4
1.5
169.67
139.57
au/ml
0.81
12
83
67
588
1.14
0.47
2.8
3.3
45.43
6946.74
u/ml
0.87
56
512
24
299
0.80
0.47
1.3
1.1
3.18
6.31
u/ml
1.03
18
178
12
87
1.38
0.42
1.1
1.8
—
—
—
0
0
5
32
1.56
0.42
6.4
5.4
8.90
8.50
mmol/l
—
5
32
10
139
0.72
0.42
1.1
1.3
—
—
—
0
0
5
33
1.52
0.41
1.4
2.3
—
—
—
0
0
170
1588
1.08
0.40
3.3
4.2
5.75
21.72
ug/l
2.15
139
1331
9
66
1.37
0.38
1.8
2.7
9.89
12.72
%
—
9
61
9
66
1.37
0.38
1.1
1.2
—
—
—
0
0
5
36
1.39
0.38
1.2
1.6
5.64
9.15
mmol/l
—
5
36
26
215
1.21
0.38
3.8
2.8
—
—
—
0
0
8
113
0.71
0.37
1.1
1.1
—
—
—
0
0
31
262
1.19
0.37
1.3
1.2
25.04
39.97
u/l
0.48
24
224
19
234
0.81
0.36
1.1
1.2
—
—
—
0
0
85
775
1.10
0.35
2.3
3.8
37.08
77.96
u/ml
1.76
79
755
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
147
1374
1.08
0.35
1.4
1.5
—
—
—
0
0
18
144
1.25
0.35
1.4
1.2
—
—
—
0
0
119
1280
0.92
0.34
1.5
1.4
—
—
—
0
0
19
154
1.24
0.34
1.2
1.1
—
—
—
0
0
21
173
1.22
0.33
2.7
3.5
58.19
56.86
%
0.12
16
151
7
53
1.32
0.30
1.3
1.5
2.99
3.23
mmol/l
—
7
48
29
336
0.86
0.30
1.3
1.2
0.77
3.28
u/ml
3.08
19
189
10
75
1.34
0.30
4.6
7.7
4.58
242.98
ug/l
—
5
53
13
102
1.28
0.30
2.1
2.2
757.29
431.55
e6/l
—
7
80
13
102
1.28
0.30
1.6
2.3
944.50
647.12
ml
—
6
65
8
110
0.73
0.29
1.3
1.2
—
—
—
0
0
21
176
1.20
0.29
1.2
1.2
—
—
—
0
0
206
1967
1.05
0.28
1.3
1.3
—
—
—
0
0
56
613
0.91
0.26
1.4
1.3
—
—
—
0
0
20
172
1.16
0.22
1.5
1.4
—
—
—
0
0
17
199
0.85
0.21
1.0
1.1
3.02
2.18
eliau/ml
—
5
82
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
3.4
—
—
—
0
0
0
12
0.00
0.21
0.0
4.4
—
2.76
—
0
5
0
12
0.00
0.21
0.0
1.0
—
0.52
—
0
6
8
105
0.76
0.21
1.1
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
0.21
—
0
5
17
145
1.17
0.20
1.0
1.1
—
—
—
0
0
15
127
1.18
0.19
2.5
1.9
42.15
38.30
%
0.43
15
127
6
51
1.18
0.19
1.0
1.4
—
—
—
0
0
7
61
1.15
0.17
2.3
4.0
—
—
—
0
0
16
138
1.16
0.17
2.4
2.3
—
—
—
0
0
5
66
0.76
0.17
1.0
1.2
10.20
8.29
mm/h
—
5
66
21
186
1.13
0.17
1.4
1.4
—
—
—
0
0
19
215
0.88
0.16
1.2
1.1
2.49
6.41
u/ml
1.23
12
104
9
81
1.11
0.15
2.1
1.4
5.52
7.10
u/l
—
9
66
39
363
1.08
0.14
1.5
1.3
284.16
255.52
u/ml
0.25
25
205
33
356
0.93
0.13
1.2
1.3
—
—
—
0
0
12
104
1.15
0.12
2.6
2.4
229.43
186.05
e6/l
—
7
85
10
86
1.16
0.11
1.1
1.2
0.40
2.33
u/ml
—
5
37
19
208
0.91
0.10
1.1
1.3
—
—
—
0
0
10
87
1.15
0.09
2.0
3.6
0.80
0.89
index
—
10
87
11
124
0.89
0.09
1.3
1.5
—
—
—
0
0
6
56
1.07
0.08
1.2
1.1
—
—
—
0
0
20
216
0.93
0.08
1.9
2.6
4.13
9.69
umol/l
1.34
15
164
6
58
1.03
0.08
1.2
1.6
—
—
—
0
0
17
185
0.92
0.08
1.3
1.2
—
—
—
0
0
7
64
1.09
0.08
1.0
2.9
18.93
145.00
ug/l
—
7
56
7
64
1.09
0.08
2.3
3.9
—
—
—
0
0
8
74
1.08
0.07
1.1
1.7
—
—
—
0
0
25
237
1.06
0.05
1.7
2.2
—
9.33
—
0
6
15
139
1.08
0.05
1.9
2.1
1922.22
1043.22
e6/l
—
9
118
16
150
1.07
0.04
2.9
3.6
12.70
12.33
index
—
10
87
17
162
1.05
0.02
1.2
1.1
—
—
—
0
0
48
489
0.98
0.02
1.1
1.1
—
—
—
0
0
39
398
0.98
0.01
1.5
1.2
2.66
2.78
u/ml
—
7
36
17
163
1.04
0.01
1.2
1.2
—
—
—
0
0
18
185
0.97
0.00
1.9
1.8
—
—
—
0
0
21
205
1.02
0.00
1.1
1.2
—
—
—
0
0
16
157
1.02
0.00
2.6
2.9
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
5
51
0.98
-0.00
3.6
2.6
9.70
9.68
mg/l
—
5
45
5
53
0.94
-0.00
1.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
51
0.98
-0.00
1.4
1.7
18.60
29.63
%
—
5
51
0
7
0.00
-0.00
0.0
4.3
—
104.14
—
0
7
0
7
0.00
-0.00
0.0
1.0
—
160.14
—
0
7
5
52
0.96
-0.00
1.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_OTHER_SYMPTOMS_SIGNS_INVOLVI_GENERAL_SENSA_PERCEP – Other symptoms and signs involving general sensations and perceptions

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).